100706-药理学

肿瘤药理

1986-10--1991-10 日本国立九州大学 获博士学位
1980-09--1983-08 中国医科大学 获硕士学位
1975-11--1978-09 江西医学院 学习

-- 研究生

-- 博士

   

2005-01--2012-01 新药研究国家重点实验室 主任/研究员
2001-01--2003-01 国家新药筛选中心 主任/研究员
1996-08--2004-11 中科院上海药物研究所 副所长/研究员
1994-02--今 中科院上海药物研究所 课题组组长/研究员
1992-02--1994-02 中科院上海药物研究所 博士后
1991-11--1992-01 日本国立九州大学 访问学者
1978-10--1986-09 江西医学院 教师
1969-09--1975-09 江西省崇仁县插队落户 知识青年

2012-01--今 Molecular Pharmacology，编委
2009-11--今 Journal of Biological Chemistry，编委
2007-05--今 中国药理学会肿瘤药理专业委员会，主任委员
2007-05--今 中国抗癌协会抗癌药物专业委员会，主任委员
2007-01--今 Journal of Ethnopharmacology，编委
2007-01--今 Cancer Biology & Therapy，编委
2007-01--今 中国药理协会，常务理事
2007-01--今 中国抗癌协会，常务理事
2007-01--今 中国药学会，常任理事
2007-01--今 European Journal of Pharmacology，编委
2006-01--今 Acta Pharmacologica Sinica，主编

   

（1） 国家自然科学奖，二等奖，国家级，2013
（2） 上海市自然科学一等奖，一等奖，省级，2010
（3） 国家自然科学奖二等奖，二等奖，国家级，2009
（4） 上海市自然科学一等奖，一等奖，省级，2007

[1] 胡有洪, 陈奕, 谢志铖, 丁健, 李欣, 方艳芬, 沈倩倩. 含2-芳杂环取代的脲类化合物、其制备方法和用途. CN115703738A, 2023-02-17.
[2] 胡有洪, 陈奕, 张卓, 方艳芬, 蒋婧升, 沈倩倩, 龙国璋, 丁健, 陈五红. 去唾液酸糖蛋白受体配体与细胞毒素的偶联物及其应用. 202310079838.3, 2023-01-17.
[3] 胡有洪, 耿美玉, 李大强, 沈爱军, 张卓, 李亚磊, 杨华杰, 刘红椿, 钟韩悦, 丁健. 含S构型的氨基苯甲酰胺基哒嗪酮类化合物、其制备方法、药物组合物及应用. CN114957132A, 2022-08-30.
[4] 胡有洪, 陈奕, 曾艳萍, 丁健, 肖剑. 一种蛋白降解剂及其制备方法和用途. 2022105722297, 2022-05-24.
[5] 丁健, 段文虎, 谢华, 耿美玉, 王彩霞, 詹正生, 高娜, 张阳. CSF1R激酶抑制剂及其用途. CN: CN114246864A, 2022-03-29.
[6] 王春河, 耿美玉, 谢作权, 王艳菲, 许慧, 陈艺丽, 黄承浩, 罗文新, 夏宁邵, 丁健. 一种靶向HER2和PD-1的双特异性抗体及其应用. CN: CN111995685B, 2022-03-08.
[7] 耿美玉, 孙广强, 王薪懿, 张靖, 冯腾, 丁健. 甘露糖醛酸寡糖治疗Th1主导相关疾病的用途. CN: CN113924100A, 2022-01-11.
[8] 耿美玉, 孙广强, 王薪懿, 张靖, 冯腾, 丁健. 用于识别阿尔茨海默病患者中的糖类药物敏感性患者的方法. CN: CN113891730A, 2022-01-04.
[9] 耿美玉, 孙广强, 王薪懿, 张靖, 冯腾, 丁健. 通过调节氨基酸水平治疗阿尔茨海默病的方法. CN: CN113891716A, 2022-01-04.
[10] 耿美玉, 孙广强, 王薪懿, 张靖, 冯腾, 丁健. 通过调节肠道微生物治疗阿尔茨海默病的方法. CN: CN113874039A, 2021-12-31.
[11] 耿美玉, 孙广强, 王薪懿, 张靖, 冯腾, 丁健. 通过抑制T细胞摄取氨基酸治疗阿尔茨海默病的方法. CN: CN113874038A, 2021-12-31.
[12] 张翱, 耿美玉, 艾菁, 王彩霞, 彭霞, 张阳, 丁健. 一种CSF-1R激酶抑制剂的用途. CN: CN113318110A, 2021-08-31.
[13] 张翱, 耿美玉, 宋子兰, 谢作权, 丁健, 张燕, 顾王婷, 王玺渊. 一类杂环取代的苯并咪唑二聚体或其药学上可接受的盐、组合物及其用途. CN: CN113248475A, 2021-08-13.
[14] 丁克, 丁健, 陆小云, 耿美玉, 李姗, 谢华, 陈灏, 童林江, 任小梅, 冯芳. 2-氨基嘧啶类化合物及其应用. CN: CN113166110A, 2021-07-23.
[15] 张翱, 耿美玉, 宋子兰, 谢作权, 丁健, 张燕, 顾王婷, 王玺渊. 一类苯并咪唑二聚体、其制备方法及用途. CN: CN113087668A, 2021-07-09.
[16] 周兵, 耿美玉, 高愚哲, 谢作权, 杨亚玺, 王玺渊, 张燕, 丁健. 一种杂环化合物及其用途. CN: CN112940004A, 2021-06-11.
[17] 段文虎, 耿美玉, 詹正生, 谢作权, 赵凯燕, 郭玉婷, 王玺渊, 张燕, 周晓倩, 丁健. 五元杂环氧代羧酸类化合物及其医药用途. CN: CN112724127A, 2021-04-30.
[18] 段文虎, 丁健, 陈运, 谢华, 张惠斌, 周金培. 一类IRAK4激酶抑制剂及其制备和应用. CN: CN112480101A, 2021-03-12.
[19] 段文虎, 耿美玉, 张贺峰, 丁健, 艾菁, 彭霞, 季寅淳. 具有Axl与c-Met激酶抑制活性的化合物及其制备和应用. CN: CN112457295A, 2021-03-09.
[20] 丁克, 耿美玉, 陈成斌, 丁健, 谈理, 艾菁, 张章, 彭霞, 任小梅, 季寅淳, 涂正超, 戴阳, 陆小云. 喹啉或喹唑啉类化合物及其应用. CN: CN112351971A, 2021-02-09.
[21] 丁克, 耿美玉, 陈成斌, 丁健, 谈理, 艾菁, 张章, 彭霞, 任小梅, 季寅淳, 段云鑫, 戴阳, 涂正超, 陆小云. 3-氨基吡唑类化合物及其应用. CN: CN112313213A, 2021-02-02.
[22] 柳红, 耿美玉, 周宇, 丁健, 方非非, 艾菁, 李建, 彭霞, 蒋华良, 季寅淳, 陈凯先. 一类并环吡唑啉酮甲酰胺类化合物及其制备方法、药物组合物和用途. CN: CN112236430A, 2021-01-15.
[23] 李洪林, 丁健, 徐玉芳, 谢华, 李倩男, 张弢, 赵振江. 喹唑啉类化合物作为EGFR三突变抑制剂及其应用. CN: CN112236422A, 2021-01-15.
[24] 胡有洪, 耿美玉, 陈菁菁, 沈爱军, 谢志铖, 刘红椿, 曾丽敏, 李亚磊, 彭润泽, 张敏敏, 张婕, 丁健. 一种吡咯并吡啶酮类化合物、其制备方法、其组合物和用途. CN: CN112094266A, 2020-12-18.
[25] 张翱, 丁健, 谢华, 宋子兰, 薛宇, 邢莉, 童林江, 耿美玉. 嘧啶并5,4-b吡呤化合物、其光学异构体、制备方法及用途. CN: CN111848634A, 2020-10-30.
[26] 李波, 谢华, 刘鹏, 童林江, 周云飞, 张勇, 徐志建, 施菊妹, 朱维良, 丁健. 芳基酮酰胺类化合物及其制备方法和用途. CN: CN111825605A, 2020-10-27.
[27] 夏林, 耿美玉, 叶艳, 丁健, 张琼, 沈爱军, 黄颖, 刘红椿, 杨浩然, 艾菁, 张敏敏. 具有BET抑制活性的化合物及其制备方法和用途. CN: CN111683932A, 2020-09-18.
[28] 胡有洪, 丁健, 唐炜, 谢华, 谢志铖, 童林江, 任文明, 高远卓. 邻氨基吡啶炔类化合物及其制备方法和用途. CN: CN111662227A, 2020-09-15.
[29] 杨春皓, 缪泽鸿, 陈旭星, 宦霞娟, 王玉勤, 谭村, 陈奕. 2-取代苯并咪唑-4-甲酰胺类化合物及制备方法和应用. CN: CN107922430B, 2020-09-04.
[30] 耿美玉, 丁健, 艾菁. 癌症患者根据脾酪氨酸激酶进行分层. CN: CN111521810A, 2020-08-11.
[31] 张翱, 耿美玉, 丁春勇, 谢作权, 丁健, 张燕, 沈安成, 王玺渊. 一类含氟取代的苯并噻吩类化合物及其药物组合物及应用. CN: CN111393405A, 2020-07-10.
[32] 段文虎, 丁健, 陈运, 谢华, 张惠斌, 周金培. 一类FLT3激酶抑制剂及其制备和应用. CN: CN111217816A, 2020-06-02.
[33] 丁克, 丁健, 申佳奕, 耿美玉, 陆小云, 谢华, 孙敏, 宗在伟. 嘧啶并吡啶酮或者吡啶并吡啶酮类化合物及其应用. CN: CN110914267A, 2020-03-24.
[34] 耿美玉, 丁健, 黄洵. EZH2异常相关癌症的治疗. CN: CN110856720A, 2020-03-03.
[35] 耿美玉, 辛现良, 张真庆, 丁健. 甘露糖醛二酸的组合物在治疗炎症中的应用. CN: CN110652525A, 2020-01-07.
[36] 耿美玉, 辛现良, 杜晓光, 张真庆, 丁健. 甘露糖醛二酸的组合物在治疗血管性痴呆症中的应用. CN: CN110652523A, 2020-01-07.
[37] 耿美玉, 张真庆, 晋迎申, 肖中平, 丁健. 褐藻胶寡糖二酸的组合物. CN: CN110652517A, 2020-01-07.
[38] 耿美玉, 辛现良, 杜晓光, 张真庆, 丁健. 甘露糖醛二酸的组合物在治疗帕金森氏症中的应用. CN: CN110652516A, 2020-01-07.
[39] 耿美玉, 辛现良, 张真庆, 丁健. 甘露糖醛二酸的组合物在治疗糖尿病中的应用. CN: CN110652526A, 2020-01-07.
[40] 耿美玉, 辛现良, 张真庆, 丁健. 甘露糖醛二酸的组合物在治疗疼痛中的应用. CN: CN110652524A, 2020-01-07.
[41] 胡有洪, 耿美玉, 任文明, 丁健, 官晓聪, 艾菁, 王浪, 彭霞, 刘杨, 戴阳, 曾丽敏. 含邻氨基杂芳环炔基的化合物及其制备方法和用途. CN: CN110582483A, 2019-12-17.
[42] 柳红, 耿美玉, 周宇, 丁健, 方非非, 艾菁, 李建, 彭霞, 蒋华良, 季寅淳, 陈凯先. 一类并环吡唑啉酮甲酰胺类化合物及其制备方法、药物组合物和用途. CN: CN110511218A, 2019-11-29.
[43] 赵玉军, 陈德恒, 郭德祥, 严子琴, 周飞龙, 耿美玉, 丁健, 沈爱军, 刘红椿, 张敏敏. 一种BRD4抑制剂及其制备和应用. CN: CN110506044A, 2019-11-26.
[44] 陈庆财, 丁健, 丁克, 金雪锋, 耿美玉, 谢华. 一种2-氨基嘧啶类化合物的药用组合物及其制备方法. CN: CN110446701A, 2019-11-12.
[45] 熊兵, 耿美玉, 郭祖浩, 黄洵, 沈竞康, 丁健, 杨红, 张竹青, 陈丹琦. 一类精氨酸甲基转移酶抑制剂及其药物组合物和用途. CN: CN110343095A, 2019-10-18.
[46] 丁克, 丁健, 李姗, 谢华, 陆小云, 耿美玉, 任小梅, 童林江. 2-氨基嘧啶类化合物及其应用. CN: CN110305161A, 2019-10-08.
[47] 张翱, 耿美玉, 宋子兰, 艾菁, 顾王婷, 刘博, 丁健. 一类芳基二氟苄基醚类化合物、制备方法及用途. CN: CN110240587A, 2019-09-17.
[48] 陈旭星, 耿美玉, 赵兆, 陈奕, 黄颖, 丁健, 张琼, 沈倩倩, 苏毅. 嘧啶并五元芳香杂环类化合物、其制备方法及用途. CN: CN110229157A, 2019-09-13.
[49] 陈旭星, 陈奕, 黄颖, 耿美玉, 张琼, 丁健, 姚虞财, 沈倩倩, 沈雁雁. 吲嗪类化合物、其制备方法及用途. CN: CN110229151A, 2019-09-13.
[50] 谭村, 张小飞, 杨春皓, 缪泽鸿, 宋姗姗, 宦霞娟, 陈奕, 丁健. 酞嗪酮类衍生物、其制备方法和用途. CN: CN110194762A, 2019-09-03.
[51] 张翱, 蒙凌华, 丁健, 陈树伦, 丁春勇, 郭伟. 含杂环侧链的噁二唑衍生物、合成方法及其应用. CN: CN110143955A, 2019-08-20.
[52] 耿美玉, 沈爱军, 刘红椿, 张敏敏, 丁健. 治疗肝癌的药物组合和方法. CN: CN110063956A, 2019-07-30.
[53] 段文虎, 耿美玉, 王蔚, 丁健, 艾菁, 许丹丹, 彭霞, 曹素芬, 季寅淳. 一种具有AXL抑制活性的化合物及其制备和应用. CN: CN110036014A, 2019-07-19.
[54] 南发俊, 丁健, 耿美玉, 陈奕, 胡有洪, 陈悦婷, 徐济民, 刘桦楠. EZH2抑制剂及其制备和抗肿瘤治疗中的应用. CN: CN110016014A, 2019-07-16.
[55] 张翱, 丁健, 谢华, 宋子兰, 薛宇, 童林江, 耿美玉. 嘧啶并5,4-b吲嗪或嘧啶并5,4-b吡呤化合物、其制备方法及用途. CN: CN109983016A, 2019-07-05.
[56] 李磊, 耿美玉, 黄颖, 丁健, 张琼, 黄敏, 唐帅, 沈宁, 陈奕. 具有ERK激酶抑制活性的化合物及其用途. CN: CN109863147A, 2019-06-07.
[57] 丁克, 寻秋菊, 丁健, 陆小云, 谢华, 张章, 耿美玉, 任小梅, 童林江. 嘧啶并嘧啶酮类化合物及其应用. CN: CN109836427A, 2019-06-04.
[58] 陈旭星, 耿美玉, 江磊, 陈奕, 曹建华, 蒋青云, 沈倩倩, 丁健, 姚虞财, 赵兆, 熊远芳. 吡啶并五元芳香环类化合物、其制备方法及用途. CN: CN109790160A, 2019-05-21.
[59] 南发俊, 李佳, 丁健, 耿美玉, 张仰明, 陈奕, 周宇波, 龚超骏, 苏明波, 高安慧. 一类芳基2,2’-串联双噻唑类化合物及其制备方法和用途. CN: CN109641888A, 2019-04-16.
[60] 段文虎, 耿美玉, 王玉明, 艾菁, 范珺, 戴阳, 丁健. 一种具有FGFR抑制活性的新型化合物及其制备和应用. CN: CN109328187A, 2019-02-12.
[61] 段文虎, 耿美玉, 王玉明, 艾菁, 范珺, 戴阳, 丁健. 一种具有FGFR抑制活性的新型化合物及其制备和应用. CN: CN109328187A, 2019-02-12.
[62] 杨玉社, 钮奥, 汪洋, 谢华, 丁健. 新型嘧啶并杂环类化合物及制备方法和用途. CN: CN109305967A, 2019-02-05.
[63] 胡有洪, 耿美玉, 段文文, 丁健, 万鹏辉, 沈爱军, 陆栋, 刘红椿, 魏爱环, 张敏敏, 曾丽敏, 曹靖晨. 一种哒嗪酮母核结构的组蛋白去乙酰化酶抑制剂及其制备方法和用途. CN: CN109280032A, 2019-01-29.
[64] 杨春皓, 缪泽鸿, 陈建阳, 宦霞娟, 丁健, 陈奕, 谭村, 贺茜. 吡咯1,2-b哒嗪类化合物或其可药用盐及它们的用途. CN: CN109232575A, 2019-01-18.
[65] 杨春皓, 缪泽鸿, 谭村, 宦霞娟, 丁健, 陈奕. 盐酸美呋哌瑞多晶型物及其制备方法与应用. CN: CN109134409A, 2019-01-04.
[66] 杨春皓, 蒙凌华, 向皞月, 李京, 王祥, 谭村, 贺茜, 丁健, 陈奕. 7-位取代吡咯并三嗪类化合物或其药学上可用的盐，及其制备方法和用途. CN: CN109111447A, 2019-01-01.
[67] 段文虎, 耿美玉, 詹正生, 艾菁, 丁健. 氘代SGX523及其用途. CN: CN108864101A, 2018-11-23.
[68] 李洪林, 丁健, 徐玉芳, 谢华, 赵振江, 陈海洋, 刁妍妍. 作为BTK抑制剂的杂环化合物及其应用. CN: CN108727382A, 2018-11-02.
[69] 李洪林, 丁健, 徐玉芳, 谢华, 赵振江, 陈海洋, 刁妍妍. 作为布鲁顿酪氨酸激酶抑制剂的嘧啶并杂环化合物及其应用. CN: CN108721298A, 2018-11-02.
[70] 赵玉军, 陈德恒, 郭德祥, 严子琴, 周飞龙, 耿美玉, 丁健, 沈爱军, 刘红椿, 张敏敏. 一种BRD4抑制剂及其制备和应用. CN: CN108727380A, 2018-11-02.
[71] 张翱, 耿美玉, 邢莉, 艾菁, 宋子兰, 彭霞, 顾王婷, 丁健. 一类取代的氨基六元氮杂环类化合物及其制备和用途. CN: CN108699030A, 2018-10-23.
[72] 沈竞康, 丁健, 耿美玉, 熊兵, 艾菁, 马宇驰, 戴阳. 五元杂环并吡嗪化合物、制备方法、中间体、组合和应用. CN: CN108570052A, 2018-09-25.
[73] 沈竞康, 丁健, 耿美玉, 熊兵, 艾菁, 马宇驰, 戴阳. 五元并六元杂环化合物、制备方法、中间体、组合和应用. CN: CN108570053A, 2018-09-25.
[74] 陈庆财, 丁健, 丁克, 金雪锋, 耿美玉, 谢华. 一种2-氨基嘧啶类化合物的药用组合物及其制备方法. CN: CN108498477A, 2018-09-07.
[75] 丁克, 耿美玉, 谈理, 丁健, 张章, 艾菁, 任小梅, 高冬林, 涂正超, 陆小云, 张冬梅. 取代喹诺酮类衍生物或其药学上可接受的盐或立体异构体及其药用组合物和应用. CN: CN108473434A, 2018-08-31.
[76] 胡有洪, 耿美玉, 任文明, 丁健, 官晓聪, 艾菁, 彭霞, 刘杨, 戴阳, 王浪, 曾丽敏. 含邻氨基杂芳环炔基的化合物及其制备方法和用途. CN: CN108456163A, 2018-08-28.
[77] 吕伟, 刘双喜, 陈奕, 张秋萌, 沈倩倩, 丁健. 伏立诺他和紫杉醇的共前药及其制备方法与应用. CN: CN108424405A, 2018-08-21.
[78] 张翱, 缪泽鸿, 王平原, 宋姗姗, 宋子兰, 宦霞娟, 樊州龙, 丁健. 一类取代三唑并哌嗪类PARP抑制剂及其制备方法和用途. CN: CN108290897A, 2018-07-17.
[79] 胡有洪, 陈笑艳, 丁健, 任文明, 钟大放, 陈奕, 谢华. 吲哚-1-碳酸酯类化合物、其制备方法和应用. CN: CN108250187A, 2018-07-06.
[80] 段文虎, 耿美玉, 王蔚, 丁健, 艾菁, 许丹丹, 彭霞, 曹素芬, 季寅淳. 一种具有Axl抑制活性的化合物及其制备和应用. CN: CN108250200A, 2018-07-06.
[81] 张翱, 丁健, 谢华, 宋子兰, 薛宇, 童林江, 耿美玉. 嘧啶并5,4-b吲嗪或嘧啶并5,4-b吡呤化合物、其制备方法及用途. CN: CN108101905A, 2018-06-01.
[82] 曹建华, 耿美玉, 黄敏, 江磊, 李磊, 唐帅, 冯加权, 杨晓彤, 郑红艳, 吴英雄, 任芳芳, 丁健. 具有ERK激酶抑制活性的化合物、其制备方法和用途. CN: CN107922405A, 2018-04-17.
[83] 杨春皓, 缪泽鸿, 陈旭星, 宦霞娟, 王玉勤, 谭村, 陈奕, 丁健. 2‑取代苯并咪唑‑4‑甲酰胺类化合物及制备方法和应用. CN: CN107922430A, 2018-04-17.
[84] 南发俊, 李佳, 丁健, 耿美玉, 张仰明, 陈奕, 周宇波, 龚超骏, 苏明波, 高安慧. 一类芳基2,2’‑串联双噻唑类化合物及其制备方法和用途. CN: CN107793375A, 2018-03-13.
[85] 朱维良, 蒙凌华, 李波, 王贺瑶, 徐志建, 王祥, 朱剑明, 郭彬彬, 王桂敏, 李钊, 丁健. 去氮嘌呤类化合物及其药物组合物、制备方法和用途. CN: CN107722013A, 2018-02-23.
[86] 江磊, 耿美玉, 郑乾刚, 黄敏, 万惠新, 唐帅, 付贤磊, 兰小晶, 曹建华, 丁健. 具有突变型异柠檬酸脱氢酶抑制活性的化合物、其制备方法及用途. CN: CN107556366A, 2018-01-09.
[87] 梅雪锋, 丁克, 丁健, 谢华, 陈成斌, 赵俊, 宋婷婷, 宗在伟, 孙敏. 一种2‑氨基嘧啶类化合物的多晶型形式. CN: CN107417626A, 2017-12-01.
[88] 江磊, 耿美玉, 郑乾刚, 黄敏, 万惠新, 唐帅, 付贤磊, 兰小晶, 曹建华, 刘斐斐, 丁健. 一种具有突变型IDH抑制活性的化合物、其制备方法及用途. CN: CN107216312A, 2017-09-29.
[89] 张翱, 耿美玉, 宋子兰, 艾青, 刘志清, 陈奕, 彭霞, 丁健. 一种2,4-二氨基嘧啶类衍生物、其制备方法及用途. CN: CN107216319A, 2017-09-29.
[90] 赵兴东, 丁健, 蒙凌华. 蛋白激酶抑制剂. CN: CN107207441A, 2017-09-26.
[91] 黄成钢, 李佳, 李志雄, 李静雅, 孙兆林, 潘国宇, 陈明苍, 田小亭, 崔仕超, 林云飞, 刘磊, 江磊, 丁健. 含小檗碱和知母皂苷的组合物及其应用. CN: CN107184590A, 2017-09-22.
[92] 李英霞, 丁健, 闫琪, 耿美玉, 谢华. 嘧啶类化合物. CN: CN107098887A, 2017-08-29.
[93] 张翱, 耿美玉, 邢莉, 艾菁, 宋子兰, 彭霞, 顾王婷, 丁健. 一类取代的氨基吡啶类化合物及其制备和用途. CN: CN107098884A, 2017-08-29.
[94] 张翱, 蒙凌华, 魏曼曼, 张希, 丁健. 一类取代喹唑啉-4-酮类化合物及其制备方法和医药用途. CN: CN106995438A, 2017-08-01.
[95] 曹建华, 耿美玉, 黄敏, 江磊, 李磊, 唐帅, 冯家权, 杨晓彤, 丁健. 具有ERK激酶抑制活性的化合物、其制备方法和用途. CN: CN106928216A, 2017-07-07.
[96] 张翱, 缪泽鸿, 王平原, 宦霞娟, 丁健. 一类取代三唑并哌嗪类PARP抑制剂及其制备方法和用途. CN: CN106749261A, 2017-05-31.
[97] 李英霞, 丁健, 肖强, 耿美玉, 刘建, 谢华. 5-(硫醚基)嘧啶类化合物及其药用组合物和应用. CN: CN106608868A, 2017-05-03.
[98] 黄成钢, 李佳, 李志雄, 李静雅, 孙兆林, 潘国宇, 陈明苍, 田小亭, 崔仕超, 林云飞, 刘磊, 江磊, 丁健. 含有螺甾烷化合物的组合物及其用途. CN: CN106551943A, 2017-04-05.
[99] 丁克, 耿美玉, 谈理, 丁健, 张章, 艾菁, 任小梅, 高冬林, 涂正超, 陆小云, 张冬梅. 取代喹诺酮类衍生物或其药学上可接受的盐或立体异构体及其药用组合物和应用. CN: CN106467541A, 2017-03-01.
[100] 丁克, 丁健, 陈成斌, 耿美玉, 任小梅, 谢华, 涂正超, 陈奕. 2‑氨基嘧啶类化合物及其药物组合物和应用. CN: CN106458930A, 2017-02-22.
[101] 段文虎, 耿美玉, 严伟, 丁健, 艾菁, 赵彬, 范珺, 彭霞, 陈奕. 吲唑类化合物的制备方法和用途. CN: CN106317023A, 2017-01-11.
[102] 曹建华. 一类具有激酶抑制活性的化合物、制备方法和用途. CN: CN106317055A, 2017-01-11.
[103] 段文虎, 耿美玉, 詹正生, 艾菁, 丁健. 氘代的3-(6-喹啉基)二氟甲基-6-(1-甲基)-4-吡唑基1,2,4三唑并4,3-b哒嗪及其应用. CN: CN106279176A, 2017-01-04.
[104] 柳红, 耿美玉, 朱未, 黄敏, 陈先杰, 刘红椿, 何玉龙, 李淳朴, 丁健, 蒋华良, 陈凯先. 苯并吡唑联吡啶类化合物、包含此类化合物的药物组合物及其用途. CN: CN106279101A, 2017-01-04.
[105] 刘磊, 程鹏, 耿美玉, 曹文杰, 江磊, 艾菁, 黄敏, 杨新颖, 查传涛, 曹建华, 陈春麟, 丁健. 一种新型激酶抑制剂的制备及其应用. CN: CN106279119A, 2017-01-04.
[106] 郭仕艳, 甘勇, 张翱, 缪泽鸿, 高丽, 丁健. SOMCL-9112固体分散体、其制备方法及包含其的SOMCL-9112固体制剂. CN: CN106265580A, 2017-01-04.
[107] 万惠新, 耿美玉, 程鹏, 黄敏, 江磊, 曹建华, 陈筑熙, 李磊, 唐帅, 苏毅, 曹文杰, 刘磊, 陈春麟, 丁健. 一类具有激酶抑制活性的化合物、制备方法和用途. 中国: CN106188038A, 2016.12.07.
[108] 万惠新, 耿美玉, 程鹏, 黄敏, 江磊, 曹建华, 陈筑熙, 李磊, 唐帅, 苏毅, 曹文杰, 刘磊, 陈春麟, 丁健. 一类具有激酶抑制活性的化合物、制备方法和用途. CN: CN106188038A, 2016-12-07.
[109] 段文虎, 耿美玉, 赵彬, 丁健, 艾菁, 范珺, 彭霞, 严伟, 陈奕. 吡唑并3,4-b吡啶类和吲唑类化合物的制备方法和用途. CN: CN106146493A, 2016-11-23.
[110] 李英霞, 耿美玉, 刘健, 丁健, 张伟, 艾菁. 吲唑类化合物及其制备方法和用途. CN: CN106032359A, 2016-10-19.
[111] 杨春皓, 缪泽鸿, 张小飞, 衣君玫, 贺茜, 宦霞娟, 宋姗姗, 王迎庆, 陈奕, 丁健. α-咔啉类化合物，其制备方法以及用途. CN: CN105820165A, 2016-08-03.
[112] 丁克, 丁健, 陈成斌, 耿美玉, 任小梅, 谢华, 涂正超, 陈奕. 2-氨基嘧啶类化合物及其药物组合物和应用. CN: CN105601573A, 2016-05-25.
[113] 张翱, 耿美玉, 宋子兰, 艾菁, 郭俊峰, 彭霞, 季寅淳, 丁健. 一类杂环取代的吲哚并萘酮衍生物、其制备方法、药物组合物及其用途. CN: CN105566307A, 2016-05-11.
[114] 耿美玉, 刘磊, 江磊, 黄敏, 查传涛, 艾菁, 王磊, 曹建华, 丁健. 作为FGFR激酶抑制剂的吲唑类化合物及其制备和应用. CN: CN105524048A, 2016-04-27.
[115] 丁健, 艾菁, 陈奕, 黄洵. 一种硫酸酯化聚古洛糖酸多糖或其可药用盐及其制备方法和用途. CN: CN105358582A, 2016-02-24.
[116] 张翱, 缪泽鸿, 王平原, 宦霞娟, 丁健. 一类氮芳基苯并噻唑类PARP抑制剂及其制备方法和用途. CN: CN105272936A, 2016-01-27.
[117] 江磊, 耿美玉, 丁健, 刘磊, 黄敏, 查传涛, 艾菁. 一种新型杂环化合物及其制备方法和作为激酶抑制剂的用途. CN: CN105218548A, 2016-01-06.
[118] 段文虎, 丁健, 吕永聪, 谢华. 萘酰胺类化合物、其制备方法和用途. CN: CN104860885A, 2015-08-26.
[119] 王为波, 耿美玉, 丁健, 赵兴东, 艾菁, 田强, 彭霞, 张卫鹏, 刘洪彬, 谭浩瀚, 陈岭. ALK激酶抑制剂. CN: CN104854101A, 2015-08-19.
[120] 段文虎, 丁健, 吕永聪, 谢华. 苯胺嘧啶类化合物、其制备方法和医药用途. CN: CN104829542A, 2015-08-12.
[121] 吕伟, 王磊, 陈奕, 丁健. 一类新型高喜树碱衍生物、制备方法和用途. CN: CN104530066A, 2015-04-22.
[122] 丁健, 艾菁, 陈奕, 黄洵. 一种硫酸酯化聚古洛糖酸多糖或其可药用盐及其制备方法和用途. CN: CN104277130A, 2015-01-14.
[123] 张倩, 丁健, 晋建文, 谢华, 董孟杰, 童林江, 刘振峰. 2-氟代喹唑啉环类化合物及其制备方法和药用用途. CN: CN104230826A, 2014-12-24.
[124] 张翱, 耿美玉, 宋子兰, 艾菁, 刘志清, 陈奕, 彭霞, 丁健. 2,4-二氨基嘧啶类化合物及其医药用途. CN: CN104230954A, 2014-12-24.
[125] 胡有洪, 耿美玉, 刘杨, 丁健, 艾菁. 一类炔基杂环类化合物及其应用. CN: CN104211639A, 2014-12-17.
[126] 张翱, 耿美玉, 宋子兰, 艾菁, 赵垠莹, 彭霞, 丁健. 杂环取代的吲哚并萘酮衍生物、其制备方法、药物组合物及其用途. CN: CN104211687A, 2014-12-17.
[127] 张翱, 耿美玉, 丁健, 宋子兰, 艾菁, 李晓刚, 彭霞. 杂环基取代的吲哚并萘酮衍生物及其医药用途. CN: CN104177342A, 2014-12-03.
[128] 张翱, 耿美玉, 丁健, 宋子兰, 艾菁, 李晓刚, 彭霞. 酰胺基取代的吲哚并萘酮衍生物及其医药用途. CN: CN104177332A, 2014-12-03.
[129] 李剑, 缪泽鸿, 丁健, 蒋华良, 刘云霞, 宦霞娟, 宋姗姗, 陈奕, 任国宾. 2,4-二氟-5-(酞嗪酮-1-甲基)-苯甲酰哌嗪类化合物及其用途. CN: CN104003940A, 2014-08-27.
[130] 郭跃伟, 丁健, 周振芳, 刘海利, 许承辉. 木果楝庚素及其制备方法和用途. CN: CN103864876A, 2014-06-18.
[131] 张翱, 缪泽鸿, 叶娜, 宦霞娟, 宋子兰, 陈川惠子, 陈奕, 丁健. 一类哒嗪酮类化合物及其制备方法和用途. CN: CN103833756A, 2014-06-04.
[132] 胡有洪, 耿美玉, 邢唯强, 丁健, 艾菁. 哒嗪酮类化合物、其制备方法、药物组合物及其用途. CN: CN103664895A, 2014-03-26.
[133] 张翱, 耿美玉, 刘志清, 丁健, 艾菁, 彭霞, 宋子兰, 张静, 纪寅淳. 苯氮卓类化合物及其制备方法和用途. CN: CN103664903A, 2014-03-26.
[134] 沈竞康, 丁健, 蒙凌华, 孟韬, 周华勇, 马兰萍, 胡定宇, 王昕, 王艺, 陈奕. 双环稠杂环化合物及其用途和药物组合物. CN: CN103626783A, 2014-03-12.
[135] 张翱, 缪泽鸿, 叶娜, 宦霞娟, 宋子兰, 陈川惠子, 陈奕, 丁健. 具有桥环结构的稠环哒嗪酮类化合物及其制备方法和用途. CN: CN103570730A, 2014-02-12.
[136] 张翱, 缪泽鸿, 叶娜, 宦霞娟, 宋子兰, 陈川惠子, 陈奕, 丁健. 哌嗪并三唑类化合物及其制备方法和用途. CN: CN103570725A, 2014-02-12.
[137] 张翱, 缪泽鸿, 叶娜, 宦霞娟, 宋子兰, 陈川惠子, 陈奕, 丁健. 稠环哒嗪酮类化合物及其制备方法和用途. CN: CN103570722A, 2014-02-12.
[138] 沈竞康, 丁健, 蒙凌华, 孟韬, 周华勇, 王昕, 王艺, 陈奕. 一类吡唑并吡啶类化合物及其制备方法、用途和药物组合物. CN: CN103570709A, 2014-02-12.
[139] 吕伟, 张儇, 刘雅倩, 于秀华, 罗宇, 方艳芬, 章雄文, 陈奕, 丁健. 含有组蛋白去乙酰化酶抑制活性的秋水仙碱衍生物及制备方法和用途. CN: CN103553957A, 2014-02-05.
[140] 罗成, 柳红, 陈奕, 孔祥谦, 栗增, 冯恩光, 刘世恩, 陈先杰, 朱维良, 丁健, 蒋华良. 2-取代-5-苯基呋喃类化合物、其制备方法、药物组合物及其用途. CN: CN103509009A, 2014-01-15.
[141] 杨春皓, 蒙凌华, 陈艳红, 王祥, 谭村, 李家鹏, 丁健, 陈奕. 吡咯2,1-f1,2,4并三嗪类化合物,其制备方法及用途. CN: CN103450204A, 2013-12-18.
[142] 杨春皓, 缪泽鸿, 丁健, 王猛, 贺金雪, 谭村, 陈奕. 2-芳基苯并呋喃-7-甲酰胺类化合物、其制备方法及用途. CN: CN103242273A, 2013-08-14.
[143] 柳红, 耿美玉, 张登友, 艾菁, 罗成, 李淳朴, 陈曦, 梁中洁, 彭霞, 季寅淳, 蒋华良, 丁健, 陈凯先. 新型咪唑并1,2-a吡啶类化合物、其制备方法、包含此类化合物的药物组合物及其用途. CN: CN103214481A, 2013-07-24.
[144] 杨春皓, 江敏, 王祥, 蒙凌华, 丁健. 一类三嗪类化合物、该化合物的制备方法及其用途. CN: CN102887867A, 2013-01-23.
[145] 耿美玉, 丁健, 艾菁, 樊嘉. pIgR作为肿瘤早期复发和/或转移的分子标志物和抗肿瘤转移的药物干预靶点的用途. CN: CN102841200A, 2012-12-26.
[146] 南发俊, 陈飞, 张仰明, 李佳, 周宇波, 苏明波, 丁健, 蒙凌华, 谢欣, 王识贤. 一类噻唑类化合物及其制备方法和用途. CN: CN102775368A, 2012-11-14.
[147] 吕伟, 余善宝, 罗宇, 陈奕, 丁健. 含有稳定7元内酯环的喜树碱类化合物、制备方法和用途. CN: CN102746314A, 2012-10-24.
[148] 蒙凌华, 王祥, 丁健. 一种检测化合物对人Ⅰ型PI3Ks抑制活性的方法. CN: CN102719517A, 2012-10-10.
[149] 沈竞康, 蒙凌华, 周华勇, 孟韬, 王昕, 王祥, 刘加利, 丁健. 一类吲唑类化合物及其制备方法、用途和药物组合物. CN: CN102675286A, 2012-09-19.
[150] 吕伟, 张翾, 罗宇, 陈奕, 李佳, 李静雅, 丁健. 含有异羟肟酸结构的表鬼臼毒化合物及制备方法和用途. CN: CN102603761A, 2012-07-25.
[151] 南发俊, 张仰明, 刘桦楠, 丁健, 蒙凌华, 许承辉. 一种对映-贝壳杉烷型二萜及其衍生物和制备方法. CN: CN102584760A, 2012-07-18.
[152] 王玉勤, 贺茜, 杨春皓, 缪泽鸿, 陈奕, 丁健. 一类苯并咔唑酰胺类化合物、其制备方法和用途. CN: CN102584679A, 2012-07-18.
[153] 龙亚秋, 丁健, 王勇, 谢华, 曾立凡. 5,8-二取代-1,6-二氮杂萘-7-羰酰胺类化合物及其二聚体化合物,其制备方法和用途. CN: CN102558172A, 2012-07-11.
[154] 王嘉, 蒙凌华, 杨春皓, 王祥, 丁健, 谢毓元. 吡啶并吡咯三嗪化合物、其制备方法和用途. CN: CN102558185A, 2012-07-11.
[155] 段文虎, 耿美玉, 陈方, 艾菁, 陈奕, 詹正生, 吕永聪, 王英, 丁健. 1,2,4三唑并4,3-b1,2,4三嗪类化合物、其制备方法和用途. CN: CN102532141A, 2012-07-04.
[156] 郭跃伟, 缪泽鸿, 蔡由生, 丁健. 棕榈菌素BG5及其制备方法和用途. CN: CN102382098A, 2012-03-21.
[157] 邓斐, 缪泽鸿, 赵铭, 丁健, 张金生. 一类新型咪唑类化合物及其用途. CN: CN102336740A, 2012-02-01.
[158] 郭跃伟, 丁健, 王贱荣, 缪泽鸿, 刘海利. 毛红椿苦素及其制备方法和用途. CN: CN102311476A, 2012-01-11.
[159] 赖宜生, 沙磊, 缪泽鸿, 张奕华, 宦霞娟, 丁健. 一种具有1,12-二烯-3-酮骨架的甘草次酸衍生物、其制备方法及医药用途. CN: CN102250189A, 2011-11-23.
[160] 丁健, 徐玉芳, 谢华, 钱旭红, 陈奕, 陈卓, 王艺, 王新. 8-氧-8H-苊并1,2-b吡咯衍生物的新用途. CN: CN102204905A, 2011-10-05.
[161] 蒋华良, 丁健, 李洪林, 谢华, 刘晓峰, 童林江, 徐玉芳. 5-取代-2,4-噻唑烷二酮类化合物在制备IGF1R功能调节药物中的应用. CN: CN102078318A, 2011-06-01.
[162] 龙亚秋, 金毅, 丁健, 林莉萍. 5,8-二取代喹唑啉及其制备方法和用途. CN: CN1858040B, 2011-04-06.
[163] 周祥山, 张元兴, 王雅, 倪振华, 丁健, 林莉萍. 在毕赤酵母细胞器中表达的重组酪氨酸激酶及其基因、衍生融合蛋白和制备方法. CN: CN1920015B, 2010-09-08.
[164] 沈竞康, 孟韬, 张志翔, 缪泽鸿, 丁健, 马兰萍, 胡定宇, 张永良, 金羽, 王昕. 一类取代吡啶并2’,1’:2,3咪唑并4,5-c异喹啉酮类化合物及其合成方法和用途,以及包含该类化合物的药物组合物. CN: CN101717397A, 2010-06-02.
[165] 龙亚秋, 曾立凡, 王勇, 丁健. 5,8－二取代－1,6－二氮杂萘－7－羰酰胺类化合物及其制备方法、组合物和用途. CN: CN101684119A, 2010-03-31.
[166] 贺茜, 杨春皓, 吴茂江, 缪泽鸿, 丁健, 谢毓元. 一类3位取代的1,8－萘酰亚胺类化合物及其合成方法和医药用途. CN: CN101684094A, 2010-03-31.
[167] 南发俊, 丁健, 左建平, 余琳千, 蒙凌华, 张仰明, 杨娜, 顾民. 一类雷帕霉素碳酸酯类似物、其药物组合物及其制备方法和用途. CN: CN101676291A, 2010-03-24.
[168] 陈国庆, 丁健, 林莉萍. 作为血管生成抑制剂的螺取代化合物. US: CN101558055A, 2009-10-14.
[169] 南发俊, 李佳, 丁健, 刘钢, 谢传明, 缪泽鸿, 台万一. α－氨基－N－取代酰胺化合物、包含该化合物的药物组合物及其用途. CN: CN101456824A, 2009-06-17.
[170] 易杨华, 丁健, 孙鹏, 缪泽鸿, 李玲, 林莉萍, 汤红叶, 李明, 刘宝姝. 海参中皂苷类化合物echinoside A在制备肿瘤拓扑异构酶Ⅱ抑制剂中的应用. CN: CN101336928A, 2009-01-07.
[171] 黄成钢, 马春辉, 丁健, 楼丽广, 孙兆林, 唐意红, 李志雄, 范明松. 从中药王不留行中分离获得的三萜类化合物及它们的用途. CN: CN101333238A, 2008-12-31.
[172] 郭跃伟, 丁健, 缪泽鸿, 贾睿, 周兆丽. 二聚西松烷四萜化合物皱褶肉芝内酯甲、乙素及其制备方法和用途. CN: CN101328184A, 2008-12-24.
[173] 段文虎, 赵翠花, 蒋华良, 丁健, 陈晓蓓, 谢华. 苯胺喹唑啉衍生物、其制备方法及其用途. CN: CN101289445A, 2008-10-22.
[174] 郭跃伟, 丁健, 张文, 林莉萍, 周秀红. 西松烷内酯型二萜化合物豆荚软珊瑚甲、乙素及其制备方法和用途. CN: CN101265248A, 2008-09-17.
[175] 李援朝, 李征, 周兆丽, 林莉萍, 缪泽宏, 任进, 李川, 甘勇, 丁健, 冯慧瑾. 雷公藤二萜类内酯衍生物及其应用. CN: CN101255186A, 2008-09-03.
[176] 段文虎, 赵曦, 张士磊, 丁健, 桂敏. 曲古抑菌素A衍生物及其制备方法和用途. CN: CN101239929A, 2008-08-13.
[177] 钱旭红, 李永刚, 徐玉芳, 丁健, 林莉萍, 曲宝源. 含硫杂环并萘酰亚胺类化合物及其在肿瘤细胞中应用. CN: CN100406461C, 2008-07-30.
[178] 柳红, 蒋华良, 丁健, 林莉萍, 黄河, 罗小民, 朱维良, 沈建华, 陈凯先. 1－取代－4,4－二取代氨基硫脲类化合物、其制备方法以及其用途. CN: CN101195597A, 2008-06-11.
[179] 郭跃伟, 王继栋, 于嘉陵, 丁健. 一类海芒果苷衍生物、其制备方法及用途. CN: CN100371344C, 2008-02-27.
[180] 吕伟, 朱勤, 潘俊芳, 蔡俊超, 丁健. 一类喜树碱衍生物及制备方法. CN: CN100363366C, 2008-01-23.
[181] 南发俊, 李佳, 丁健, 刘钢, 谢传明, 陈奕, 台万一. 一类α－氨基－N－取代酰胺化合物、其组合物及用途. 中国: CN101092384, 2007-12-26.
[182] 左建平, 袁重生, 吴庆莉, 丁健, 杨以阜. 6－氨基－α(R)－羟基－9H－嘌呤－9－丁酸乙酯的免疫抑制作用. CN: CN100345545C, 2007-10-31.
[183] 段文虎, 周云隆, 丁健. 藤黄酸衍生物及其制备方法和用途. CN: CN101054382A, 2007-10-17.
[184] 吕伟, 丁健, 高河勇, 林莉萍, 陈奕. 一类喜树碱衍生物及其应用. CN: CN101033230A, 2007-09-12.
[185] 张金生, 邓斐, 丁健. 4,5－开环二萜醌类化合物、及其制备方法和应用. CN: CN1990448A, 2007-07-04.
[186] 叶阳, 司马骏一, 唐春萍, 杉本规矩夫, 柯昌强, 李希强, 谭敏佳, 葛凡, 杨新洲, 丁健. 莽草酸的分离纯化方法. CN: CN1978422A, 2007-06-13.
[187] 郭跃伟, 严小红, 丁健, 林莉萍. 抗肿瘤活性成份多棘酸酯、制备方法和用途. CN: CN1319983C, 2007-06-06.
[188] 柳红, 蒋华良, 沈旭, 丁健, 朱兴族, 林莉萍, 郑鸣芳, 郑明月, 周宇, 季新泉, 罗海彬, 罗小民, 沈建华, 陈凯先. 取代1,3,5三嗪类化合物及其制备方法和应用. CN: CN1970552A, 2007-05-30.
[189] 丁华胜, 张超, 吴希罕, 杨春皓, 章雄文, 丁健, 谢毓元. 一类α－亚甲基－γ－丁内酯化合物、其制备方法及应用. CN: CN1872851A, 2006-12-06.
[190] 吴茂江, 丁健, 陈奕, 林莉萍, 杨春皓, 谢毓元. 4,5－二取代苯基－1,2,3－噻二唑类衍生物,及其制备方法和用途. CN: CN1865252A, 2006-11-22.
[191] 郭跃伟, 丁健, 林莉萍, 严小红. 肉芝内酯A、及其制备方法和用途. CN: CN1861605A, 2006-11-15.
[192] 罗小民, 柳红, 蒋华良, 李海泓, 沈旭, 杜毅, 丁健, 林莉萍, 陈凯先. 4－取代苯氨基－3－硝基喹啉类化合物及其制备方法和用途. CN: CN1830964A, 2006-09-13.
[193] 钱旭红, 李志刚, 杨青, 徐玉芳, 丁健, 林莉萍. 硫、氮杂环并萘酰亚胺类化合物及其在肿瘤细胞中应用. CN: CN1786003A, 2006-06-14.
[194] 吕伟, 高河勇, 章雄文, 丁健. 喜树碱衍生物、制备方法和用途. CN: CN1781922A, 2006-06-07.
[195] 林莉萍, 秦松, 丁健, 葛保胜, 韩璐. 重组别藻蓝蛋白作为制备抗肝癌药物的应用. CN: CN1771925A, 2006-05-17.
[196] 蒋华良, 罗小民, 李海泓, 谭金芝, 丁健, 林莉萍, 柳红, 陈凯先. 取代 1H－吲哚－2－酮类化合物及其制备方法和用途. CN: CN1769284A, 2006-05-10.
[197] 段文虎, 周云隆, 蒋华良, 丁健, 罗小民, 陈奕. 新藤黄酸衍生物及其制备方法和用途. CN: CN1715283A, 2006-01-04.
[198] 吕伟, 高河勇, 章雄文, 丁健. 喜树碱的新型结构衍生物、制备方法和用途. CN: CN1704416A, 2005-12-07.
[199] 段文虎, 章建刚, 丁健, 陈奕, 蔡俊超. 一类5,8－二氢萘醌衍生物、其制备方法和用途. CN: CN1690044A, 2005-11-02.
[200] 郭跃伟, 黄孝春, 赵迪, 吴厚铭, 丁健, 林莉萍. 抗肿瘤活性成分陵水醇、制备方法和用途. CN: CN1680304A, 2005-10-12.
[201] 吕伟, 何训贵, 章雄文, 丁健. 羟基喜树碱及其衍生物的羧酸酯前药、其制备方法与应用. 中国: CN1673226, 2005-09-28.
[202] 吕伟, 何训贵, 章雄文, 丁健. 羟基喜树碱及其衍生物的碳酸酯前药、制备方法与应用. CN: CN1673225A, 2005-09-28.
[203] 赵维民, 丁健, 袁盛涛, 施玉花, 童云广, 林莉萍, 唐坚. 11,11'－二去氧沃替西林的医学用途. CN: CN1429552A, 2003-07-16.
[204] 陆群, 段文虎, 蔡俊超, 刘卫军, 丁健. 一类萘茜衍生物及其制备方法和用途. CN: CN1420111A, 2003-05-28.
[205] 岳建民, 杨升平, 丁健, 肖东, 袁胜涛, 吴艳, 董蕾, 童云广. 土槿皮酸类衍生物及其制备方法和用途. CN: CN1405164A, 2003-03-26.
[206] 易杨华, 许强芝, 吴厚铭, 孙金华, 丁健, 童云广. 一种从条纹拟海牛中提取的抑制肿瘤新生血管生成的化合物. CN: CN1342657A, 2002-04-03.
[207] 李英, 山峰, 吴锦明, 吴光韶, 丁健, 韩家娴, G·阿塔希, P·莱纳德. 青蒿素衍生物,其制备方法以及含有它们的药物组合物. CN: CN1305482A, 2001-07-25.
[208] 李英, 山峰, 吴锦明, 吴光韶, 丁健, 韩家娴, G·阿塔斯, P·里纳德. 新的青蒿素化合物,其制备方法以及含有它们的药物组合物. CN: CN1239097A, 1999-12-22.
[209] 施继成, 陈陵际, 康北笙, 丁健. 带有2－脱氧－2－(二苯膦基)或3－脱氧－3－(二苯膦基－α－D－阿卓糖类膦配体的金(工)类化合物的用途. CN: CN1186810A, 1998-07-08.
[210] 张金生, 丁健, 乐秀芳. 红根草邻醌类化学修饰物及它们的用途. CN: CN1127742A, 1996-07-31.

   

[1] Xu Zhang, Yuxiang Wang, Xi Zhang, Yanyan Shen, Kang Yang, Qingyang Ma, Yuemei Qiao, Jiajie Shi, Yi Wang, Lan Xu, Biyu Yang, Gaoxiang Ge, Landian Hu, Xiangyin Kong, Chunhao Yang, Yi Chen, Jian Ding, Linghua Meng. Intact regulation of G1/S transition renders esophageal squamous cell carcinoma sensitive to PI3Kα inhibitors. SIGNAL TRANSDUCTION AND TARGETED THERAPY[J]. 2023, 8(1): 1-14, https://doaj.org/article/334f2a57e34f491b8c4c6cdba5a34ed0.
[2] Zonglong Hu, Fan Wei, Yi Su, Yafang Wang, Yanyan Shen, Yanfen Fang, Jian Ding, Yi Chen. Histone deacetylase inhibitors promote breast cancer metastasis by elevating NEDD9 expression. SIGNAL TRANSDUCTION AND TARGETED THERAPY[J]. 2023, 8(1): 1-13, http://dx.doi.org/10.1038/s41392-022-01221-6.
[3] Liu, Yingqiang, Lai, Mengzhen, Li, Shan, Wang, Yanan, Feng, Fang, Zhang, Tao, Tong, Linjiang, Zhang, Mengge, Chen, Hao, Chen, Yi, Song, Peiran, Li, Yan, Bai, Gang, Ning, Yi, Tang, Haotian, Fang, Yan, Chen, Yi, Lu, Xiaoyun, Geng, Meiyu, Ding, Ke, Yu, Ker, Xie, Hua, Ding, Jian. LS-106, a novel EGFR inhibitor targeting C797S, exhibits antitumor activities both in vitro and in vivo. CANCER SCIENCE[J]. 2022, 113(2): 709-720, http://dx.doi.org/10.1111/cas.15229.
[4] Zhang, Shurui, Chen, Xiaoxu, Wu, Chenglin, Xu, Hui, Xie, Xiong, Feng, Mingshun, Hu, Shulei, Hudagula Bai, Gao, Feng, Tong, Linjiang, Ding, Jian, Liu, Hong, Xie, Zuoquan, Wang, Jiang. A Novel SphK1 Inhibitor Suppresses Growth of Solid Tumor and Inhibits the Lung Metastasis of Triple-negative Breast Cancer.. JOURNAL OF MEDICINAL CHEMISTRY[J]. 2022, 65: 7697-7716, [5] Song, Peiran, Bai, Gang, Chan, Shingpan, Zhang, Tao, Tong, Linjiang, Su, Yi, Shen, Yanyan, Chen, Yi, Liu, Yingqiang, Lai, Mengzhen, Ning, Yi, Tang, Haotian, Fang, Yan, Chen, Yi, Ding, Ke, Ding, Jian, Xie, Hua. ASK120067 potently suppresses B-cell or T-cell malignancies in vitro and in vivo by inhibiting BTK and ITK. FRONTIERS IN PHARMACOLOGY[J]. 2022, 13: http://dx.doi.org/10.3389/fphar.2022.1071114.
[6] Hui Xing, Mengshi Gao, Yuxiang Wang, Xu Zhang, Jiajie Shi, Xiang Wang, Xueling Liu, Qingyang Ma, Xiangyin Kong, Chunhao Yang, Jian Ding, Linghua Meng. Genome‐wide gain‐of‐function screening identifies EZH2 mediating resistance to PI3Kα inhibitors in oesophageal squamous cell carcinoma. CLINICAL AND TRANSLATIONAL MEDICINE[J]. 2022, 12(5): n/a-n/a, https://doaj.org/article/4162cdb8eebc44a3881b2644ed5355aa.
[7] Zhang Xi, Duan Yuting, Wang Yi, Zhao Xingdong, Sun Yiming, Lin Dongze, Chen Yi, Wang Yuxiang, Zhou Zuwen, Liu Yanxin, Jiang Lihua, Geng Meiyu, Ding Jian, Meng Linghua. SAF-248,a novel PI3Kδ-selective inhibitor,potently suppresses the growth of diffuse large B-cell lymphoma. ACTA PHARMACOLOGICA SINICA[J]. 2022, 43(1): 209-219, http://sciencechina.cn/gw.jsp?action=detail.jsp&internal_id=7134245&detailType=1.
[8] Gao, Feng, Chen, Xiaoxu, Lu, Junyan, Hu, Shulei, Xu, Hui, Shi, Yuqiang, Feng, Mingshun, Ding, Jian, Liu, Hong, Luo, Cheng, Xie, Zuoquan, Wang, Jiang. Discovery of novel ceramide analogs with favorable pharmacokinetic properties and combination with AKT inhibitor against colon cancer. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY[J]. 2021, 215: http://dx.doi.org/10.1016/j.ejmech.2021.113274.
[9] Wang, Yuxiang, Zhang, Xu, Ma, Qingyang, Hu, Landian, Zhang, Xi, Wang, Yi, Xu, Lan, Yang, Chunhao, Tan, Cun, Kong, Xiangyin, Ding, Jian, Meng, Linghua. Adaptive resistance to PI3K alpha-selective inhibitor CYH33 is mediated by genomic and transcriptomic alterations in ESCC cells. CELL DEATH & DISEASE[J]. 2021, 12(1): https://www.webofscience.com/wos/woscc/full-record/WOS:000609814100003.
[10] Xie Qin, Chi Shuaishuai, Fang Yanfen, Sun Yiming, Meng Linghua, Ding Jian, Chen Yi. PI3Kα inhibitor impairs AKT phosphorylation and synergizes with novel angiogenesis inhibitor AL3810 in human hepatocellular carcinoma. SIGNAL TRANSDUCTION AND TARGETED THERAPY[J]. 2021, 6(4): 1125-1127, http://sciencechina.cn/gw.jsp?action=detail.jsp&internal_id=6959746&detailType=1.
[11] Xiao, Shifu, Chan, Piu, Wang, Tao, Hong, Zhen, Wang, Shuzhen, Kuang, Weihong, He, Jincai, Pan, Xiaoping, Zhou, Yuying, Ji, Yong, Wang, Luning, Cheng, Yan, Peng, Ying, Ye, Qinyong, Wang, Xiaoping, Wu, Yuncheng, Qu, Qiumin, Chen, Shengdi, Li, Shuhua, Chen, Wei, Xu, Jun, Peng, Dantao, Zhao, Zhongxin, Li, Yansheng, Zhang, Junjian, Du, Yifeng, Chen, Weixian, Fan, Dongsheng, Yan, Yong, Liu, Xiaowei, Zhang, Wei, Luo, Benyan, Wu, Wenyuan, Shen, Lu, Liu, Chunfeng, Mao, Peixian, Wang, Qiumei, Zhao, Qianhua, Guo, Qihao, Zhou, Yongtao, Li, Yi, Jiang, Lijun, Ren, Wenwei, Ouyang, Yingjun, Wang, Yan, Liu, Shuai, Jia, Jianjun, Zhang, Nan, Liu, Zhonglin, He, Raoli, Feng, Tingyi, Lu, Wenhui, Tang, Huidong, Gao, Ping, Zhang, Yingchun, Chen, Lanlan, Wang, Lei, Yin, You, Xu, Qun, Xiao, Jinsong, Cong, Lin, Cheng, Xi, Zhang, Hui, Gao, Dan, Xia, Minghua, Lian, Tenghong, Peng, Guoping, Zhang, Xu, Jiao, Bin, Hu, Hua, Chen, Xueyan, Guan, Yihui, Cui, Ruixue, Huang, Qiu, Xin, Xianliang, Chen, Hongjian, Ding, Yu, Zhang, Jing, Feng, Teng, Cantillon, Marc, Chen, Kewei, Cummings, Jeffrey L, Ding, Jian, Geng, Meiyu, Zhang, Zhenxin. A 36-week multicenter, randomized, double-blind, placebo-controlled, parallel-group, phase 3 clinical trial of sodium oligomannate for mild-to-moderate Alzheimer's dementia. ALZHEIMERS RESEARCH & THERAPY[J]. 2021, 13(1): https://www.webofscience.com/wos/woscc/full-record/WOS:000630011200001.
[12] Chen, Yun, Ning, Yi, Bai, Gang, Tong, Linjiang, Zhang, Tao, Zhou, Jinpei, Zhang, Huibin, Xie, Hua, Ding, Jian, Duan, Wenhu. Design, Synthesis, and Biological Evaluation of IRAK4-Targeting PROTACs. ACS MEDICINAL CHEMISTRY LETTERS[J]. 2021, 12(1): 82-87, [13] 丁健. Adaptive resistance to PI3Kα-selective inhibitor CYH33 is mediated by genomic and transcriptomic alterations in ESCC cell. Cell Death Dis .[J]. 2021, [14] Xi Zhang, Yi Wang, Jian Ding, Lan Xu, Pu Sun, RongJing Wang, QingYang Ma, HuiPing Liao, HaiLong Wang, LanDian Hu, Xiangyin Kong, LingHua Meng. PI3Kα inhibitor CYH33 triggers antitumor immunity in murine breast cancer by activating CD8+T cells and promoting fatty acid metabolism. JOURNAL FOR IMMUNOTHERAPY OF CANCER[J]. 2021, 9(8): https://doaj.org/article/ca722686de844e43aff24305744ac672.
[15] Xie, Qin, Chi, Shuaishuai, Fang, Yanfen, Sun, Yiming, Meng, Linghua, Ding, Jian, Chen, Yi. PI3K alpha inhibitor impairs AKT phosphorylation and synergizes with novel angiogenesis inhibitor AL3810 in human hepatocellular carcinoma. SIGNAL TRANSDUCTION AND TARGETED THERAPY. 2021, 6(1): https://www.webofscience.com/wos/woscc/full-record/WOS:000636231100001.
[16] Zhang, Xi, Duan, Yuting, Wang, Yi, Zhao, Xingdong, Sun, Yiming, Lin, Dongze, Chen, Yi, Wang, Yuxiang, Zhou, Zuwen, Liu, Yanxin, Jiang, Lihua, Geng, Meiyu, Ding, Jian, Meng, Linghua. SAF-248, a novel PI3K delta-selective inhibitor, potently suppresses the growth of diffuse large B-cell lymphoma. ACTA PHARMACOLOGICA SINICA[J]. 2021, https://www.webofscience.com/wos/woscc/full-record/WOS:000634685300004.
[17] Liu, Yuting, Ding, Huihua, Lin, Zemin, Wang, Que, Chen, Li, Liu, Shuangshuang, Yang, Xiaoqian, Zhu, Fenghua, Huang, Yueteng, Cao, Shiqi, Yang, Fangming, Song, Zilan, Ding, Jian, Geng, Meiyu, Xie, Hua, Zhang, Ao, He, Shijun, Zuo, Jianping. A novel tricyclic BTK inhibitor suppresses B cell responses and osteoclastic bone erosion in rheumatoid arthritis. ACTA PHARMACOLOGICA SINICA[J]. 2021, 42(10): 1653-1664, http://dx.doi.org/10.1038/s41401-020-00578-0.
[18] Xiang, HaoYue, Chen, JianYang, Huan, XiaJuan, Chen, Yi, Gao, Zhaobing, Ding, Jian, Miao, ZeHong, Yang, ChunHao. Identification of 2-substituted pyrrolo1,2-bpyridazine derivatives as new PARP-1 inhibitors. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS[J]. 2021, 31: http://dx.doi.org/10.1016/j.bmcl.2020.127710.
[19] Wang, Lu, Ai, Jing, Shen, Yanyan, Zhang, Haotian, Peng, Xia, Huang, Min, Zhang, Ao, Ding, Jian, Geng, Meiyu. SOMCL-863, a novel, selective and orally bioavailable small-molecule c-Met inhibitor, exhibits antitumor activity both in vitro and in vivo (vol 351, pg 413, 2014). CANCER LETTERS. 2020, 486: 71-72, https://www.webofscience.com/wos/woscc/full-record/WOS:000540255500008.
[20] Bi, Aiwei, Xu, Jun, Jin, Nan, Lan, Xiaojing, Tang, Shuai, Shou, Matthew, Liu, Jia, Ding, Jian, Geng, Meiyu, Lin, Shuhai, Huang, Min. Mutant isocitrate dehydrogenase driven metabolic reprogramming results in therapeutic vulnerability to lactate dehydrogenase inhibition. CANCER RESEARCH[J]. 2020, 80(16): https://www.webofscience.com/wos/woscc/full-record/WOS:000590059305309.
[21] Wu, Yao, Du, Hongzhi, Zhan, Meixiao, Wang, Hongxv, Chen, Peng, Du, Danyu, Liu, Xinyi, Huang, Xingxv, Ma, Pengcheng, Peng, Dezheng, Sun, Li, Yuan, Shengtao, Ding, Jian, Lu, Ligong, Jiang, Jingwei. Sepiapterin reductase promotes hepatocellular carcinoma progression via FoxO3a/Bim signaling in a nonenzymatic manner. CELL DEATH & DISEASE[J]. 2020, 11(4): https://doaj.org/article/df7c542cb89b4a3b8f02060fe9c943ab.
[22] Dai, Yang, Ji, Yichun, Shen, Yanyan, Su, Yi, Liu, Bo, Wang, Yueliang, Sun, Deqiao, Jiang, Yuchen, Zha, Chuantao, Xie, Zuoquan, Ding, Jian, Geng, Meiyu, Ai, Jing, Peng, Xia, Hou, Pengcong, Chen, Yi. Preclinical evaluation of 3D185, a novel potent inhibitor of FGFR1/2/3 and CSF-1R, in FGFR-dependent and macrophage-dominant cancer models.. CANCER IMMUNOLOGY RESEARCH[J]. 2020, 8(3): 70-70, https://www.webofscience.com/wos/woscc/full-record/WOS:000518188200112.
[23] Wang, Tao, Kuang, Weihong, Chen, Wei, Xu, Wenwei, Zhang, Liming, Li, Yingjie, Li, Hailin, Peng, Ying, Chen, Yangmei, Wang, Baojun, Xiao, Jinsong, Li, Honghua, Yan, Chuanzhu, Du, Yifeng, Tang, Mouni, He, Zhiyi, Chen, Haibo, Li, Wei, Lin, Hong, Shi, Shugui, Bi, Jianzhong, Zhou, Huadong, Cheng, Yan, Gao, Xiaoping, Guan, Yihui, Huang, Qiu, Chen, Kewei, Xin, Xianliang, Ding, Jian, Geng, Meiyu, Xiao, Shifu. A phase II randomized trial of sodium oligomannate in Alzheimer's dementia. ALZHEIMERS RESEARCH & THERAPY[J]. 2020, 12(1): http://dx.doi.org/10.1186/s13195-020-00678-3.
[24] Xian Li, LinJiang Tong, Jian Ding, LingHua Meng. Corrigendum to "Systematic combination screening reveals synergism between rapamycin and sutent against human lung cancer" Cancer Letter 342(2014) 159-166. CANCER LETTERS. 2020, 470: 220-220, http://dx.doi.org/10.1016/j.canlet.2019.12.001.
[25] Wang, Xinyi, Sun, Guangqiang, Feng, Teng, Zhang, Jing, Huang, Xun, Wang, Tao, Xie, Zuoquan, Chu, Xingkun, Yang, Jun, Wang, Huan, Chang, Shuaishuai, Gong, Yanxue, Ruan, Lingfei, Zhang, Guanqun, Yan, Siyuan, Lian, Wen, Du, Chen, Yang, Dabing, Zhang, Qingli, Lin, Feifei, Liu, Jia, Zhang, Haiyan, Ge, Changrong, Xiao, Shifu, Ding, Jian, Geng, Meiyu. Geng et al. reply. CELL RESEARCH[J]. 2020, 30(9): 820-820, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7609299/.
[26] 李正翔, 丁健, 张玉, 张伶俐, 周颖玉, 杨克虎, 段蓉. 医疗机构药品遴选指南计划书. 中国医院药学杂志[J]. 2020, 40(24): 2501-2505, http://lib.cqvip.com/Qikan/Article/Detail?id=7103776597.
[27] Zhang, ShuWei, Gong, ChaoJun, Su, MingBo, Chen, Fei, He, Ting, Zhang, YangMing, Shen, QianQian, Su, Yi, Ding, Jian, Li, Jia, Chen, Yi, Nan, FaJun. Synthesis and in Vitro and in Vivo Biological Evaluation of Tissue-Specific Bisthiazole Histone Deacetylase (HDAC) Inhibitors. JOURNAL OF MEDICINAL CHEMISTRY[J]. 2020, 63(2): 804-815, http://dx.doi.org/10.1021/acs.jmedchem.9b01792.
[28] Chen, Yun, Bai, Gang, Ning, Yi, Cai, Shi, Zhang, Tao, Song, Peiran, Zhou, Jinpei, Duan, Wenhu, Ding, Jian, Xie, Hua, Zhang, Huibin. Design and synthesis of Imidazo1,2-bpyridazine IRAK4 inhibitors for the treatment of mutant MYD88 L265P diffuse large B-cell lymphoma. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY[J]. 2020, 190: http://dx.doi.org/10.1016/j.ejmech.2020.112092.
[29] Fan, YaoYue, Shi, ShuQin, Deng, GuoZhen, Liu, HongChun, Xu, ChengHui, Ding, Jian, Wang, GuanWu, Yue, JianMin. Crokonoids A-C, A Highly Rearranged and Dual-Bridged Spiro Diterpenoid and Two Other Diterpenoids from Croton kongensis. ORGANIC LETTERS[J]. 2020, 22(3): 929-933, https://www.webofscience.com/wos/woscc/full-record/WOS:000513082700034.
[30] Zhang, Tao, Qu, Rong, Chan, Shingpan, Lai, Mengzhen, Tong, Linjiang, Feng, Fang, Chen, Hongyu, Song, Tingting, Song, Peiran, Bai, Gang, Liu, Yingqiang, Wang, Yanan, Li, Yan, Su, Yi, Shen, Yanyan, Sun, Yiming, Chen, Yi, Geng, Meiyu, Ding, Ke, Ding, Jian, Xie, Hua. Discovery of a novel third-generation EGFR inhibitor and identification of a potential combination strategy to overcome resistance. MOLECULAR CANCER[J]. 2020, 19(1): http://dx.doi.org/10.1186/s12943-020-01202-9.
[31] Lu Wang, Jing Ai, Yanyan Shen, Haotian Zhang, Xia Peng, Min Huang, Ao Zhang, Jian Ding, Meiyu Geng. Corrigendum to "SOMCL-863, a novel, selective and orally bioavailable small-molecule c-Met inhibitor, exhibits antitumor activity both in vitro and in vivo" Cancer Lett. 351 (2014) 143–50. CANCER LETTERS. 2020, 486: 71-72, http://dx.doi.org/10.1016/j.canlet.2020.05.010.
[32] Xiang, HaoYue, Chen, YanHong, Wang, Yi, Zhang, Xi, Ding, Jian, Meng, LingHua, Yang, ChunHao. Design, synthesis and antiproliferative activity evaluation of a series of pyrrolo 2,1-f 1,2,4 triazine derivatives. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS[J]. 2020, 30(12): http://dx.doi.org/10.1016/j.bmcl.2020.127194.
[33] Xie, Shao, Wei, Fan, Sun, Yiming, Gao, Yinglei, Pan, Lulu, Tan, Minjia, Wang, Shudong, Ding, Jian, Chen, Yi. EZH2 inhibitors abrogate upregulation of trimethylation of H3K27 by CDK9 inhibitors and potentiate its activity against diffuse large B-cell lymphoma. HAEMATOLOGICA[J]. 2020, 105(4): 1021-1031, https://www.webofscience.com/wos/woscc/full-record/WOS:000522793900035.
[34] Li, Xian, Tong, LinJiang, Ding, Jian, Meng, LingHua. Systematic combination screening reveals synergism between rapamycin and sutent against human lung cancer (vol 342, pg 159, 2014). CANCER LETTERS. 2020, 470: 220-220, https://www.webofscience.com/wos/woscc/full-record/WOS:000509628700023.
[35] Wang, Yuxiang, Li, Xian, Liu, Xueling, Wang, Bobo, Chen, Yi, Yang, Chunhao, Ding, Jian, Meng, Linghua. Simultaneous inhibition of PI3K alpha and CDK4/6 synergistically suppresses Kras-mutated non-small cell lung cancer. MOLECULAR CANCER RESEARCHnull. 2020, 18(10): 44-45, https://www.webofscience.com/wos/woscc/full-record/WOS:000576804500063.
[36] Zhang, Kaili, Shen, Qianqian, Fang, Yanfeng, Sun, Yiming, Ding, Jian, Chen, Yi. AZD9291 inactivates the PRC2 complex to mediate tumor growth inhibition (vol 0, pg 1, 2019). ACTA PHARMACOLOGICA SINICA. 2020, 41(5): 733-734, https://www.webofscience.com/wos/woscc/full-record/WOS:000513383400001.
[37] Wang, Yueqin, Shen, Aijun, Sun, Jingya, Wang, Xin, Liu, Hongchun, Zhang, Minmin, Chen, Danqi, Xiong, Bing, Shen, Jingkang, Geng, Meiyu, Zheng, Min, Ding, Jian. Targeting Hsp90 with FS-108 circumvents gefitinib resistance in EGFR mutant non-small cell lung cancer cells (vol 37, pg 1587, 2020). ACTA PHARMACOLOGICA SINICA. 2020, 41(5): 731-732, https://www.webofscience.com/wos/woscc/full-record/WOS:000514941800004.
[38] Lai Mengzhen, Song Peiran, Dou Dou, Diao Yanyan, Tong Linjiang, Zhang Tao, Xie Hua, Li Honglin, Ding Jian. Discovery and biological evaluation of N-(3-(7-((2-methoxy-4- (4-methylpiperazin-1-yl)phenyl)amino)-4-methyl-2-oxo-2Hpyrimido 4,5-d1,3oxazin-1(4H)-yl)phenyl)acrylamide as potent Bruton’s tyrosine kinase inhibitors. ACTA PHARMACOLOGICA SINICA[J]. 2020, 41(3): 415-422, http://lib.cqvip.com/Qikan/Article/Detail?id=7101290527.
[39] Jiajie Shi, Hui Xing, Yuxiang Wang, Xi Zhang, Qimin Zhan, Meiyu Geng, Jian Ding, Linghua Meng. PI3Kα inhibitors sensitize esophageal squamous cell carcinoma to radiation by abrogating survival signals in tumor cells and tumor microenvironment. CANCER LETTERS. 2019, 459: 145-155, http://dx.doi.org/10.1016/j.canlet.2019.05.040.
[40] Zhang Kaili, Shen Qianqian, Fang Yanfen, Sun Yiming, Ding Jian, Chen Yi. AZD9291 inactivates the PRC2 complex to mediate tumor growth inhibition. ACTA PHARMACOLOGICA SINICA[J]. 2019, 40(12): 1587-1595, http://sciencechina.cn/gw.jsp?action=detail.jsp&internal_id=6627159&detailType=1.
[41] Zhang, Tao, Qu, Rong, Chen, Chengbin, Tong, Linjiang, Feng, Fang, Chen, Yi, Geng, Meiyu, Ding, Ke, Xie, Hua, Ding, Jian. Discovery of a novel third generation EGFR TKI and identification of its potential mechanism of resistance. CANCER RESEARCH[J]. 2019, 79(13): https://www.webofscience.com/wos/woscc/full-record/WOS:000488279400205.
[42] Liu, XueLing, Wang, BoBo, Wang, Yi, Wang, YuXiang, Yang, Chunhao, Tan, Cun, Zhang, Xi, He, Qiaojun, Ding, Jian, Meng, LingHua. Unbiased screening reveals that blocking exportin 1 overcomes resistance to PI3K alpha inhibition in breast cancer. SIGNAL TRANSDUCTION AND TARGETED THERAPY. 2019, 4: https://www.webofscience.com/wos/woscc/full-record/WOS:000497730000001.
[43] Diao, Yanyan, Fang, Xiaoyu, Song, Peiran, Lai, Mengzhen, Tong, Linjiang, Hao, Yongjia, Dou, Dou, Liu, Yingqiang, Ding, Jian, Zhao, Zhenjiang, Xie, Hua, Li, Honglin. Discovery and Biological evaluation of pyrimido4,5-d pyrimidine-2,4(1H, 3H)-dione derivatives as potent Bruton's tyrosine kinase inhibitors. BIOORGANICMEDICINALCHEMISTRY[J]. 2019, 27(15): 3390-3395, http://dx.doi.org/10.1016/j.bmc.2019.06.023.
[44] Han, Guifang, Qing, Lihua, Wu, Meng, Wang, Yuxiang, Liu, Yuxiu, Liu, Xueling, Wang, Ziwen, Ding, Jian, Meng, Linghua, Wang, Qingmin. Design, synthesis, and biological activity evaluation of (-)-6-O-desmethylantofine analogues as potent anti-cancer agents. BIOORGANIC & MEDICINAL CHEMISTRY[J]. 2019, 27(14): 3070-3081, http://dx.doi.org/10.1016/j.bmc.2019.05.030.
[45] Wang, Yuxiang, Li, Xian, Liu, Xueling, Chen, Yi, Yang, Chunhao, Tan, Cun, Wang, Bobo, Sun, Yiming, Zhang, Xi, Gao, Yinglei, Ding, Jian, Meng, Linghua. Simultaneous inhibition of PI3K alpha and CDK4/6 synergistically suppresses KRAS-mutated non-small cell lung cancer. CANCER BIOLOGY & MEDICINE[J]. 2019, 16(1): 66-+, [46] Wang, Yuxiang, Zhang, Xu, Ma, Qingyang, Zhang, Xi, Yang, Chunhao, Tan, Cun, Hu, Landing, Ding, Jian, Meng, Linghua. HRAS(G12s) mutant mediates resistance to a PI3K alpha inhibitor CYH33 in esophageal squamous cell carcinomas. MOLECULAR CANCER THERAPEUTICS[J]. 2019, 18(12): [47] Leung, Elaine LaiHan, Luo, Lian Xiang, Li, Ying, Liu, ZhongQiu, Li, Lan Lan, Shi, Dan Feng, Xie, Ying, Huang, Min, Lu, Lin Lin, Duan, Fu Gang, Huang, Ju Min, Fan, Xing Xing, Yuan, Zhong Wen, Ding, Jian, Yao, Xiao Jun, Ward, David C, Liu, Liang. Identification of a new inhibitor of KRAS-PDE delta interaction targeting KRAS mutant nonsmall cell lung cancer. INTERNATIONAL JOURNAL OF CANCER[J]. 2019, 145(5): 1334-1345, http://dx.doi.org/10.1002/ijc.32222.
[48] 丁健. 肿瘤的精准治疗与挑战. 中国药理学与毒理学杂志[J]. 2019, 33(10): 1-, http://lib.cqvip.com/Qikan/Article/Detail?id=7100596754.
[49] Qin, Wenyan, Wang, Xiaodong, Wang, Yilin, Li, Yalun, Chen, Qiuchen, Hu, Xiaoyun, Wu, Zhikun, Zhao, Pengfei, Li, Shanqiong, Zhao, Haishan, Yao, Weifan, Ding, Jian, Wei, Minjie, Wu, Huizhe. Functional polymorphisms of the lncRNA H19 promoter region contribute to the cancer risk and clinical outcomes in advanced colorectal cancer. CANCER CELL INTERNATIONAL[J]. 2019, 19(1): http://gooa.las.ac.cn/external/index?type=-1&pid=1509460.
[50] Wang, Xinyi, Ai, Jing, Liu, Hongyan, Peng, Xia, Chen, Hui, Chen, Yi, Su, Yi, Shen, Aijun, Huang, Xun, Ding, Jian, Geng, Meiyu. The Secretome Engages STAT3 to Favor a Cytokine-rich Microenvironment in Mediating Acquired Resistance to FGFR Inhibitors. MOLECULAR CANCER THERAPEUTICS[J]. 2019, 18(3): 667-679, http://dx.doi.org/10.1158/1535-7163.MCT-18-0179.
[51] Liu, XueLing, Liu, JiaLi, Xu, YiChao, Zhang, Xi, Wang, YuXiang, Qing, LiHua, Guo, Wei, Ding, Jian, Meng, LingHua. Membrane metallo-endopeptidase mediates cellular senescence induced by oncogenic PIK3CA(H1047R) accompanied with pro-tumorigenic secretome. INTERNATIONAL JOURNAL OF CANCER[J]. 2019, 145(3): 817-829, [52] Xia Peng, Pengcong Hou, Yi Chen, Yang Dai, Yinchun Ji, Yanyan Shen, Yi Su, Bo Liu, Yueliang Wang, Deqiao Sun, Yuchen Jiang, Chuantao Zha, Zuoquan Xie, Jian Ding, Meiyu Geng, Jing Ai. Preclinical evaluation of 3D185, a novel potent inhibitor of FGFR1. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH[J]. 2019, 38(1): http://dx.doi.org/10.1186/s13046-019-1357-y.
[53] Wang Xinyi, Sun Guangqiang, Feng Teng, Zhang Jing, Huang Xun, Wang Tao, Xie Zuoquan, Chu Xingkun, Yang Jun, Wang Huan, Chang Shuaishuai, Gong Yanxue, Ruan Lingfei, Zhang Guanqun, Yan Siyuan, Lian Wen, Du Chen, Yang Dabing, Zhang Qingli, Lin Feifei, Liu Jia, Zhang Haiyan, Ge Changrong, Xiao Shifu, Ding Jian, Geng Meiyu. Sodium oligomannate therapeutically remodels gut microbiota and suppresses gut bacterial amino acids-shaped neuroinflammation to inhibit Alzheimer’s disease progression. CELL RESEARCH[J]. 2019, 29(10): 787-803, http://sciencechina.cn/gw.jsp?action=detail.jsp&internal_id=6581799&detailType=1.
[54] Nan Jin, Aiwei Bi, Xiaojing Lan, Jun Xu, Xiaomin Wang, Yingluo Liu, Ting Wang, Shuai Tang, Hanlin Zeng, Ziqi Chen, Minjia Tan, Jing Ai, Hua Xie, Tao Zhang, Dandan Liu, Ruimin Huang, Yue Song, Elaine LaiHan Leung, Xiaojun Yao, Jian Ding, Meiyu Geng, ShuHai Lin, Min Huang. Identification of metabolic vulnerabilities of receptor tyrosine kinases-driven cancer. NATURE COMMUNICATIONS[J]. 2019, 10(1): 1-15, https://doaj.org/article/9657645615f24b61be1f24096a3bc13c.
[55] Ge, ZhanPeng, Liu, HongChun, Wang, GuoCai, Liu, QunFang, Xu, ChengHui, Ding, Jian, Fan, YaoYue, Yue, JianMin. 17-nor-Cephalotane-Type Diterpenoids from Cephalotaxus fortunei. JOURNAL OF NATURAL PRODUCTS[J]. 2019, 82(6): 1565-1575, https://www.webofscience.com/wos/woscc/full-record/WOS:000473827300021.
[56] Niu, Ao, Wang, Yang, Yang, Yushe, Wei, Jianhai, Ding, Jian, Chen, Yi, Tong, Linjiang, Xie, Hua. Synthesis and Biological Evaluation of Oxopyrido2,3-d Pyrimidine-7-ones Derivatives as Covalent L85812/T790M Mutant Selective Epidermal Growth Factor Receptor (EGFR) Inhibitors. LETTERS IN DRUG DESIGN & DISCOVERY[J]. 2019, 16(8): 826-834, https://www.webofscience.com/wos/woscc/full-record/WOS:000480359800001.
[57] Wang, Xin, Zhang, Minmin, Ping, Fangfang, Liu, Hongchun, Sun, Jingya, Wang, Yueqin, Shen, Aijun, Ding, Jian, Geng, Meiyu. Identification and Therapeutic Intervention of Coactivated Anaplastic Lymphoma Kinase, Fibroblast Growth Factor Receptor 2, and Ephrin Type-A Receptor 5 Kinases in Hepatocellular Carcinoma. HEPATOLOGY[J]. 2019, 69(2): 573-586, http://dx.doi.org/10.1002/hep.29792.
[58] Wang, Xiaomin, Xu, Jun, Ding, Jian, Geng, Meiyu, Huang, Min. Histone marks interplay at LIFR enhancer determines the response to HDAC inhibitors in breast cancer. CANCERRESEARCH[J]. 2019, 79(13): https://www.webofscience.com/wos/woscc/full-record/WOS:000488129903482.
[59] Shen, Jiayi, Zhang, Tao, Zhu, SuJie, Sun, Min, Tong, Linjiang, Lai, Mengzhen, Zhang, Rong, Xu, Wei, Wu, Ruibo, Ding, Jian, Yun, CaiHong, Xie, Hua, Lu, Xiaoyun, Ding, Ke. Structure-Based Design of 5-Methylpyrimidopyridone Derivatives as New Wild-Type Sparing Inhibitors of the Epidermal Growth Factor Receptor Triple Mutant (EGFR(L858R/T790M/C797S)). JOURNAL OF MEDICINAL CHEMISTRY[J]. 2019, 62(15): 7302-7308, https://www.webofscience.com/wos/woscc/full-record/WOS:000480500600029.
[60] Guo, Zuhao, Zhang, Zhuqing, Yang, Hong, Cao, Danyan, Xu, Xiaowei, Zheng, Xineng, Chen, Danqi, Wang, Qi, Li, Yanlian, Li, Jian, Du, Zhiyan, Wang, Xin, Chen, Lin, Ding, Jian, Shen, Jingkang, Geng, Meiyu, Huang, Xun, Xiong, Bing. Design and Synthesis of Potent, Selective Inhibitors of Protein Arginine Methyltransferase 4 against Acute Myeloid Leukemia. JOURNAL OF MEDICINAL CHEMISTRY[J]. 2019, 62(11): 5414-5433, [61] Ma, Rong, Zhao, Yanyun, He, Miao, Zhao, Hongliang, Zhang, Yifan, Zhou, Shuqi, Gao, Mengcong, Di, Di, Wang, Jue, Ding, Jian, Wei, Minjie. Identifying a ten-microRNA signature as a superior prognosis biomarker in colon adenocarcinoma. CANCER CELL INTERNATIONAL[J]. 2019, 19(1): http://dx.doi.org/10.1186/s12935-019-1074-9.
[62] Shi, Jiajie, Xing, Hui, Wang, Yuxiang, Zhang, Xi, Zhan, Qimin, Geng, Meiyu, Ding, Jian, Meng, Linghua. PI3K alpha inhibitors sensitize esophageal squamous cell carcinoma to radiation by abrogating survival signals in tumor cells and tumor microenvironment. CANCER LETTERS[J]. 2019, 459: 145-155, [63] Hu, Zonglong, Wang, Yafang, Su, Yi, Shen, Yanyan, Fang, Yanfen, Ding, Jian, Chen, Yi. Histone deacetylase inhibitors promote breast cancer metastasis by elevating NEDD9 expression. CANCER RESEARCH[J]. 2019, 79(13): [64] Wang Yuxiang, Li Xian, Liu Xueling, Chen Yi, Yang Chunhao, Tan Cun, Wang Bobo, Sun Yiming, Zhang Xi, Gao Yinglei, Ding Jian, Meng Linghua. Simultaneous inhibition of PI3Kα and CDK4/6 synergistically suppresses KRAS-mutated non-small cell lung cancer. CANCER BIOLOGY AND MEDICINE[J]. 2019, 16(1): 66-78, http://lib.cqvip.com/Qikan/Article/Detail?id=7001836976.
[65] Peng, Xia, Hou, Pengcong, Chen, Yi, Dai, Yang, Ji, Yinchun, Shen, Yanyan, Su, Yi, Liu, Bo, Wang, Yueliang, Sun, Deqiao, Jiang, Yuchen, Zha, Chuantao, Xie, Zuoquan, Ding, Jian, Geng, Meiyu, Ai, Jing. Preclinical evaluation of 3D185, a novel potent inhibitor of FGFR1/2/3 and CSF-1R, in FGFR-dependent and macrophage-dominant cancer models. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH[J]. 2019, 38(1): https://doaj.org/article/4d6fda581db942d897ce0702a1011ea4.
[66] Yuxiang Wang, Xian Li, Xueling Liu, Yi Chen, Chunhao Yang, Cun Tan, Bobo Wang, Yiming Sun, Xi Zhang, Yinglei Gao, Jian Ding, Linghua Meng. Simultaneous inhibition of PI3Kα and CDK4/6 synergistically suppresses KRAS-mutated non-small cell lung cancer. 癌症生物学与医学:英文版[J]. 2019, 16(1): 66-, http://lib.cqvip.com/Qikan/Article/Detail?id=7001836976.
[67] Chen Zhuo, Tong Linjiang, Tang Baiyou, Liu Hongyan, Wang Xin, Zhang Tao, Cao Xianwen, Chen Yi, Li Honglin, Qian Xuhong, Xu Yufang, Xie Hua, Ding Jian. C11, a novel fibroblast growth factor receptor 1 (FGFR1) inhibitor, suppresses breast cancer metastasis and angiogenesis. ACTA PHARMACOLOGICA SINICA[J]. 2019, 40(6): 823-832, http://sciencechina.cn/gw.jsp?action=detail.jsp&internal_id=6506349&detailType=1.
[68] Cui, JiaoJiao, Ji, KaiLong, Liu, HongChun, Zhou, Bin, Liu, QunFang, Xu, ChengHui, Ding, Jian, Zhao, JinXin, Yue, JianMin. Cytotoxic Tigliane Diterpenoids from Croton damayeshu. JOURNAL OF NATURAL PRODUCTS[J]. 2019, 82(6): 1550-1557, https://www.webofscience.com/wos/woscc/full-record/WOS:000473827300019.
[69] Zhu, Wenjing, Niu, Jumin, He, Miao, Zhang, Liwen, Lv, Xuemei, Liu, Fangxiao, Jiang, Longyang, Zhang, Jing, Yu, Zhaojin, Zhao, Lin, Bi, Jia, Yan, Yuanyuan, Wei, Qian, Huo, Hong, Fan, Yue, Chen, Yuzong, Ding, Jian, Wei, Minjie. SNORD89 promotes stemness phenotype of ovarian cancer cells by regulating Notch1-c-Myc pathway. JOURNAL OF TRANSLATIONAL MEDICINE[J]. 2019, 17(1): http://dx.doi.org/10.1186/s12967-019-2005-1.
[70] Li, Qiannan, Zhang, Tao, Li, Shiliang, Tong, Linjiang, Li, Junyu, Su, Zhicheng, Feng, Fang, Sun, Deheng, Tong, Yi, Wang, Xia, Zhao, Zhenjiang, Zhu, Lili, Ding, Jian, Li, Honglin, Xie, Hua, Xu, Yufang. Discovery of Potent and Noncovalent Reversible EGFR Kinase Inhibitors of EGFR(L858R/T790M/C797S). ACS MEDICINAL CHEMISTRY LETTERS[J]. 2019, 10(6): 869-873, [71] Xun, Huang, Juan, Yan, Min, Zhang, Yafang, Wang, Yi, Chen, Xuhong, Fu, Rongrui, Wei, Xingling, Zheng, Zhiwei, Liu, Xiong, Zhang, Hong, Yang, Bingbing, Hao, Yanyan, Shen, Yi, Su, Xiaoji, Cong, Min, Huang, 谭敏佳, 丁健, 耿美玉. 靶向表观遗传相互作用为EZH2异常的实体瘤群体提供精准治疗策略. 科学新闻[J]. 2019, 44-44, http://lib.cqvip.com/Qikan/Article/Detail?id=75888869504849574850485051.
[72] Zhang, Xiong, Zheng, Xingling, Yang, Hong, Yan, Juan, Fu, Xuhong, Wei, Rongrui, Xu, Xiaowei, Zhang, Zhuqing, Yu, Aisong, Zhou, Kaixin, Ding, Jian, Geng, Meiyu, Huang, Xun. Piribedil disrupts the MLL1-WDR5 interaction and sensitizes MLL-rearranged acute myeloid leukemia (AML) to doxorubicin-induced apoptosis. CANCER LETTERS[J]. 2018, 431: 150-160, http://dx.doi.org/10.1016/j.canlet.2018.05.034.
[73] Rong-rui WEI, Dan-ni SUN, Hong YANG, Juan YAN, Xiong ZHANG, Xing-ling ZHENG, Xu-hong FU, Mei-yu GENG, Xun HUANG, Jian DING. CTC clusters induced by heparanase enhance breast cancer metastasis. 中国药理学报：英文版[J]. 2018, 39(8): 1326-1337, http://lib.cqvip.com/Qikan/Article/Detail?id=676188535.
[74] Liu, Xueling, Xu, Yichao, Wang, Yuxiang, Chen, Yi, Wang, Bobo, Wang, Yi, Chen, Yanhong, Tan, Cun, Hu, Landing, Ma, Qingyang, Zhang, Yuchao, Sun, Yiming, Gao, Yinglei, Yan, Chunhao, Ding, Jian, Meng, Linghua. Decrease in phosphorylated ERK indicates the therapeutic efficacy of a clinical PI3K alpha-selective inhibitor CYH33 in breast cancer. CANCER LETTERS[J]. 2018, 433: 273-282, https://www.webofscience.com/wos/woscc/full-record/WOS:000441489500027.
[75] Fang, Xiaona, Xie, Hua, Luo, Min, Chen, Zhen, Wang, Fang, Li, Qingshan, Wang, Xiaokun, Ding, Jian, Fu, Liwu. PBA2 exhibits potent anti-tumor activity via suppression of VEGFR2 mediated-cell proliferation and angiogenesis. BIOCHEMICAL PHARMACOLOGY[J]. 2018, 150: 131-140, http://dx.doi.org/10.1016/j.bcp.2018.01.051.
[76] Zhang, Jie, Wang, Yafang, Shen, Yanyan, He, Pengxing, Ding, Jian, Chen, Yi. G9a stimulates CRC growth by inducing p53 Lys373 dimethylation-dependent activation of Plk1. THERANOSTICS[J]. 2018, 8(10): 2884-2895, https://www.webofscience.com/wos/woscc/full-record/WOS:000509101800006.
[77] Zheng, YuanDong, Bai, Gang, Tang, Chunping, Ke, ChangQiang, Yao, Sheng, Tong, LinJiang, Feng, Fang, Li, Yan, Ding, Jian, Xie, Hua, Ye, Yang. 7 alpha,8 alpha-Epoxynagilactones and their glucosides from the twigs of Podocarpus nagi: Isolation, structures, and cytotoxic activities. FITOTERAPIA[J]. 2018, 125: 174-183, https://www.webofscience.com/wos/woscc/full-record/WOS:000425560500027.
[78] Xie, Shao, Wei, Fan, Sun, Yiming, Gao, Yinglei, Ding, Jian, Chen, Yi. EZH2 inhibitors abrogate upregulation of H3K27me3 by CDK9 inhibitors and potentiate its antitumor activity in DLBCL. CANCER RESEARCH[J]. 2018, 78(13): https://www.webofscience.com/wos/woscc/full-record/WOS:000468818900405.
[79] Wei, Rongrui, Sun, Danni, Yang, Hong, Yan, Juan, Zhang, Xiong, Zheng, Xingling, Fu, Xuhong, Geng, Meiyu, Huang, Xun, Ding, Jian. CTC clusters induced by heparanase enhance breast cancer metastasis. ACTA PHARMACOLOGICA SINICA[J]. 2018, 39(8): 1326-1337, http://lib.cqvip.com/Qikan/Article/Detail?id=676188535.
[80] Xiang, Haoyue, Wang, Xiang, Chen, Yanhong, Zhang, Xi, Chen, Yi, Tan, Cun, Wang, Yi, Ding, Jian, Meng, LingHua, Yang, Chunhao. Discovery of clinical candidate methyl (5-(6-((4(methylsulfonyl)piperazin-1-yl)methyl)-4-morpholinopyrrolo2,1-f1,2,4triazin-2-yl)-4-(trifluoromethyl)pyridin-2-yl)carbamate (CYH33) : A highly potent and selective PI3K alpha inhibitor for the treatment of advanced solid tumors. CANCER RESEARCH[J]. 2018, 78(13): https://www.webofscience.com/wos/woscc/full-record/WOS:000468818900414.
[81] Chen, Xuxing, Huan, Xiajuan, Liu, Qiufeng, Wang, Yuqin, He, Qian, Tan, Cun, Chen, Yi, Ding, Jian, Xu, Yechun, Miao, Zehong, Yang, Chunhao. Design and synthesis of 2-(4,5,6,7-tetrahydrothienopyridin-2-yl)-benzoimidazole carboxamides as novel orally efficacious Poly(ADP-ribose)polymerase (PARP) inhibitors. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY[J]. 2018, 145: 389-403, http://dx.doi.org/10.1016/j.ejmech.2018.01.018.
[82] 郭小彬, 刘红椿, 丁健. DCLAK11经线粒体通路诱导非小细胞肺癌细胞凋亡研究. 中华肿瘤防治杂志[J]. 2018, 25(23): 1621-1626, http://lib.cqvip.com/Qikan/Article/Detail?id=6100170495.
[83] Hao, Yongjia, Lyu, Jiankun, Qu, Rong, Tong, Yi, Sun, Deheng, Feng, Fang, Tong, Linjiang, Yang, Tingyuan, Zhao, Zhenjiang, Zhu, Lili, Ding, Jian, Xu, Yufang, Xie, Hua, Li, Honglin. Design, Synthesis, and Biological Evaluation of Pyrimido4,5-dpyrimidine-2,4(1H,3H)-diones as Potent and Selective Epidermal Growth Factor Receptor (EGFR) Inhibitors against L858R/T790M Resistance Mutation. JOURNAL OF MEDICINAL CHEMISTRY[J]. 2018, 61(13): 5609-5622, https://www.webofscience.com/wos/woscc/full-record/WOS:000439006100011.
[84] Shi, ShuQin, Fan, YaoYue, Xu, ChengHui, Ding, Jian, Wang, GuanWu, Yue, JianMin. Cytotoxic 8,9-seco-ent-kaurane diterpenoids from Croton kongensis. JOURNALOFASIANNATURALPRODUCTSRESEARCH[J]. 2018, 20(10): 920-927, https://www.webofscience.com/wos/woscc/full-record/WOS:000457087900002.
[85] Xue, Yu, Song, Peiran, Song, Zilan, Wang, Aoli, Tong, Linjiang, Geng, Meiyu, Ding, Jian, Liu, Qingsong, Sun, Liping, Xie, Hua, Zhang, Ao. Discovery of 4,7-Diamino-5-(4-phenoxyphenyl)-6-methylene-pyrinnido5,4-bpyrrolizines as Novel Bruton's Tyrosine Kinase Inhibitors. JOURNAL OF MEDICINAL CHEMISTRY[J]. 2018, 61(10): 4608-4627, https://www.webofscience.com/wos/woscc/full-record/WOS:000433403600022.
[86] Lu, Xiaoyun, Zhang, Tao, Zhu, SuJie, Xun, Qiuju, Tong, Lingjiang, Hu, Xianglong, Li, Yan, Chan, Shingpan, Su, Yi, Sun, Yiming, Chen, Yi, Ding, Jian, Yun, CaiHong, Xie, Hua, Ding, Ke. Discovery of JND3229 as a New EGFR(C797S) Mutant Inhibitor with In Vivo Monodrug Efficacy. ACS MEDICINAL CHEMISTRY LETTERS[J]. 2018, 9(11): 1123-1127, https://www.webofscience.com/wos/woscc/full-record/WOS:000449888400011.
[87] Jiang, Alan, Liu, Qiufeng, Wang, Ruifeng, Wei, Peng, Dai, Yang, Wang, Xin, Xu, Yechun, Ma, Yuchi, Ai, Jing, Shen, Jingkang, Ding, Jian, Xiong, Bing. Structure-Based Discovery of a Series of 5H-Pyrrolo2,3-bpyrazine FGFR Kinase Inhibitors. MOLECULES[J]. 2018, 23(3): https://doaj.org/article/c3498663542d4080999bd8c4f7ff08bb.
[88] Liu, Xueling, Ding, Jian, Meng, Linghua. Oncogene-induced senescence: a double edged sword in cancer. ACTA PHARMACOLOGICA SINICA[J]. 2018, 39(10): 1553-1558, http://lib.cqvip.com/Qikan/Article/Detail?id=676700479.
[89] Zheng, Qiangang, Chen, Ziqi, Wan, Huixin, Tang, Shuai, Ye, Yan, Xu, Yuan, Jiang, Lei, Ding, Jian, Geng, Meiyu, Huang, Min, Huang, Ying. Discovery and structure-activity-relationship study of novel imidazole cyclopropyl amine analogues for mutant isocitric dehydrogenase 1 (IDH1) inhibitors. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS[J]. 2018, 28(23-24): 3808-3812, http://dx.doi.org/10.1016/j.bmcl.2018.07.002.
[90] Huang, Xun, Yan, Juan, Zhang, Min, Wang, Yafang, Chen, Yi, Fu, Xuhong, Wei, Rongrui, Zheng, Xingling, Liu, Zhiwei, Zhang, Xiong, Yang, Hong, Hao, Bingbing, Shen, Yanyan, Su, Yi, Cong, Xiaoji, Huang, Min, Tan, Minjia, Ding, Jian, Geng, Meiyu. Targeting Epigenetic Crosstalk as a Therapeutic Strategy for EZH2-Aberrant Solid Tumors. CELL[J]. 2018, 175(1): 186-+, http://dx.doi.org/10.1016/j.cell.2018.08.058.
[91] Leung, Elaine Lai Han, Luo, Lian Xiang, Liu, Zhong Qiu, Wong, Vincent Kam Wai, Lu, Lin Lin, Xie, Ying, Zhang, Ni, Qu, Yuan Qing, Fan, Xing Xing, Li, Ying, Huang, Min, Xiao, Dai Kai, Huang, Jun, Zhou, Yan Ling, He, Jian Xing, Ding, Jian, Yao, Xiao Jun, Ward, David C, Liu, Liang. Inhibition of KRAS-dependent lung cancer cell growth by deltarasin: blockage of autophagy increases its cytotoxicity. CELL DEATH & DISEASE[J]. 2018, 9: https://doaj.org/article/94a4a044ebcf409f8b461f2f7ce44d66.
[92] Huang, MuYang, Zhang, LeLe, Ding, Jian, Lu, JinJian. Anticancer drug discovery from Chinese medicinal herbs. CHINESE MEDICINEnull. 2018, 13(1): https://doaj.org/article/bee01c7619c8430daabbb995f58a7910.
[93] Yafang Wang, Lei Yu, Jian Ding, Yi Chen. Iron Metabolism in Cancer. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES[J]. 2018, 20(1): https://doaj.org/article/1cf39946d4f944029afbd19f8a45c824.
[94] Shi, Jiajie, Chen, Simeng, Guo, ChenLiang, Li, Yixue, Ding, Jian, Meng, Linghua. The mTOR inhibitor AZD8055 overcomes tamoxifen resistance in breast cancer cells by down-regulating HSPB8. ACTA PHARMACOLOGICA SINICA[J]. 2018, 39(8): 1338-1346, http://lib.cqvip.com/Qikan/Article/Detail?id=676188536.
[95] YingQiang Liu, YaNan Wang, XiaoYun Lu, LinJiang Tong, Yan Li, Tao Zhang, QiuJu Xun, Fang Feng, YuZhe Chen, Yi Su, YanYan Shen, Yi Chen, MeiYu Geng, Ke Ding, YanLi Li, Hua Xie, Jian Ding. Identification of compound D2923 as a novel anti-tumor agent targeting CSF1R. 中国药理学报：英文版[J]. 2018, 39(11): 1768-1776, http://lib.cqvip.com/Qikan/Article/Detail?id=676856573.
[96] Jia-jie SHI, Si-meng CHEN, Chen-liang GUO, Yi-xue LI, Jian DING, Ling-hua MENG. The mTOR inhibitor AZD8055 overcomes tamoxifen resistance in breast cancer cells by down-regulating HSPB8. 中国药理学报：英文版[J]. 2018, 39(8): 1338-1346, http://lib.cqvip.com/Qikan/Article/Detail?id=676188536.
[97] 丁健. Piribedil disrupts the MLL1-WDR5 interaction aZengnd sensitizes MLL-rearranged acute MYeloid leukemia (AML) to doxorubicin-induced apoptosis.. Cancer Lett.[J]. 2018, [98] Liu, YingQiang, Wang, YaNan, Lu, XiaoYun, Tong, LinJiang, Li, Yan, Zhang, Tao, Xun, QiuJu, Feng, Fang, Chen, YuZhe, Su, Yi, Shen, YanYan, Chen, Yi, Geng, MeiYu, Ding, Ke, Li, YanLi, Xie, Hua, Ding, Jian. Identification of compound D2923 as a novel anti-tumor agent targeting CSF1R. ACTA PHARMACOLOGICA SINICA[J]. 2018, 39(11): 1768-1776, http://lib.cqvip.com/Qikan/Article/Detail?id=676856573.
[99] Xueling Liu, Yichao Xu, Yuxiang Wang, Yi Chen, Bobo Wang, Yi Wang, Landing Hu, Qingyang Ma, Yuchao Zhang, Yiming Sun, Yinglei Gao, Chunhao Yang, Jian Ding, Linghua Meng. Decrease in phosphorylated ERK indicates the therapeutic efficacy of a clinical PI3Kα-selective inhibitor CYH33 in breast cancer. CANCER LETTERS. 2018, 433: 273-282, http://dx.doi.org/10.1016/j.canlet.2018.07.011.
[100] Chen, Haiyang, Song, Peiran, Diao, Yanyan, Hao, Yongjia, Dou, Dou, Wang, Wanqi, Fang, Xiaoyu, Wang, Yanling, Zhao, Zhenjiang, Ding, Jian, Li, Honglin, Xie, Hua, Xu, Yufang. Discovery and biological evaluation of N5-substituted 6,7-dioxo-6,7-dihydropteridine derivatives as potent Bruton's tyrosine kinase inhibitors. MEDCHEMCOMM[J]. 2018, 9(4): 697-704, https://www.webofscience.com/wos/woscc/full-record/WOS:000435859400010.
[101] Yan, Qi, Chen, Yuzhe, Tang, Baiyou, Xiao, Qiang, Qu, Rong, Tong, Linjiang, Liu, Jian, Ding, Jian, Chen, Yi, Ding, Ning, Tan, Wenfu, Xie, Hua, Li, Yingxia. Discovery of novel 2,4-diarylaminopyrimidine derivatives as potent and selective epidermal growth factor receptor (EGFR) inhibitors against L858R/T790M resistance mutation. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY[J]. 2018, 152: 298-306, http://dx.doi.org/10.1016/j.ejmech.2018.04.052.
[102] Zha, Chuantao, Deng, Wenjia, Fu, Yan, Tang, Shuai, Lan, Xiaojing, Ye, Yan, Su, Yi, Jiang, Lei, Chen, Yi, Huang, Ying, Ding, Jian, Geng, Meiyu, Huang, Min, Wan, Huixin. Design, synthesis and biological evaluation of tetrahydronaphthyridine derivatives as bioavailable CDK4/6 inhibitors for cancer therapy. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY[J]. 2018, 148: 140-153, http://dx.doi.org/10.1016/j.ejmech.2018.02.022.
[103] Ai, Jing, Chen, Yi, Peng, Xia, Ji, Yinchun, Xi, Yong, Shen, Yanyan, Yang, Xinying, Su, Yi, Sun, Yiming, Gao, Yinglei, Ma, Yuchi, Xiong, Bing, Shen, Jingkang, Ding, Jian, Geng, Meiyu. Preclinical Evaluation of SCC244 (Glumetinib), a Novel, Potent, and Highly Selective Inhibitor of c-Met in MET-dependent Cancer Models. MOLECULAR CANCER THERAPEUTICS[J]. 2018, 17(4): 751-762, [104] Sun, Jingya, Wang, Xin, Tang, Boyun, Liu, Hongchun, Zhang, Minmin, Wang, Yueqin, Ping, Fangfang, Ding, Jian, Shen, Aijun, Geng, Meiyu. A tightly controlled Src-YAP signaling axis determines therapeutic response to dasatinib in renal cell carcinoma. THERANOSTICS[J]. 2018, 8(12): 3256-3267, [105] Xu, Jun, Jin, Nan, Huang, Min, Ding, Jian, Geng, Meiyu. CREB orchestrates metabolic reprogramming in PDGFRA-addicted lung squamous cell cancer. CANCER RESEARCH[J]. 2018, 78(13): https://www.webofscience.com/wos/woscc/full-record/WOS:000468818905278.
[106] Xueling LIU, Jian DING, Linghua MENG. Oncogene-induced senescence: a double edged sword in cancer. 中国药理学报：英文版[J]. 2018, 39(10): 1553-1558, http://lib.cqvip.com/Qikan/Article/Detail?id=676700479.
[107] Xie, Qin, Chen, Hui, Ai, Jing, Gao, Yinglei, Geng, Meiyu, Ding, Jian, Chen, Yi. Evaluation of in vitro and in vivo activity of a multityrosine kinase inhibitor, AL3810, against human thyroid cancer. ACTA PHARMACOLOGICA SINICA[J]. 2017, 38(11): 1533-1542, http://lib.cqvip.com/Qikan/Article/Detail?id=673835641.
[108] Li, Xiaoguang, Tang, Shuai, Wang, QianQian, Leung, Elaine L H, Jin, Hongyue, Huang, Yongzhuo, Liu, Jia, Geng, Meiyu, Huang, Min, Yuan, Shengtao, Yao, XiaoJun, Ding, Jian. Identification of Epigallocatechin-3-Gallate as an Inhibitor of Phosphoglycerate Mutase 1. FRONTIERS IN PHARMACOLOGY[J]. 2017, 8: https://doaj.org/article/6f19c15bad5a4070b262f71b749f7348.
[109] Wang, Guimin, Wang, Xiang, Zhu, Jianming, Guo, Binbin, Yang, Zhuo, Xu, Zhijian, Li, Bo, Wang, Heyao, Meng, Linghua, Zhu, Weiliang, Ding, Jian. Docking-based structural splicing and reassembly strategy to develop novel deazapurine derivatives as potent B-Raf(V600E) inhibitors. ACTA PHARMACOLOGICA SINICA[J]. 2017, 38(7): 1059-1068, http://dx.doi.org/10.1038/aps.2016.173.
[110] Wen-hua CHEN, Shan-shan SONG, Ming-hui QI, Xia-juan HUAN, Ying-qing WANG, Hualiang JIANG, Jian DING, Guo-bin REN, Ze-hong MIAO, Jian LI. Discovery of potent 2,4-difluoro-linker poly(ADPribose) polymerase i inhibitors with enhanced water solubility and in vivo anticancer efficacy. 中国药理学报：英文版[J]. 2017, 38(11): 1521-1532, http://lib.cqvip.com/Qikan/Article/Detail?id=673835640.
[111] Yang, Zhongmin, Liao, Xuemei, Chen, Yi, Shen, Yanyan, Yang, Xinying, Su, Yi, Sun, Yiming, Gao, Yinglei, Ding, Jian, Zhang, Ao, He, Jinxue, Miao, Zehong. Combining 53BP1 with BRCA1 as a biomarker to predict the sensitivity of poly(ADP-ribose) polymerase (PARP) inhibitors. ACTA PHARMACOLOGICA SINICA[J]. 2017, 38(7): 1038-1047, https://www.webofscience.com/wos/woscc/full-record/WOS:000404918600007.
[112] He, JinXue, Wang, Meng, Huan, XiaJuan, Chen, ChuanHuizi, Song, ShanShan, Wang, YingQing, Liao, XueMei, Tan, Cun, He, Qian, Tong, LinJiang, Wang, YuTing, Li, XiaoHua, Su, Yi, Shen, YanYan, Sun, YiMing, Yang, XinYing, Chen, Yi, Gao, ZhiWei, Chen, XiaoYan, Xiong, Bing, Lu, XiuLian, Ding, Jian, Yang, ChunHao, Miao, ZeHong. Novel PARP1/2 inhibitor mefuparib hydrochloride elicits potent in vitro and in vivo anticancer activity, characteristic of high tissue distribution. ONCOTARGET[J]. 2017, 8(3): 4156-4168, https://www.webofscience.com/wos/woscc/full-record/WOS:000393228400033.
[113] Xu, Yichao, Wang, Xiang, Chen, Yi, Chen, Simeng, Yang, Xinying, Sun, Yiming, Geng, Meiyu, Ding, Jian, Meng, Linghua. Integration of Receptor Tyrosine Kinases Determines Sensitivity to PI3K alpha-selective Inhibitors in Breast Cancer. THERANOSTICS[J]. 2017, 7(4): 974-986, http://dx.doi.org/10.7150/thno.17830.
[114] Qin XIE, Hui CHEN, Jing AI, Ying-lei GAO, Mei-yu GENG, Jian DING, Yi CHEN. Evaluation of in vitro and in vivo activity of a multityrosine kinase inhibitor, AL3810, against human thyroid cancer. 中国药理学报：英文版[J]. 2017, 38(11): 1533-1542, http://lib.cqvip.com/Qikan/Article/Detail?id=673835641.
[115] Dai, Xiaoyang, Yan, Juan, Fu, Xuhong, Pan, Qiuming, Sun, Danni, Xu, Yuan, Wang, Jiang, Nie, Litong, Tong, Linjiang, Shen, Aijun, Zheng, Mingyue, Huang, Min, Tan, Minjia, Liu, Hong, Huang, Xun, Ding, Jian, Geng, Meiyu. Aspirin Inhibits Cancer Metastasis and Angiogenesis via Targeting Heparanase. CLINICAL CANCER RESEARCH[J]. 2017, 23(20): 6267-6278, https://www.webofscience.com/wos/woscc/full-record/WOS:000413151000027.
[116] Yue, Xihua, Ai, Jing, Xu, Yang, Chen, Yi, Huang, Min, Yang, Xinying, Hu, Bo, Zhang, Haotian, He, Changxi, Yang, Xinrong, Tang, Weiguo, Peng, Xia, Dong, Liwei, Wang, Hongyang, Fan, Jia, Ding, Jian, Geng, Meiyu. Polymeric Immunoglobulin Receptor Promotes Tumor Growth in Hepatocellular Carcinoma. HEPATOLOGY[J]. 2017, 65(6): 1948-1962, https://www.webofscience.com/wos/woscc/full-record/WOS:000401608900017.
[117] 郭小彬, 刘红椿, 丁健. DCLAK11对非小细胞肺癌细胞HCC827的抗肿瘤作用. 中国医院药学杂志[J]. 2017, 37(19): 1914-1917, http://lib.cqvip.com/Qikan/Article/Detail?id=673755583.
[118] Li, Jing, Zhang, Xiaofei, Xiang, Haoyue, Tong, Linjiang, Feng, Fang, Xie, Hua, Ding, Jian, Yang, Chunhao. C-H Trifluoromethylation of 2-Substituted/Unsubstituted Aminonaphthoquinones at Room Temperature with Bench-Stable (CF3SO2)(2)Zn: Synthesis and Antiproliferative Evaluation. JOURNAL OF ORGANIC CHEMISTRY[J]. 2017, 82(13): 6795-6800, https://www.webofscience.com/wos/woscc/full-record/WOS:000405358000029.
[119] Yongjia Hao, Jiankun Lyu, Rong Qu, Deheng Sun, Zhenjiang Zhao, Zhuo Chen, Jian Ding, Hua Xie, Yufang Xu, Honglin Li. Structure-Guided Design of C4-alkyl-1,4-dihydro-2H-pyrimido4,5-d1,3oxazin-2-ones as Potent and Mutant-Selective Epidermal Growth Factor Receptor (EGFR) L858R/T790M Inhibitors. SCIENTIFIC REPORTS[J]. 2017, 7(1): https://doaj.org/article/ec058e038ab0407bb9e8ffb910e0f32f.
[120] Yuan, Bo, Ye, Na, Song, ShanShan, Wang, YuTing, Song, Zilan, Chen, HuaDong, Chen, ChuanHuizi, Huan, XiaJuan, Wang, YingQing, Su, Yi, Shen, YanYan, Sun, YiMing, Yang, XinYing, Chen, Yi, Guo, ShiYan, Gan, Yong, Gao, ZhiWei, Chen, XiaoYan, Ding, Jian, He, JinXue, Zhang, Ao, Miao, ZeHong. Poly(ADP-ribose)polymerase (PARP) inhibition and anticancer activity of simmiparib, a new inhibitor undergoing clinical trials. CANCER LETTERS[J]. 2017, 386: 47-56, http://dx.doi.org/10.1016/j.canlet.2016.11.010.
[121] Zhou, Bin, Wu, Yan, Dalal, Seema, Merino, Emilio F, Liu, QunFang, Xu, ChengHui, Yuan, Tao, Ding, Jian, Kingston, David G I, Cassera, Maria B, Yue, JianMin. Nanomolar Antimalarial Agents against Chloroquine-Resistant Plasmodium falciparum from Medicinal Plants and Their Structure-Activity Relationships. JOURNAL OF NATURAL PRODUCTS[J]. 2017, 80(1): 96-107, https://www.webofscience.com/wos/woscc/full-record/WOS:000393089600014.
[122] Fan, YaoYue, Xu, JinBiao, Liu, HongChun, Gan, LiShe, Ding, Jian, Yue, JianMin. Cephanolides A-J, Cephalotane-Type Diterpenoids from Cephalotaxus sinensis. JOURNAL OF NATURAL PRODUCTS[J]. 2017, 80(12): 3160-3167, https://www.webofscience.com/wos/woscc/full-record/WOS:000418879300010.
[123] Fu, Yan, Tang, Shuai, Su, Yi, Lan, Xiaojing, Ye, Yan, Zha, Chuantao, Li, Lei, Cao, Jianhua, Chen, Yi, Jiang, Lei, Huang, Ying, Ding, Jian, Geng, Meiyu, Huang, Min, Wan, Huixin. Discovery of a class of diheteroaromatic amines as orally bioavailable CDK1/4/6 inhibitors. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS[J]. 2017, 27(23): 5332-5336, http://dx.doi.org/10.1016/j.bmcl.2017.09.050.
[124] Lu, DaYong, Chen, EnHong, Wu, HongYing, Lu, TingRen, Xu, Bin, Ding, Jian. Anticancer Drug Combinations, How Far We can Go Through?. ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY[J]. 2017, 17(1): 21-28, http://www.corc.org.cn/handle/1471x/2193054.
[125] Liu, Yuxiu, Qing, Lihua, Meng, Chuisong, Shi, Jiajie, Yang, Yan, Wang, Ziwen, Han, Guifang, Wang, Yi, Ding, Jian, Meng, Linghua, Wang, Qingmin. 6-OH-Phenanthroquinolizidine Alkaloid and Its Derivatives Exert Potent Anticancer Activity by Delaying S Phase Progression. JOURNAL OF MEDICINAL CHEMISTRY[J]. 2017, 60(7): 2764-2779, https://www.webofscience.com/wos/woscc/full-record/WOS:000399436100011.
[126] Sun, Danni, Liu, Hongchun, Dai, Xiaoyang, Zheng, Xingling, Yan, Juan, Wei, Rongrui, Fu, Xuhong, Huang, Min, Shen, Aijun, Huang, Xun, Ding, Jian, Geng, Meiyu. Aspirin disrupts the mTOR-Raptor complex and potentiates the anti-cancer activities of sorafenib via mTORC1 inhibition. CANCER LETTERS[J]. 2017, 406: 105-115, http://dx.doi.org/10.1016/j.canlet.2017.06.029.
[127] Liu, Hongyan, Ai, Jing, Shen, Aijun, Chen, Yi, Wang, Xinyi, Peng, Xia, Chen, Hui, Shen, Yanyan, Huang, Min, Ding, Jian, Geng, Meiyu. c-Myc Alteration Determines the Therapeutic Response to FGFR Inhibitors. CLINICAL CANCER RESEARCH[J]. 2017, 23(4): 974-984, https://www.webofscience.com/wos/woscc/full-record/WOS:000393885700012.
[128] Yafang Wang, Jie Zhang, Yi Su, Yanyan Shen, Dongxian Jiang, Yingyong Hou, Meiyu Geng, Jian Ding, Yi Chen. G9a regulates breast cancer growth by modulating iron homeostasis through the repression of ferroxidase hephaestin. NATURE COMMUNICATIONS[J]. 2017, 8(1): https://doaj.org/article/c2b4a30f130740a69c6fdad77d98f0fb.
[129] Ding Jian. Phosphoglycerate mutase 1 (PGAM1) regulates dNTP pool and promotes homologous recombination repair in cancer cells.. J Cell Biology.. 2017, [130] Meiyu Geng. c-Myc alteration determines the therapeutic response to FGFR inhibitors.. Clin Cancer Res.. 2017, [131] Zheng, Qiangang, Tang, Shuai, Fu, Xianlei, Chen, Ziqi, Ye, Yan, Lan, Xiaojing, Jiang, Lei, Huang, Ying, Ding, Jian, Geng, Meiyu, Huang, Min, Wan, Huixin. Discovery and structure-activity-relationship study of novel conformationally restricted indane analogues for mutant isocitric dehydrogenase 1 (IDH1) inhibitors. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS[J]. 2017, 27(23): 5262-5266, http://dx.doi.org/10.1016/j.bmcl.2017.10.029.
[132] Fan, YaoYue, Gan, LiShe, Liu, HongChun, Li, Heng, Xu, ChengHui, Zuo, JianPing, Ding, Jian, Yue, JianMin. Phainanolide A, Highly Modified and Oxygenated Triterpenoid from Phyllanthus hainanensis. ORGANIC LETTERS[J]. 2017, 19(17): 4580-4583, http://dx.doi.org/10.1021/acs.orglett.7b02181.
[133] Chen, Lingfeng, Fu, Weitao, Feng, Chen, Qu, Rong, Tong, Linjiang, Zheng, Lulu, Fang, Bo, Qiu, Yinda, Hu, Jie, Cai, Yuepiao, Feng, Jianpeng, Xie, Hua, Ding, Jian, Liu, Zhiguo, Liang, Guang. Structure-based design and synthesis of 2,4-diaminopyrimidines as EGFR L858R/T790M selective inhibitors for NSCLC. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY[J]. 2017, 140: 510-527, http://dx.doi.org/10.1016/j.ejmech.2017.08.061.
[134] Chen, Wenhua, Guo, Ne, Qi, Minghui, Dai, Haiying, Hong, Minghuang, Guan, Longfei, Huan, Xiajuan, Song, Shanshan, He, Jinxue, Wang, Yingqing, Xi, Yong, Yang, Xinying, Shen, Yanyan, Su, Yi, Sun, Yiming, Gao, Yinglei, Chen, Yi, Ding, Jian, Tang, Yun, Ren, Guobin, Miao, Zehong, Li, Jian. Discovery, mechanism and metabolism studies of 2,3-difluorophenyl-linker-containing PARP1 inhibitors with enhanced in vivo efficacy for cancer therapy. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY[J]. 2017, 138: 514-531, http://dx.doi.org/10.1016/j.ejmech.2017.06.053.
[135] Qu, Jia, Sun, Wenyi, Zhong, Jie, Lv, Hao, Zhu, Mingrui, Xu, Jun, Jin, Nan, Xie, Zuoquan, Tan, Minjia, Lin, ShuHai, Geng, Meiyu, Ding, Jian, Huang, Min. Phosphoglycerate mutase 1 regulates dNTP pool and promotes homologous recombination repair in cancer cells. JOURNAL OF CELL BIOLOGY[J]. 2017, 216(2): 409-424, https://www.webofscience.com/wos/woscc/full-record/WOS:000394244800016.
[136] Chen, Wenhua, Song, Shanshan, Qi, Minghui, Huan, Xiajuan, Wang, Yingqing, Jiang, Hualiang, Ding, Jian, Ren, Guobin, Miao, Zehong, Li, Jian. Discovery of potent 2,4-difluoro-linker poly(ADP-ribose) polymerase 1 inhibitors with enhanced water solubility and in vivo anticancer efficacy. ACTA PHARMACOLOGICA SINICA[J]. 2017, 38(11): 1521-1532, https://www.webofscience.com/wos/woscc/full-record/WOS:000414248600010.
[137] Zhao, JinXin, Fan, YaoYue, Xu, JinBiao, Gan, LiShe, Xu, ChengHui, Ding, Jian, Yue, JianMin. Diterpenoids and Lignans from Cephalotaxus fortunei. JOURNAL OF NATURAL PRODUCTS[J]. 2017, 80(2): 356-362, https://www.webofscience.com/wos/woscc/full-record/WOS:000395046900015.
[138] Lian, Qiaoshi, Xu, Jun, Yan, Shanshan, Huang, Min, Ding, Honghua, Sun, Xiaoyu, Bi, Aiwei, Ding, Jian, Sun, Bing, Geng, Meiyu. Chemotherapy-induced intestinal inflammatory responses are mediated by exosome secretion of double-strand DNA via AIM2 inflammasome activation. CELL RESEARCH[J]. 2017, 27(6): 784-800, http://dx.doi.org/10.1038/cr.2017.54.
[139] Yichao Xu, Xiang Wang, Yi Chen, Simeng Chen, Xinying Yang, Yiming Sun, Meiyu Geng, Jian Ding, Linghua Meng. Integration of Receptor Tyrosine Kinases Determines Sensitivity to PI3Kα-selective Inhibitors in Breast Cancer. THERANOSTICS. 2017, 7(4): 974-986, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5381259/.
[140] Liu, CuiPing, Wang, GuoCai, Gan, LiShe, Xu, ChengHui, Liu, QunFang, Ding, Jian, Yue, JianMin. Ciliatonoids A and B, Two Limonoids from Toona ciliata. ORGANIC LETTERS[J]. 2016, 18(12): 2894-2897, http://dx.doi.org/10.1021/acs.orglett.6b01213.
[141] Ni, Gang, Zhang, Hua, Fan, YaoYue, Liu, HongChun, Ding, Jian, Yue, JianMin. Mannolides A-C with an Intact Diterpenoid Skeleton Providing Insights on the Biosynthesis of Antitumor Cephalotaxus Troponoids. ORGANIC LETTERS[J]. 2016, 18(8): 1880-1883, https://www.webofscience.com/wos/woscc/full-record/WOS:000374436800043.
[142] Meiyu Geng. Feedback activation of leukemia inhibitory factor receptor limits response to histone deacetylases inhibitors in breast cancer.. Cancer Cell,. 2016, [143] Zhou, Caihong, Dai, Xinchuan, Chen, Yi, Shen, Yanyan, Lei, Saifei, Xiao, Ting, Bartfai, Tamas, Ding, Jian, Wang, MingWei. G protein-coupled receptor GPR160 is associated with apoptosis and cell cycle arrest of prostate cancer cells. ONCOTARGET[J]. 2016, 7(11): 12823-12839, https://www.webofscience.com/wos/woscc/full-record/WOS:000375679600081.
[144] Meng-yuan LI, Yong-cong LV, Lin-jiang TONG, Ting PENG, Rong QU, Tao ZHANG, Yi-ming SUN, Yi CHEN, Li-xin WEI, Mei-yu GENG, Wen-hu DUAN, Hua XIE, Jian DING. DW10075, a novel selective and small-molecule inhibitor of VEGFR, exhibits antitumor activities both in vitro and in vivo. 中国药理学报：英文版[J]. 2016, 398-407, http://lib.cqvip.com/Qikan/Article/Detail?id=668260644.
[145] Xie, Shao, Jiang, Hui, Zhai, Xiaowen, Wei, Fan, Wang, Shudong, Ding, Jian, Chen, Yi. Antitumor action of CDK inhibitor LS-007 as a single agent and in combination with ABT-199 against human acute leukemia cells. ACTA PHARMACOLOGICA SINICA[J]. 2016, 37(11): 1481-1489, http://dx.doi.org/10.1038/aps.2016.49.
[146] Huang, RenYong, Chen, WenTing, Kurtan, Tibor, Mandi, Attila, Ding, Jian, Li, Jia, Li, XuWen, Guo, YueWei. Bioactive isoquinolinequinone alkaloids from the South China Sea nudibranch Jorunna funebris and its sponge-prey Xestospongia sp.. FUTURE MEDICINAL CHEMISTRY[J]. 2016, 8(1): 17-27, https://www.webofscience.com/wos/woscc/full-record/WOS:000367193900004.
[147] Li, Lei, Liu, Feifei, Jin, Nan, Tang, Shuai, Chen, Zhuxi, Yang, Xiaotong, Ding, Jian, Geng, Meiyu, Jiang, Lei, Huang, Min, Cao, Jianhua. Discovery and structure activity relationship study of novel indazole amide inhibitors for extracellular signal-regulated kinase1/2 (ERK1/2). BIOORGANIC & MEDICINAL CHEMISTRY LETTERS[J]. 2016, 26(11): 2600-2604, http://dx.doi.org/10.1016/j.bmcl.2016.04.029.
[148] Yan, Wei, Huang, Zhaoru, Wang, Zhengyu, Cao, Sufen, Tong, Linjiang, Zhang, Tao, Wang, Chen, Zhou, Lin, Ding, Jian, Luo, Cheng, Zhou, Jinpei, Xie, Hua, Duan, Wenhu. Discovery of 1,3-Diaryl-pyridones as Potent VEGFR-2 Inhibitors: Design, Synthesis, and Biological Evaluation. CHEMICAL BIOLOGY & DRUG DESIGN[J]. 2016, 87(5): 694-703, https://www.webofscience.com/wos/woscc/full-record/WOS:000374031500006.
[149] Zeng, Hanlin, Qu, Jia, Jin, Nan, Xu, Jun, Lin, Chenchu, Chen, Yi, Yang, Xinying, He, Xiang, Tang, Shuai, Lan, Xiaojing, Yang, Xiaotong, Chen, Ziqi, Huang, Min, Ding, Jian, Geng, Meiyu. Feedback Activation of Leukemia Inhibitory Factor Receptor Limits Response to Histone Deacetylase Inhibitors in Breast Cancer. CANCER CELL[J]. 2016, 30(3): 459-473, http://dx.doi.org/10.1016/j.ccell.2016.08.001.
[150] Hao, Yongjia, Wang, Xia, Zhang, Tao, Sun, Deheng, Tong, Yi, Xu, Yuqiong, Chen, Haiyang, Tong, Linjiang, Zhu, Lili, Zhao, Zhenjiang, Chen, Zhuo, Ding, Jian, Xie, Hua, Xu, Yufang, Li, Honglin. Discovery and Structural Optimization of N5-Substituted 6,7-Dioxo-6,7-dihydropteridines as Potent and Selective Epidermal Growth Factor Receptor (EGFR) Inhibitors against L858R/T790M Resistance Mutation. JOURNAL OF MEDICINAL CHEMISTRY[J]. 2016, 59(15): 7111-7124, https://www.webofscience.com/wos/woscc/full-record/WOS:000381452600009.
[151] Wang, Ying, Zhan, Zhengsheng, Jiang, Xifei, Peng, Xia, Shen, Yanyan, Chen, Fang, Ji, Yinchun, Liu, Weiren, Shi, Yinghong, Duan, Wenhu, Ding, Jian, Ai, Jing, Geng, Meiyu. Simm530, a novel and highly selective c-Met inhibitor, blocks c-Met-stimulated signaling and neoplastic activities. ONCOTARGET[J]. 2016, 7(25): 38091-38104, https://www.webofscience.com/wos/woscc/full-record/WOS:000378229100054.
[152] Xiao, Qiang, Qu, Rong, Gao, Dingding, Yan, Qi, Tong, Linjiang, Zhang, Wei, Ding, Jian, Xie, Hua, Li, Yingxia. Discovery of 5-(methylthio)pyrimidine derivatives as L858R/T790M mutant selective epidermal growth factor receptor (EGFR) inhibitors. BIOORGANIC & MEDICINAL CHEMISTRY[J]. 2016, 24(12): 2673-2680, http://dx.doi.org/10.1016/j.bmc.2016.04.032.
[153] Wang, Yueqin, Shen, Aijun, Sun, Jingya, Wang, Xin, Liu, Hongchun, Zhang, Minmin, Chen, Danqi, Xiong, Bing, Shen, Jingkang, Geng, Meiyu, Zheng, Min, Ding, Jian. Targeting Hsp90 with FS-108 circumvents gefitinib resistance in EGFR mutant non-small cell lung cancer cells. ACTA PHARMACOLOGICA SINICA[J]. 2016, 37(12): 1587-1596, https://www.webofscience.com/wos/woscc/full-record/WOS:000389704500007.
[154] Gao, GuoRui, Li, MengYuan, Lv, YongCong, Cao, SuFen, Tong, LinJiang, Wei, LiXin, Ding, Jian, Xie, Hua, Duan, WenHu. Design, synthesis and biological evaluation of biphenylurea derivatives as VEGFR-2 kinase inhibitors (II). CHINESE CHEMICAL LETTERS[J]. 2016, 27(2): 200-204, http://dx.doi.org/10.1016/j.cclet.2015.10.004.
[155] 丁健. 精准医疗时代的肿瘤药理学研究. 药学进展. 2015, 721-722, https://kns.cnki.net/KCMS/detail/detail.aspx?dbcode=CJFQ&dbname=CJFDLAST2016&filename=YXJZ201510002&v=MjYwNDZHNEg5VE5yNDlGWm9SOGVYMUx1eFlTN0RoMVQzcVRyV00xRnJDVVI3cWZiK1ptRnluZ1VielBQRFhCZEw=.
[156] Xiao-bin GUO, Wei ZHU, Xian-jie CHEN, Lin-jiang TONG, Xia PENG, Min HUANG, Hong-chun LIU, Hong LIU, Jian DING. DCLAK11, a multi-tyrosine kinase inhibitor, exhibits potent antitumor and antiangiogenic activity in vitro. 中国药理学报：英文版[J]. 2015, 1266-1276, http://lib.cqvip.com/Qikan/Article/Detail?id=666593595.
[157] Gao, Yongping, Li, Yongsheng, Wang, Yao, Chen, Yi, Gu, Jinlou, Zhao, Wenru, Ding, Jian, Shi, Jianlin. Controlled Synthesis of Multilayered Gold Nanoshells for Enhanced Photothermal Therapy and SERS Detection. SMALL[J]. 2015, 11(1): 77-83, https://www.webofscience.com/wos/woscc/full-record/WOS:000347280500006.
[158] Wang, Xiang, Ding, Jian, Meng, Linghua. PI3K isoform-selective inhibitors: next-generation targeted cancer therapies. ACTA PHARMACOLOGICA SINICA[J]. 2015, 36(10): 1170-1176, http://lib.cqvip.com/Qikan/Article/Detail?id=666593585.
[159] Lin, Chenchu, Zeng, Hanlin, Lu, Junyan, Xie, Zuoquan, Sun, Wenyi, Luo, Cheng, Ding, Jian, Yuan, Shengtao, Geng, Meiyu, Huang, Min. Acetylation at lysine 71 inactivates superoxide dismutase 1 and sensitizes cancer cells to genotoxic agents. ONCOTARGET[J]. 2015, 6(24): 20578-20591, https://www.webofscience.com/wos/woscc/full-record/WOS:000360138200073.
[160] Lv, Yongcong, Li, Mengyuan, Cao, Sufen, Tong, Linjiang, Peng, Ting, Wei, Lixin, Xie, Hua, Ding, Jian, Duan, Wenhu. Discovery of anilinopyrimidine-based naphthamide derivatives as potent VEGFR-2 inhibitors. MEDCHEMCOMM[J]. 2015, 6(7): 1375-1380, http://www.irgrid.ac.cn/handle/1471x/997353.
[161] Shen, Aijun, Wang, Lu, Huang, Min, Sun, Jingya, Chen, Yi, Shen, YanYan, Yang, Xinying, Wang, Xin, Ding, Jian, Geng, Meiyu. c-Myc Alterations Confer Therapeutic Response and Acquired Resistance to c-Met Inhibitors in MET-Addicted Cancers. CANCER RESEARCH[J]. 2015, 75(21): 4548-4559, https://www.webofscience.com/wos/woscc/full-record/WOS:000365602200013.
[162] 瞿戎, 陈成斌, 彭婷, 童林江, 丁克, 谢华, 丁健. 新型EGFR三代抑制剂120120的抗肿瘤作用研究. 2015, 119-120, https://kns.cnki.net/KCMS/detail/detail.aspx?dbcode=IPFD&dbname=IPFDLAST2016&filename=ZGKA201504001080&v=MTY4MzRyQWI3RzRIOVRNcTQ5Rlplc0hEQk5LdWhkaG5qOThUbmpxcXhkRWVNT1VLcmlmWmVadkhpbnRVNy9MSVZ3V1B5.
[163] Xu, Tianfeng, Peng, Ting, Ren, Xiaomei, Zhang, Lianwen, Yu, Lei, Luo, Jinfeng, Zhang, Zhang, Tu, Zhengchao, Tong, Linjiang, Huang, Zhaoru, Lu, Xiaoyun, Geng, Meiyu, Xie, Hua, Ding, Jian, Ding, Ke. C5-substituted pyrido2,3-dpyrimidin-7-ones as highly specific kinase inhibitors targeting the clinical resistance-related EGFR(T790M) mutant. MEDCHEMCOMM[J]. 2015, 6(9): 1693-1697, http://ir.foo.ac.cn/handle/2SETSVCV/721.
[164] 丁健. 精准医疗时代的抗肿瘤新药开发. 2015, 64-, https://kns.cnki.net/KCMS/detail/detail.aspx?dbcode=IPFD&dbname=IPFDLAST2016&filename=ZGKA201507001007&v=MTI3NDU5VE1xSTlGWmVzUEN4Tkt1aGRobmo5OFRuanFxeGRFZU1PVUtyaWZaZVp2SGludFU3L0pJbDhYUHlyQWI3RzRI.
[165] Zhang, DongDong, Zhou, Bin, Yu, JinHai, Xu, ChengHui, Ding, Jian, Zhang, Hua, Yue, JianMin. Cytotoxic tigliane-type diterpenoids from Croton tiglium. TETRAHEDRON[J]. 2015, 71(52): 9638-9644, http://dx.doi.org/10.1016/j.tet.2015.10.070.
[166] Song, Zilan, Yang, Yanhong, Liu, Zhiqing, Peng, Xia, Guo, Junfeng, Yang, Xinying, Wu, Kui, Ai, Jing, Ding, Jian, Geng, Meiyu, Zhang, Ao. Discovery of Novel 2,4-Diarylaminopyrimidine Analogues (DAAPalogues) Showing Potent Inhibitory Activities against Both Wild-type and Mutant ALK Kinases. JOURNAL OF MEDICINAL CHEMISTRY[J]. 2015, 58(1): 197-211, https://www.webofscience.com/wos/woscc/full-record/WOS:000347743700012.
[167] Guo, Xiaobin, Zhu, Wei, Chen, Xianjie, Tong, Linjiang, Peng, Xia, Huang, Min, Liu, Hongchun, Liu, Hong, Ding, Jian. DCLAK11, a multi-tyrosine kinase inhibitor, exhibits potent antitumor and antiangiogenic activity in vitro. ACTA PHARMACOLOGICA SINICA[J]. 2015, 36(10): 1266-1276, http://lib.cqvip.com/Qikan/Article/Detail?id=666593595.
[168] Sun, Wenyi, Xie, Zuoquan, Liu, Yifu, Zhao, Dan, Wu, Zhixiang, Zhang, Dadong, Lv, Hao, Tang, Shuai, Jin, Nan, Jiang, Hualiang, Tan, Minjia, Ding, Jian, Luo, Cheng, Li, Jian, Huang, Min, Geng, Meiyu. JX06 Selectively Inhibits Pyruvate Dehydrogenase Kinase PDK1 by a Covalent Cysteine Modification. CANCER RESEARCH[J]. 2015, 75(22): 4923-4936, https://www.webofscience.com/wos/woscc/full-record/WOS:000365602600024.
[169] Chan, Shingpan, Han, Kun, Qu, Rong, Tong, Linjiang, Li, Yingjun, Zhang, Zhang, Cheng, Huimin, Lu, Xiaoyun, Patterson, Adam, Smaill, Jeff, Ren, Xiaomei, Ding, Jian, Xie, Hua, Ding, Ke. 2,4-Diarylamino-pyrimidines as kinase inhibitors co-targeting IGF1R and EGFR(L858R/T790M). BIOORGANIC & MEDICINAL CHEMISTRY LETTERS[J]. 2015, 25(19): 4277-4281, http://dx.doi.org/10.1016/j.bmcl.2015.07.089.
[170] 衣君玫, 张小飞, 宦霞娟, 宋姗姗, 王炜, 田倩婷, 孙益铭, 陈奕, 丁健, 王迎庆, 杨春皓, 缪泽鸿. 微管与拓扑异构酶Ⅱ双靶点抑制剂YCH337的抗肿瘤作用与机制研究. 2015, 67-, https://kns.cnki.net/KCMS/detail/detail.aspx?dbcode=IPFD&dbname=IPFDLAST2016&filename=ZGKA201504001041&v=MjA5MjY4V1B5ckFiN0c0SDlUTXE0OUZaZXNMRFJOS3VoZGhuajk4VG5qcXF4ZEVlTU9VS3JpZlplWnZIaW50VTcvSUtG.
[171] Han, MeiLing, Zhao, JinXin, Liu, HongChun, Ni, Gang, Ding, Jian, Yang, ShengPing, Yue, JianMin. Limonoids and Triterpenoids from Dysoxylum mollissimum var. glaberrimum. JOURNAL OF NATURAL PRODUCTS[J]. 2015, 78(4): 754-761, http://ir.xtbg.org.cn/handle/353005/9091.
[172] Gao, GuoRui, Liu, JiaLi, Mei, DeSheng, Ding, Jian, Meng, LingHua, Duan, WenHu. Design, synthesis and biological evaluation of acylhydrazone derivatives as PI3K inhibitors. CHINESE CHEMICAL LETTERS[J]. 2015, 26(1): 118-120, http://dx.doi.org/10.1016/j.cclet.2014.10.016.
[173] Ma, Yuchi, Sun, Guangqiang, Chen, Danqi, Peng, Xia, Chen, YueLei, Su, Yi, Ji, Yinchun, Liang, Jin, Wang, Xin, Chen, Lin, Ding, Jian, Xiong, Bing, Ai, Jing, Geng, Meiyu, Shen, Jingkang. Design and Optimization of a Series of 1-Sulfonylpyrazolo4,3-bpyridines as Selective c-Met Inhibitors. JOURNAL OF MEDICINAL CHEMISTRY[J]. 2015, 58(5): 2513-2529, https://www.webofscience.com/wos/woscc/full-record/WOS:000351186500034.
[174] 卿丽华, 韩贵芳, 吴萌, 刘玉秀, 丁健, 蒙凌华, 汪清民. 新娃儿藤碱类似物抗肿瘤作用机制研究. 2015, 118-, https://kns.cnki.net/KCMS/detail/detail.aspx?dbcode=IPFD&dbname=IPFDLAST2016&filename=ZGKA201504001079&v=MjczMDZPVUtyaWZaZVp2SGludFU3L0lLRm9jUHlyQWI3RzRIOVRNcTQ5Rlplc0lCUk5LdWhkaG5qOThUbmpxcXhkRWVN.
[175] 李梦园, 吕永聪, 童林江, 瞿戎, 魏立新, 段文虎, 谢华, 丁健. 新型VEGFR选择性抑制剂DW10075的抗肿瘤与抗新生血管生成作用研究. 2015, 38-39, https://kns.cnki.net/KCMS/detail/detail.aspx?dbcode=IPFD&dbname=IPFDLAST2016&filename=ZGKA201504001018&v=MTU4MjNGWmVzT0JCTkt1aGRobmo5OFRuanFxeGRFZU1PVUtyaWZaZVp2SGludFU3L0lLVjBRUHlyQWI3RzRIOVRNcTQ5.
[176] Yi, JunMei, Zhang, XiaoFei, Huan, XiaJuan, Song, ShanShan, Wang, Wei, Tian, QianTing, Sun, YiMing, Chen, Yi, Ding, Jian, Wang, YingQing, Yang, ChunHao, Miao, ZeHong. Dual targeting of microtubule and topoisomerase II by alpha-carboline derivative YCH337 for tumor proliferation and growth inhibition. ONCOTARGET[J]. 2015, 6(11): 8960-8973, https://www.webofscience.com/wos/woscc/full-record/WOS:000358774600038.
[177] Wei, Manman, Wang, Xiang, Song, Zilan, Jiao, Mingkun, Ding, Jian, Meng, LingHua, Zhang, Ao. Targeting PI3K: Emerging Therapy for Chronic Lymphocytic Leukemia and Beyond. MEDICINAL RESEARCH REVIEWSnull. 2015, 35(4): 720-752, https://www.webofscience.com/wos/woscc/full-record/WOS:000356068800004.
[178] Gao, GuoRui, Li, MengYuan, Tong, LinJiang, Wei, LiXin, Ding, Jian, Xie, Hua, Duan, WenHu. Design, synthesis and biological evaluation of O-linked indoles as VEGFR-2 kinase inhibitors (I). CHINESE CHEMICAL LETTERS[J]. 2015, 26(9): 1165-1168, http://dx.doi.org/10.1016/j.cclet.2015.07.016.
[179] Qiang YU Jian DING. Precision cancer medicine: where to target?. 中国药理学报：英文版[J]. 2015, 1161-1162, http://lib.cqvip.com/Qikan/Article/Detail?id=666593583.
[180] Fan, XingXing, Yao, XiaoJun, Xu, Su Wei, Wong, Vincent KamWai, He, JianXing, Ding, Jian, Xue, WeiWei, Mujtaba, Tahira, Michelangeli, Francesco, Huang, Min, Huang, Jun, Xiao, DaKai, Jiang, ZeBo, Zhou, YanLing, Kam, Richard KinTing, Liu, Liang, Leung, Elaine LaiHan. (Z)3,4,5,4 '-trans-tetramethoxystilbene, a new analogue of resveratrol, inhibits gefitinb-resistant non-small cell lung cancer via selectively elevating intracellular calcium level. SCIENTIFIC REPORTS[J]. 2015, 5: http://dx.doi.org/10.1038/srep16348.
[181] Yu, Qiang, Ding, Jian. Precision cancer medicine: where to target?. ACTA PHARMACOLOGICA SINICA[J]. 2015, 36(10): 1161-1162, http://lib.cqvip.com/Qikan/Article/Detail?id=666593583.
[182] Wu, Jianrui, Peng, Ting, Chen, Fang, Leng, Yixin, Tong, Linjiang, Li, Mengyuan, Qu, Rong, Xie, Hua, Ding, Jian, Duan, Wenhu. Synthesis and Anticancer Activity of 7,8-dihydroxy-4-arylcoumarins. LETTERS IN DRUG DESIGN & DISCOVERY[J]. 2015, 12(5): 366-373, https://www.webofscience.com/wos/woscc/full-record/WOS:000351780700004.
[183] Ding Jian. Discovery of Novel 2,4-Diarylaminopyrimidine Analogues (DAAPalogues) Showing Potent Inhibitory Activities against both Wild-type and Mutant ALK Kinases.. J Med Chem.. 2015, [184] Zhang, Jie, He, Pengxing, Xi, Yong, Geng, Meiyu, Chen, Yi, Ding, Jian. Down-regulation of G9a triggers DNA damage response and inhibits colorectal cancer cells proliferation. ONCOTARGET[J]. 2015, 6(5): 2917-+, http://dx.doi.org/10.18632/oncotarget.2784.
[185] Lv, Yongcong, Li, Mengyuan, Liu, Ting, Tong, Linjiang, Peng, Ting, Wei, Lixin, Ding, Jian, Xie, Hua, Duan, Wenhu. Discovery of a New Series of Naphthamides as Potent VEGFR-2 Kinase Inhibitors. ACS MEDICINAL CHEMISTRY LETTERS[J]. 2014, 5(5): 592-597, http://www.irgrid.ac.cn/handle/1471x/914358.
[186] Peng-xing HE, Jie ZHANG, Yong-sheng CHE, Qiao-jun HE, Yi CHEN, Jian DING. G226, a new epipolythiodioxopiperazine derivative, triggers DNA damage and apoptosis in human cancer cells in vitro via ROS generation. 中国药理学报：英文版[J]. 2014, 1546-1555, http://lib.cqvip.com/Qikan/Article/Detail?id=663548650.
[187] Ji, Xun, Peng, Ting, Zhang, Xu, Li, Jian, Yang, Wei, Tong, Linjiang, Qu, Rong, Jiang, Hualiang, Ding, Jian, Xie, Hua, Liu, Hong. Design, synthesis and biological evaluation of novel 6-alkenylamides substituted of 4-anilinothieno2,3-dpyrimidines as irreversible epidermal growth factor receptor inhibitors. BIOORGANIC & MEDICINAL CHEMISTRY[J]. 2014, 22(7): 2366-2378, http://dx.doi.org/10.1016/j.bmc.2014.01.035.
[188] Liu, Jiali, Gao, Guorui, Zhang, Xi, Cao, Sufen, Guo, Chenliang, Wang, Xiang, Tong, Linjiang, Ding, Jian, Duan, Wenhu, Meng, Linghua. DW09849, a Selective Phosphatidylinositol 3-Kinase (PI3K) Inhibitor, Prevents PI3K Signaling and Preferentially Inhibits Proliferation of Cells Containing the Oncogenic Mutation p110 alpha (H1047R). JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS[J]. 2014, 348(3): 432-441, https://www.webofscience.com/wos/woscc/full-record/WOS:000332230000008.
[189] Chen, SiMeng, Guo, ChenLiang, Shi, JiaJie, Xu, YiChao, Chen, Yi, Shen, YanYan, Su, Yi, Ding, Jian, Meng, LingHua. HSP90 inhibitor AUY922 abrogates up-regulation of RTKs by mTOR inhibitor AZD8055 and potentiates its antiproliferative activity in human breast cancer. INTERNATIONAL JOURNAL OF CANCER[J]. 2014, 135(10): 2462-2474, https://www.webofscience.com/wos/woscc/full-record/WOS:000341984500026.
[190] Peng-xing HE, Yong-sheng CHE, Qiao-jun HE, Yi CHEN, Jian DING. G226, a novel epipolythiodioxopiperazine derivative, induces autophagy and caspase-dependent apoptosis in human breast cancer cells in vitro. 中国药理学报：英文版[J]. 2014, 1055-1064, http://lib.cqvip.com/Qikan/Article/Detail?id=662144460.
[191] Wang, Xiang, Zhang, Xi, Li, Benshang, Zhai, Xiaowen, Yang, Zhuo, Ding, Lixia, Wang, Hongsheng, Liang, Chris, Zhu, Weiliang, Ding, Jian, Meng, Linghua. Simultaneous targeting of PI3K delta and a PI3K delta-dependent MEK1/2-Erk1/2 pathway for therapy in pediatric B-cell acute lymphoblastic leukemia. ONCOTARGET[J]. 2014, 5(21): 10732-10744, https://www.webofscience.com/wos/woscc/full-record/WOS:000348036900040.
[192] He, Pengxing, Che, Yongsheng, He, Qiaojun, Chen, Yi, Ding, Jian. G226, a novel epipolythiodioxopiperazine derivative, induces autophagy and caspase-dependent apoptosis in human breast cancer cells in vitro. ACTA PHARMACOLOGICA SINICA[J]. 2014, 35(8): 1055-1064, http://lib.cqvip.com/Qikan/Article/Detail?id=662144460.
[193] Wu, WenBin, Zhang, Hua, Liu, HongChun, Dong, ShiHui, Wu, Yan, Ding, Jian, Yue, JianMin. Ivorenoids A-F: limonoids from Khaya ivorensis. TETRAHEDRON[J]. 2014, 70(22): 3570-3575, http://dx.doi.org/10.1016/j.tet.2014.04.007.
[194] Li, Xian, Tong, LinJiang, Ding, Jian, Meng, LingHua. Systematic combination screening reveals synergism between rapamycin and sunitinib against human lung cancer. CANCER LETTERS[J]. 2014, 342(1): 159-166, http://dx.doi.org/10.1016/j.canlet.2013.08.046.
[195] Zhang, Haotian, Wang, Lu, Ai, Jing, Chen, Yi, He, Changxi, Ji, Yinchun, Huang, Min, Yang, Jingyu, Zhang, Ao, Ding, Jian, Geng, Meiyu. SOMG-833, a Novel Selective c-MET Inhibitor, Blocks c-MET-Dependent Neoplastic Effects and Exerts Antitumor Activity. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS[J]. 2014, 350(1): 36-45, https://www.webofscience.com/wos/woscc/full-record/WOS:000339270200005.
[196] Zhao, Yanlong, Zhang, Xi, Chen, Yingyi, Lu, Shaoyong, Peng, Yuefeng, Wang, Xiang, Guo, Chengliang, Zhou, Aiwu, Zhang, Jingmiao, Luo, Yu, Shen, QianCheng, Ding, Jian, Meng, Linghua, Zhang, Jian. Crystal Structures of PI3K alpha Complexed with PI103 and Its Derivatives: New Directions for Inhibitors Design. ACS MEDICINAL CHEMISTRY LETTERS[J]. 2014, 5(2): 138-142, https://www.webofscience.com/wos/woscc/full-record/WOS:000331493600008.
[197] Tan, Shaoying, Han, Kun, Li, Qiang, Tong, Linjiang, Yang, Yiqi, Chen, Zhuo, Xie, Hua, Ding, Jian, Qian, Xuhong, Xu, Yufang. Novel metal complexes of naphthalimide-cyclam conjugates as potential multi-target receptor tyrosine kinase (RTK) inhibitors: Synthesis and biological evaluation. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY[J]. 2014, 85: 207-214, http://dx.doi.org/10.1016/j.ejmech.2014.07.068.
[198] Wang, Lu, Ai, Jing, Shen, Yanyan, Zhang, Haotian, Peng, Xia, Huang, Min, Zhang, Ao, Ding, Jian, Geng, Meiyu. SOMCL-863, a novel, selective and orally bioavailable small-molecule c-Met inhibitor, exhibits antitumor activity both in vitro and in vivo. CANCER LETTERS[J]. 2014, 351(1): 143-150, http://dx.doi.org/10.1016/j.canlet.2014.05.012.
[199] Liu, LiPing, Han, Kun, Chen, Wei, Zhang, YingYing, Tong, LinJiang, Peng, Ting, Xie, Hua, Ding, Jian, Wang, HongBing. Topoisomerase II inhibitors from the roots of Stellera chamaejasme L.. BIOORGANIC & MEDICINAL CHEMISTRY[J]. 2014, 22(15): 4198-4203, http://dx.doi.org/10.1016/j.bmc.2014.05.042.
[200] Lin, LiGen, Xie, Hua, Wang, YiTao, Ding, Jian, Ye, Yang. Chemical Constituents from the Heartwood of Haematoxylon campechianum as Protein Tyrosine Kinase Inhibitors. CHEMISTRY & BIODIVERSITY[J]. 2014, 11(5): 776-783, https://www.webofscience.com/wos/woscc/full-record/WOS:000336376200009.
[201] Liu, Zhiqing, Yue, Xihua, Song, Zilan, Peng, Xia, Guo, Junfeng, Ji, Yinchun, Cheng, Zhen, Ding, Jian, Ai, Jing, Geng, Meiyu, Zhang, Ao. Design, synthesis and pharmacological evaluation of 2-(thiazol-2-amino)-4-arylaminopyrimidines as potent anaplastic lymphoma kinase (ALK) inhibitors. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY[J]. 2014, 86: 438-448, http://dx.doi.org/10.1016/j.ejmech.2014.09.003.
[202] Ge, YingZi, Zhang, Hua, Liu, HongChun, Dong, Lei, Ding, Jian, Yue, JianMin. Cytotoxic dinorditerpenoids from Drypetes perreticulata. PHYTOCHEMISTRY[J]. 2014, 100: 120-125, http://dx.doi.org/10.1016/j.phytochem.2014.01.013.
[203] He, Changxi, Ai, Jing, Xing, Weiqiang, Chen, Yi, Zhang, Haotian, Huang, Min, Hu, Youhong, Ding, Jian, Geng, Meiyu. Yhhu3813 is a novel selective inhibitor of c-Met kinase that inhibits c-Met-dependent neoplastic phenotypes of human cancer cells. ACTA PHARMACOLOGICA SINICA[J]. 2014, 35(1): 89-97, http://lib.cqvip.com/Qikan/Article/Detail?id=48843392.
[204] Lam, Frankie, Abbas, Abdullahi Y, Shao, Hao, Teo, Theodosia, Adams, Julian, Li, Peng, Bradshaw, Tracey D, Fischer, Peter M, Walsby, Elisabeth, Pepper, Chris, Chen, Yi, Ding, Jian, Wang, Shudong. Targeting RNA transcription and translation in ovarian cancer cells with pharmacological inhibitor CDKI-73. ONCOTARGET[J]. 2014, 5(17): 7691-7704, https://www.webofscience.com/wos/woscc/full-record/WOS:000348029800038.
[205] He, Pengxing, Zhang, Jie, Che, Yongsheng, He, Qiaojun, Chen, Yi, Ding, Jian. G226, a new epipolythiodioxopiperazine derivative, triggers DNA damage and apoptosis in human cancer cells in vitro via ROS generation. ACTA PHARMACOLOGICA SINICA[J]. 2014, 35(12): 1546-1555, http://lib.cqvip.com/Qikan/Article/Detail?id=663548650.
[206] Luo, Feng Roger, Ding, Jian, Chen, Helen X, Liu, Hao, Fung, ManCheong, Koehler, Maria, Armand, Jean Pierre, Jiang, Lei, Xu, Xiao, Zhang, Ge, Xu, Li, Qian, Pascal, Yan, Li. Breakthrough cancer medicine and its impact on novel drug development in China: report of the US Chinese Anti-Cancer Association (USCACA) and Chinese Society of Clinical Oncology (CSCO) Joint Session at the 17th CSCO Annual Meeting. CHINESE JOURNAL OF CANCERnull. 2014, 33(12): 620-624, http://lib.cqvip.com/Qikan/Article/Detail?id=663375524.
[207] Liu, CuiPing, Xu, JinBiao, Zhao, JinXin, Xu, ChengHui, Dong, Lei, Ding, Jian, Yue, JianMin. Diterpenoids from Croton laui and Their Cytotoxic and Antimicrobial Activities. JOURNAL OF NATURAL PRODUCTS[J]. 2014, 77(4): 1013-1020, https://www.webofscience.com/wos/woscc/full-record/WOS:000335127200038.
[208] Wang, Wei, Wang, YingQing, Meng, Tao, Yi, JunMei, Huan, XiaJuan, Ma, LanPing, Tong, LinJiang, Chen, Yi, Ding, Jian, Shen, JingKang, Miao, ZeHong. MCL-1 Degradation Mediated by JNK Activation via MEKK1/TAK1-MKK4 Contributes to Anticancer Activity of New Tubulin Inhibitor MT189. MOLECULAR CANCER THERAPEUTICS[J]. 2014, 13(6): 1480-1491, https://www.webofscience.com/wos/woscc/full-record/WOS:000337168600009.
[209] Huang, Xun, Sun, Danni, Pan, Qiuming, Wen, Weiwei, Chen, Yi, Xin, Xianliang, Huang, Min, Ding, Jian, Geng, Meiyu. JG6, a novel marine-derived oligosaccharide, suppresses breast cancer metastasis via binding to cofilin. ONCOTARGET[J]. 2014, 5(11): 3568-3578, https://www.webofscience.com/wos/woscc/full-record/WOS:000339054500013.
[210] Chang-xi HE, Jing AI, Wei-qiang XING, Yi CHEN, Hao-tian ZHANG, Min HUANG, You-hong HU, Jian DING, Mei-yu GENG. Yhhu3813 is a novel selective inhibitor of c-Met kinase that inhibits c-Met-dependent neoplastic phenotypes of human cancer cells. 中国药理学报：英文版[J]. 2014, 89-97, http://lib.cqvip.com/Qikan/Article/Detail?id=48843392.
[211] Feng Roger Luo, Jian Ding, Helen X. Chen, Hao Liu, Man-Cheong Fung, Maria Koehler, Jean Pierre Armand, Lei Jiang, Xiao Xu, Ge Zhang, Li Xu, Pascal Qian, Li Yan. Breakthrough cancer medicine and its impact on novel drug development in China: report of the US Chinese Anti-Cancer Association (USCACA) and Chinese Society of Clinical Oncology (CSCO) Joint Session at the 17th CSCO Annual Meeting. 癌症：英文版[J]. 2014, 33(12): 620-624, http://lib.cqvip.com/Qikan/Article/Detail?id=663375524.
[212] Huang, Min, Shen, Aijun, Ding, Jian, Geng, Meiyu. Molecularly targeted cancer therapy: some lessons from the past decade. TRENDS IN PHARMACOLOGICAL SCIENCESnull. 2014, 35(1): 41-50, http://dx.doi.org/10.1016/j.tips.2013.11.004.
[213] Peng, Ting, Wu, Jianrui, Tong, Linjiang, Li, Mengyuan, Chen, Fang, Leng, Yixin, Qu, Rong, Han, Kun, Su, Yi, Chen, Yi, Duan, Wenhu, Xie, Hua, Ding, Jian. Identification of DW532 as a novel anti-tumor agent targeting both kinases and tubulin. ACTA PHARMACOLOGICA SINICA[J]. 2014, 35(7): 916-928, https://www.webofscience.com/wos/woscc/full-record/WOS:000338910500008.
[214] Zhang, Xu, Peng, Ting, Ji, Xun, Li, Jian, Tong, Linjiang, Li, Zeng, Yang, Wei, Xu, Yungen, Li, Mengyuan, Ding, Jian, Jiang, Hualiang, Xie, Hua, Liu, Hong. Design, synthesis and biological evaluation of novel 4-anilinoquinazolines with C-6 urea-linked side chains as inhibitors of the epidermal growth factor receptor. BIOORGANIC & MEDICINAL CHEMISTRY[J]. 2013, 21(24): 7988-7998, http://dx.doi.org/10.1016/j.bmc.2013.09.049.
[215] Wang, Xiang, Li, Jiapeng, Yang, Yan, Ding, Jian, Meng, Linghua. A pharmacological model reveals biased dependency on PI3K isoforms for tumor cell growth. ACTA PHARMACOLOGICA SINICA[J]. 2013, 34(9): 1201-1207, https://www.webofscience.com/wos/woscc/full-record/WOS:000324170400010.
[216] Ye, Na, Chen, ChuanHuizi, Chen, TianTian, Song, Zilan, He, JinXue, Huan, XiaJuan, Song, ShanShan, Liu, Qiufeng, Chen, Yi, Ding, Jian, Xu, Yechun, Miao, ZeHong, Zhang, Ao. Design, Synthesis, and Biological Evaluation of a Series of Benzode1,7naphthyridin-7(8H)-ones Bearing a Functionalized Longer Chain Appendage as Novel PARP1 Inhibitors. JOURNAL OF MEDICINAL CHEMISTRY[J]. 2013, 56(7): 2885-2903, https://www.webofscience.com/wos/woscc/full-record/WOS:000317551700015.
[217] Ding Jian. Design, synthesis, and biological evaluation of novel conformationally constrained inhibitors targeting epidermal growth factor receptor threonine→ methionine mutant.. J Med Chem.. 2013, [218] Ai, Jing, Zhan, ZhengSheng, Wang, Ying, Chen, Fang, Peng, Xia, Chen, Yi, Ji, Yinchun, Ding, Jian, Geng, Meiyu, Duan, Wenhu. A novel, potent, highly selective inhibitor of c-Met kinase, Simm559, inhibits c-Met-dependent neoplastic phenotypes in vitro and in vivo.. MOLECULAR CANCER THERAPEUTICSnull. 2013, 12(11): https://www.webofscience.com/wos/woscc/full-record/WOS:000209496800450.
[219] Wang, Xin, Chen, Zhuo, Tong, Linjiang, Tan, Shaoying, Zhou, Wei, Peng, Ting, Han, Kun, Ding, Jian, Xie, Hua, Xu, Yufang. Naphthalimides exhibit in vitro antiproliferative and antiangiogenic activities by inhibiting both topoisomerase II (topo II) and receptor tyrosine kinases (RTKs). EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY[J]. 2013, 65: 477-486, http://dx.doi.org/10.1016/j.ejmech.2013.05.002.
[220] Song, Zilan, Ai, Jing, Liu, Zhiqing, Peng, Xia, Chen, Yi, Ding, Jian, Geng, Meiyu, Zhang, Ao. Discovery of 2,4-diarylaminopyrimidine SOMCL-12-81 as a potent inhibitor targeting both wild and mutant ALK kinases.. MOLECULAR CANCER THERAPEUTICSnull. 2013, 12(11): https://www.webofscience.com/wos/woscc/full-record/WOS:000209496800310.
[221] Huang, Xun, Pan, Qiuming, Sun, Danni, Chen, Wei, Shen, Aijun, Huang, Min, Ding, Jian, Geng, Meiyu. O-GlcNAcylation of Cofilin Promotes Breast Cancer Cell Invasion. JOURNAL OF BIOLOGICAL CHEMISTRY[J]. 2013, 288(51): 36418-36425, http://dx.doi.org/10.1074/jbc.M113.495713.
[222] Xie, Hua, Lee, MeeHyun, Zhu, Feng, Reddy, Kanamata, Peng, Cong, Li, Yan, Lim, Do Young, Kim, Dong Joon, Li, Xiang, Kang, Soouk, Li, Haitao, Ma, Weiya, Lubet, Ronald A, Ding, Jian, Bode, Ann M, Dong, Zigang. Identification of an Aurora Kinase Inhibitor Specific for the Aurora B Isoform. CANCER RESEARCH[J]. 2013, 73(2): 716-724, http://dx.doi.org/10.1158/0008-5472.CAN-12-2784.
[223] Mao, Yongjun, Zhu, Wenxiu, Kong, Xiaoguang, Wang, Zhen, Xie, Hua, Ding, Jian, Terrett, Nicholas Kenneth, Shen, Jingkang, Shen, Jingshan. Design, synthesis and biological evaluation of novel pyrimidine, 3-cyanopyridine and m-amino-N-phenylbenzamide based monocyclic EGFR tyrosine kinase inhibitors. BIOORGANIC & MEDICINAL CHEMISTRY[J]. 2013, 21(11): 3090-3104, http://dx.doi.org/10.1016/j.bmc.2013.03.053.
[224] Wen, Weiwei, Xie, Shao, Xin, Xianliang, Geng, Meiyu, Ding, Jian, Chen, Yi. Oligomannurarate sulfate inhibits CXCL12/SDF-1-mediated proliferation and invasion of human tumor cells in vitro. ACTA PHARMACOLOGICA SINICA[J]. 2013, 34(12): 1554-1559, https://www.webofscience.com/wos/woscc/full-record/WOS:000328268600009.
[225] Xie, Hua, Lee, MeeHyun, Zhu, Feng, Reddy, Kanamata, Huang, Zunnan, Kim, Dong Joon, Li, Yan, Peng, Cong, Lim, Do Young, Kang, Soouk, Jung, Sung Keun, Li, Xiang, Li, Haitao, Ma, Weiya, Lubet, Ronald A, Ding, Jian, Bode, Ann M, Dong, Zigang. Discovery of the Novel mTOR Inhibitor and Its Antitumor Activities In Vitro and In Vivo. MOLECULAR CANCER THERAPEUTICS[J]. 2013, 12(6): 950-958, https://www.webofscience.com/wos/woscc/full-record/WOS:000320110500011.
[226] Dong, ShiHui, Liu, Jia, Ge, YingZi, Dong, Lei, Xu, ChengHui, Ding, Jian, Yue, JianMin. Chemical constituents from Brucea javanica. PHYTOCHEMISTRY[J]. 2013, 85: 175-184, https://www.webofscience.com/wos/woscc/full-record/WOS:000314143100020.
[227] Manzo, Stefano Giustino, Zhou, ZhaoLi, Wang, YingQing, Marinello, Jessica, He, JinXue, Li, YuanChao, Ding, Jian, Capranico, Giovanni, Miao, ZeHong. Natural Product Triptolide Mediates Cancer Cell Death by Triggering CDK7-Dependent Degradation of RNA Polymerase II. CANCER RESEARCH[J]. 2012, 72(20): 5363-5373, http://dx.doi.org/10.1158/0008-5472.CAN-12-1006.
[228] Chen, Guang, Chen, SiMeng, Wang, Xiang, Ding, XiaoFei, Ding, Jian, Meng, LingHua. Inhibition of Chemokine (CXC Motif) Ligand 12/Chemokine (CXC Motif) Receptor 4 Axis (CXCL12/CXCR4)-mediated Cell Migration by Targeting Mammalian Target of Rapamycin (mTOR) Pathway in Human Gastric Carcinoma Cells. JOURNAL OF BIOLOGICAL CHEMISTRY[J]. 2012, 287(15): 12132-12141, http://dx.doi.org/10.1074/jbc.A111.302299.
[229] Zhang, Jing, Xin, Xianliang, Chen, Qin, Xie, Zuoquan, Gui, Min, Chen, Yi, Lin, Liping, Feng, Jianming, Li, Qiuning, Ding, Jian, Geng, Meiyu. Oligomannurarate sulfate sensitizes cancer cells to doxorubicin by inhibiting atypical activation of NF-?B via targeting of Mre11. INTERNATIONAL JOURNAL OF CANCER[J]. 2012, 130(2): 467-477, https://www.webofscience.com/wos/woscc/full-record/WOS:000298254400023.
[230] Lu, JinJian, Chen, SiMeng, Ding, Jian, Meng, LingHua. Characterization of dihydroartemisinin-resistant colon carcinoma HCT116/R cell line. MOLECULAR AND CELLULAR BIOCHEMISTRY[J]. 2012, 360(1-2): 329-337, https://www.webofscience.com/wos/woscc/full-record/WOS:000297722800035.
[231] Zeng, LiFan, Wang, Yong, Kazemi, Roza, Xu, Shili, Xu, ZhongLiang, Sanchez, Tino W, Yang, LiuMeng, Debnath, Bikash, Odde, Srinivas, Xie, Hua, Zheng, YongTang, Ding, Jian, Neamati, Nouri, Long, YaQiu. Repositioning HIV-1 Integrase Inhibitors for Cancer Therapeutics: 1,6-Naphthyridine-7-carboxamide as a Promising Scaffold with Drug-like Properties. JOURNAL OF MEDICINAL CHEMISTRY[J]. 2012, 55(22): 9492-9509, http://www.irgrid.ac.cn/handle/1471x/616333.
[232] Liu, HongBing, Zhang, Hua, Yu, JinHai, Xu, ChengHui, Ding, Jian, Yue, JianMin. Cytotoxic Diterpenoids from Sapium insigne. JOURNAL OF NATURAL PRODUCTS[J]. 2012, 75(4): 722-727, https://www.webofscience.com/wos/woscc/full-record/WOS:000303220500031.
[233] Miao, Zehong, Feng, Jianming, Ding, Jian. Newly discovered angiogenesis inhibitors and their mechanisms of action. ACTA PHARMACOLOGICA SINICA[J]. 2012, 33(9): 1103-1111, http://lib.cqvip.com/Qikan/Article/Detail?id=43191418.
[234] Lu, JinJian, Cai, YuJun, Ding, Jian. The short-time treatment with curcumin sufficiently decreases cell viability, induces apoptosis and copper enhances these effects in multidrug-resistant K562/A02 cells. MOLECULAR AND CELLULAR BIOCHEMISTRY[J]. 2012, 360(1-2): 253-260, https://www.webofscience.com/wos/woscc/full-record/WOS:000297722800027.
[235] Chen, Simeng, Liu, Jiali, Wang, Xiang, Liang, Chris, Ding, Jian, Meng, Linghua. Inhibition of tumor cell growth, proliferation and migration by X-387, a novel active-site inhibitor of mTOR. BIOCHEMICAL PHARMACOLOGY[J]. 2012, 83(9): 1183-1194, http://dx.doi.org/10.1016/j.bcp.2012.01.019.
[236] Ding Jian. Natural product triptolide mediates cancer cell death by triggering CDK7-dependent degradation of RNA polymerase II.. Cancer Res.. 2012, [237] 丁健. 靶向抗肿瘤药物——分子生物标志物. 2012, 3162-, https://kns.cnki.net/KCMS/detail/detail.aspx?dbcode=CPFD&dbname=CPFD0914&filename=YYWS201211001461&v=MjgyMTZVN3pOSTE4VVBEVGNmYkc0SDlQTnJvOUZaZThKRFJOS3VoZGhuajk4VG5qcXF4ZEVlTU9VS3JpZlplWnZIaW50.
[238] Wang, Jia, Wang, Xiang, Chen, Yanhong, Chen, Simeng, Chen, Guang, Tong, Linjiang, Meng, Linghua, Xie, Yuyuan, Ding, Jian, Yang, Chunhao. Discovery and bioactivity of 4-(2-arylpyrido3 ',2 ':3,4pyrrolo1,2-f1,2,4-triazin-4-yl) morpholine derivatives as novel PI3K inhibitors. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS[J]. 2012, 22(1): 339-342, http://dx.doi.org/10.1016/j.bmcl.2011.11.003.
[239] Zhou, Yuanfeng, Chen, Yi, Tong, Linjiang, Xie, Hua, Wen, Weiwei, Zhang, Jie, Xi, Yong, Shen, Yanyan, Geng, Meiyu, Wang, Yuanyuan, Jiang, Hualiang, Luo, Cheng, Lin, Liping, Ding, Jian. AL3810, a multi-tyrosine kinase inhibitor, exhibits potent anti-angiogenic and anti-tumour activity via targeting VEGFR, FGFR and PDGFR. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE[J]. 2012, 16(10): 2321-2330, https://www.webofscience.com/wos/woscc/full-record/WOS:000309237500008.
[240] Feng, JianMing, Miao, ZeHong, Jiang, Yi, Chen, Yi, Li, JiaXin, Tong, LinJiang, Zhang, Jin, Huang, YiRan, Ding, Jian. Characterization of the conversion between CD133(+) and CD133(-) cells in colon cancer SW620 cell line. CANCER BIOLOGY & THERAPY[J]. 2012, 13(14): 1396-1406, https://www.webofscience.com/wos/woscc/full-record/WOS:000312212200007.
[241] Ding Jian. Oligomannurarate sulfate sensitizes cancer cells to doxorubicin by inhibiting atypical activation of NF-kappaB via targeting of Mre11.. Int J Cancer.. 2012, [242] Zhou, ZhaoLi, Yang, YaXi, Ding, Jian, Li, YuanChao, Miao, ZeHong. Triptolide: structural modifications, structure-activity relationships, bioactivities, clinical development and mechanisms. NATURAL PRODUCT REPORTSnull. 2012, 29(4): 457-475, https://www.webofscience.com/wos/woscc/full-record/WOS:000301455600003.
[243] Ze-hong MIAO Jian-ming FENG Jian DING. Newly discovered angiogenesis inhibitors and their mechanisms of action. 中国药理学报：英文版[J]. 2012, 33(9): 1103-1111, http://lib.cqvip.com/Qikan/Article/Detail?id=43191418.
[244] Chang, Shaohua, Zhang, Lianwen, Xu, Shilin, Luo, Jinfeng, Lu, Xiaoyun, Zhang, Zhang, Xu, Tianfeng, Liu, Yingxue, Tu, Zhengchao, Xu, Yong, Ren, Xiaomei, Geng, Meiyu, Ding, Jian, Pei, Duanqing, Ding, Ke. Design, Synthesis, and Biological Evaluation of Novel Conformationally Constrained Inhibitors Targeting Epidermal Growth Factor Receptor Threonine(790) -> Methionine(790) Mutant. JOURNAL OF MEDICINAL CHEMISTRY[J]. 2012, 55(6): 2711-2723, https://www.webofscience.com/wos/woscc/full-record/WOS:000301767000016.
[245] 丁健. 分子靶向抗肿瘤药物十年历程启迪. 世界临床药物[J]. 2012, 33(1): 40-44, http://lib.cqvip.com/Qikan/Article/Detail?id=40719967.
[246] Yu, Bing, Li, MeiHong, Wang, Wei, Wang, YingQing, Jiang, Yi, Yang, ShengPing, Yue, JianMin, Ding, Jian, Miao, ZeHong. Pseudolaric acid B-driven phosphorylation of c-Jun impairs its role in stabilizing HIF-1alpha: a novel function-converter model. JOURNAL OF MOLECULAR MEDICINE-JMM[J]. 2012, 90(8): 971-981, https://www.webofscience.com/wos/woscc/full-record/WOS:000306437700011.
[247] Yang, ShengPing, Zhang, XiaoWei, Ai, Jing, Gan, LiShe, Xu, JinBiao, Wang, Ying, Su, ZuShang, Wang, Lu, Ding, Jian, Geng, MeiYu, Yue, JianMin. Potent HGF/c-Met Axis Inhibitors from Eucalyptus globulus: the Coupling of Phloroglucinol and Sesquiterpenoid Is Essential for the Activity. JOURNAL OF MEDICINAL CHEMISTRY[J]. 2012, 55(18): 8183-8187, https://www.webofscience.com/wos/woscc/full-record/WOS:000309153500021.
[248] Wang, Shuai, Huang, Xun, Sun, Danni, Xin, Xianliang, Pan, Qiuming, Peng, Shuying, Liang, Zhongjie, Luo, Cheng, Yang, Yiming, Jiang, Hualiang, Huang, Min, Chai, Wengang, Ding, Jian, Geng, Meiyu. Extensive Crosstalk between O-GlcNAcylation and Phosphorylation Regulates Akt Signaling. PLOS ONE[J]. 2012, 7(5): https://doaj.org/article/d18a3366658449a5b41ebf30bd998a72.
[249] 陈思萌, Chris Liang, 蒙凌华, 丁健. 土槿皮乙酸减弱非转录功能的c-Jun对缺氧诱导因子1α的稳定作用. 2011, 43-, https://kns.cnki.net/KCMS/detail/detail.aspx?dbcode=CPFD&dbname=CPFD0914&filename=ZGKA201104002037&v=MDI3ODI5OFRuanFxeGRFZU1PVUtyaWZaZVp2SGludFU3dktJRm9RUHlyQWI3RzRIOURNcTQ5Rlp1c01DeE5LdWhkaG5q.
[250] Xie, Hua, Lin, Liping, Tong, Linjiang, Jiang, Yong, Zheng, Mingyue, Chen, Zhuo, Jiang, Xiaoyan, Zhang, Xiaowei, Ren, Xiaowei, Qu, Wenchao, Yang, Yang, Wan, Hua, Chen, Yi, Zuo, Jianping, Jiang, Hualiang, Geng, Meiyu, Ding, Jian. AST1306, A Novel Irreversible Inhibitor of the Epidermal Growth Factor Receptor 1 and 2, Exhibits Antitumor Activity Both In Vitro and In Vivo. PLOS ONE[J]. 2011, 6(7): https://doaj.org/article/1208222555f24e728e77f19061dfeff2.
[251] Deng, Fei, Lu, Jin Jian, Liu, Hong Ying, Lin, Li Ping, Ding, Jian, Zhang, Jin Sheng. Synthesis and antitumor activity of novel salvicine analogues. CHINESE CHEMICAL LETTERS[J]. 2011, 22(1): 25-28, http://lib.cqvip.com/Qikan/Article/Detail?id=36501746.
[252] 陈思萌, Chris Liang, 蒙凌华, 丁健. 新型ATP竞争性mTOR抑制剂X-387抗肿瘤作用机制研究. 2011, 37-, https://kns.cnki.net/KCMS/detail/detail.aspx?dbcode=CPFD&dbname=CPFD0914&filename=ZGKA201104002031&v=MTcxMTBOS3VoZGhuajk4VG5qcXF4ZEVlTU9VS3JpZlplWnZIaW50VTd2S0lsMFJQeXJBYjdHNEg5RE1xNDlGWnVzTURS.
[253] Lu, JinJian, Cai, YuJun, Ding, Jian. Curcumin induces DNA damage and caffeine-insensitive cell cycle arrest in colorectal carcinoma HCT116 cells. MOLECULAR AND CELLULAR BIOCHEMISTRY[J]. 2011, 354(1-2): 247-252, https://www.webofscience.com/wos/woscc/full-record/WOS:000292215600026.
[254] Tong, Linjiang, Xie, Hua, Peng, Ting, Liu, Xiaofeng, Xin, Xianliang, Huang, Xun, Chen, Simeng, Liu, Hongyan, Li, Honglin, Geng, Meiyu, Yin, Ming, Ding, Jian. Establishment of platform for screening insulin-like growth factor-1 receptor inhibitors and evaluation of novel inhibitors. ACTA PHARMACOLOGICA SINICA[J]. 2011, 32(7): 930-938, http://lib.cqvip.com/Qikan/Article/Detail?id=38696059.
[255] Cai, YouSheng, Kurtan, Tibor, ZeHong Miao, Mandi, Attila, Komaromi, Istvan, Liu, HaiLi, Ding, Jian, Guo, YueWei. Palmarumycins BG1-BG7 and Preussomerin BG1: Establishment of Their Absolute Configurations Using Theoretical Calculations of Electronic Circular Dichroisnn Spectra. JOURNAL OF ORGANIC CHEMISTRY[J]. 2011, 76(6): 1821-1830, https://www.webofscience.com/wos/woscc/full-record/WOS:000288142800035.
[256] 沈竞康. MT119, a new planar-structured compound, targets the colchicine site of tubulin arresting mitosis and inhibiting tumor cell proliferation.. Inter J Cancer. 2011, [257] Zhu, Caihua, Chen, Qin, Xie, Zuoquan, Ai, Jing, Tong, Linjiang, Ding, Jian, Geng, Meiyu. The role of histone deacetylase 7 (HDAC7) in cancer cell proliferation: regulation on c-Myc. JOURNAL OF MOLECULAR MEDICINE-JMM[J]. 2011, 89(3): 279-289, https://www.webofscience.com/wos/woscc/full-record/WOS:000288354100010.
[258] Dong, ShiHui, Zhang, ChuanRui, Xu, ChengHui, Ding, Jian, Yue, JianMin. Daphnane-Type Diterpenoids from Trigonostemon howii. JOURNAL OF NATURAL PRODUCTS[J]. 2011, 74(5): 1255-1261, https://www.webofscience.com/wos/woscc/full-record/WOS:000291127900050.
[259] Wang, YuQin, Li, XiaoHua, He, Qian, Chen, Yi, Xie, YuYuan, Ding, Jian, Miao, ZeHong, Yang, ChunHao. Design, synthesis and biological evaluation of substituted 11H-benzoa carbazole-5-carboxamides as novel antitumor agents. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY[J]. 2011, 46(12): 5878-5884, http://dx.doi.org/10.1016/j.ejmech.2011.09.050.
[260] 丁健. 中国药物创新的机遇与展望——在“科学监管通化交流峰会”上的报告. 中国食品药品监管[J]. 2011, 10-13, http://lib.cqvip.com/Qikan/Article/Detail?id=39546610.
[261] Chen, Zhuo, Wang, Xin, Zhu, Weiping, Cao, Xianwen, Tong, Linjiang, Li, Honglin, Xie, Hua, Xu, Yufang, Tan, Shaoying, Kuang, Dong, Ding, Jian, Qian, Xuhong. Acenaphtho1,2-bpyrrole-Based Selective Fibroblast Growth Factor Receptors 1 (FGFR1) Inhibitors: Design, Synthesis, and Biological Activity. JOURNAL OF MEDICINAL CHEMISTRY[J]. 2011, 54(11): 3732-3745, https://www.webofscience.com/wos/woscc/full-record/WOS:000291082500004.
[262] 任萱, 林莉萍, 丁健. 微管抑制剂c9抑制新生血管生成的作用机. 中国新药杂志[J]. 2011, 20(17): 1703-, [263] 任萱, 林莉萍, 丁健. 微管抑制剂C9抑制新生血管生成的作用机制. 中国新药杂志[J]. 2011, 20(17): 1703-1710, http://lib.cqvip.com/Qikan/Article/Detail?id=39102809.
[264] Zhang, Zhixiang, Meng, Tao, Yang, Na, Wang, Wei, Xiong, Bing, Chen, Yi, Ma, Lanping, Shen, Jingkang, Miao, ZeHong, Ding, Jian. MT119, a new planar-structured compound, targets the colchicine site of tubulin arresting mitosis and inhibiting tumor cell proliferation. INTERNATIONAL JOURNAL OF CANCER[J]. 2011, 129(1): 214-224, https://www.webofscience.com/wos/woscc/full-record/WOS:000289987300021.
[265] Jiang, Yi, Miao, ZeHong, Xu, Lei, Yu, Bing, Gong, JingXu, Tong, LinJiang, Chen, Yi, Zhou, ZhaoLi, Liu, HongChun, Wang, Yi, Guo, YueWei, Ding, Jian. Drug Transporter-independent Liver Cancer Cell Killing by a Marine Steroid Methyl Spongoate via Apoptosis Induction. JOURNAL OF BIOLOGICAL CHEMISTRY[J]. 2011, 286(30): 26461-26469, http://dx.doi.org/10.1074/jbc.M111.232728.
[266] Dong, ShiHui, Liu, HongBing, Xu, ChengHui, Ding, Jian, Yue, JianMin. Constituents of Trigonostemon heterophyllus. JOURNAL OF NATURAL PRODUCTS[J]. 2011, 74(12): 2576-2581, http://dx.doi.org/10.1021/np200772n.
[267] Gui, Min, Shi, DaKuo, Huang, Min, Zhao, Yu, Sun, QiMing, Zhang, Jing, Chen, Qin, Feng, JianMing, Liu, ChunHong, Li, Ming, Li, YingXia, Geng, MeiYu, Ding, Jian. D11, a novel glycosylated diphyllin derivative, exhibits potent anticancer activity by targeting topoisomerase II alpha. INVESTIGATIONAL NEW DRUGS[J]. 2011, 29(5): 800-810, https://www.webofscience.com/wos/woscc/full-record/WOS:000294223500009.
[268] Ma, Jingui, Huang, He, Chen, Simeng, Chen, Yi, Xin, Xianliang, Lin, Liping, Ding, Jian, Liu, Hong, Meng, Linghua. PH006, a novel and selective Src kinase inhibitor, suppresses human breast cancer growth and metastasis in vitro and in vivo. BREAST CANCER RESEARCH AND TREATMENT[J]. 2011, 130(1): 85-96, https://www.webofscience.com/wos/woscc/full-record/WOS:000295363200009.
[269] Fei Deng, Jin Jian Lu, Hong Ying Liu, Li Ping Lin, Jian Ding, Jin Sheng Zhang. Synthesis and antitumor activity of novel salvicine analogues. 中国化学快报：英文版[J]. 2011, 22(1): 25-28, http://lib.cqvip.com/Qikan/Article/Detail?id=36501746.
[270] 王祥, Chris Liang, 蒙凌华, 丁健. PI3K-δ选择性抑制剂X370对白血病细胞增殖抑制作用的研究. 2011, 44-, https://kns.cnki.net/KCMS/detail/detail.aspx?dbcode=CPFD&dbname=CPFD0914&filename=ZGKA201104002038&v=MDAyNjhxNDlGWnVzTUJCTkt1aGRobmo5OFRuanFxeGRFZU1PVUtyaWZaZVp2SGludFU3dktJMTBkUHlyQWI3RzRIOURN.
[271] Lin-jiang TONG, Hua XIE, Ting PENG, Xiao-feng LIU, Xian-liang XIN, Xun HUANG, Si-meng CHENI, Hong-yan LIU, Hong-lin LI, Mei-yu GENG, MingYIN, Jian DING. Establishment of platform for screening insulin-like growth factor-1 receptor inhibitors and evaluation of novel inhibitors. 中国药理学报：英文版[J]. 2011, 32(7): 930-938, http://lib.cqvip.com/Qikan/Article/Detail?id=38696059.
[272] Lu, JinJian, Chen, SiMeng, Zhang, XiaoWei, Ding, Jian, Meng, LingHua. The anti-cancer activity of dihydroartemisinin is associated with induction of iron-dependent endoplasmic reticulum stress in colorectal carcinoma HCT116 cells. INVESTIGATIONAL NEW DRUGS[J]. 2011, 29(6): 1276-1283, https://www.webofscience.com/wos/woscc/full-record/WOS:000294824200016.
[273] Gong, JingXu, Miao, ZeHong, Yao, LiGong, Ding, Jian, Kurtan, Tibor, Guo, YueWei. Stereoselective Synthesis of Methyl Spongoate, a New Steroid with Potent Antitumor Activities. SYNLETT[J]. 2010, 480-482, https://www.webofscience.com/wos/woscc/full-record/WOS:000274233900029.
[274] Huang, He, Chen, Qin, Ku, Xin, Meng, Linghua, Lin, Liping, Wang, Xiang, Zhu, Caihua, Wang, Yi, Chen, Zhi, Li, Ming, Jiang, Hualiang, Chen, Kaixian, Ding, Jian, Liu, Hong. A Series of alpha-Heterocyclic Carboxaldehyde Thiosemicarbazones Inhibit Topoisomerase II alpha Catalytic Activity. JOURNAL OF MEDICINAL CHEMISTRY[J]. 2010, 53(8): 3048-3064, https://www.webofscience.com/wos/woscc/full-record/WOS:000276562400005.
[275] ZhaoLi Zhou, ZhiGuo Luo, Bing Yu, Yi Jiang, Yi Chen, JianMing Feng, Mei Dai, LinJiang Tong, Zheng Li, YuanChao Li, Jian Ding, ZeHong Miao. Increased accumulation of hypoxia-inducible factor-1α with reduced transcriptional activity mediates the antitumor effect of triptolide. MOLECULARCANCER[J]. 2010, 9(1): http://gooa.las.ac.cn/external/index?type=-1&pid=1183489.
[276] Chen, Gang, Hao, XiaoJiang, Sun, QianYun, Ding, Jian. Rapid synthesis and bioactivities of 3-(nitromethylene)indolin-2-one analogues. CHEMICAL PAPERS[J]. 2010, 64(5): 673-677, https://www.webofscience.com/wos/woscc/full-record/WOS:000280919800019.
[277] Li, Ting, Wang, Jia, Wang, Xiang, Yang, Na, Chen, Simeng, Tong, Linjiang, Yang, Chunhao, Meng, Linghua, Ding, Jian. WJD008, a Dual Phosphatidylinositol 3-Kinase (PI3K)/Mammalian Target of Rapamycin Inhibitor, Prevents PI3K Signaling and Inhibits the Proliferation of Transformed Cells with Oncogenic PI3K Mutant. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS[J]. 2010, 334(3): 830-838, https://www.webofscience.com/wos/woscc/full-record/WOS:000281114900016.
[278] Dai, Mei, Miao, ZeHong, Ren, Xuan, Tong, LinJiang, Yang, Na, Li, Ting, Lin, LiPing, Shen, YueMao, Ding, Jian. MFTZ-1 reduces constitutive and inducible HIF-1 alpha accumulation and VEGF secretion independent of its topoisomerase II inhibition. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE[J]. 2010, 14(9): 2281-2291, http://www.irgrid.ac.cn/handle/1471x/967422.
[279] 缪泽鸿. Echinoside A, a new marine-derived anticancer saponin, targets topoisomerase II? by unique interference with its DNA binding and catalytic cycle.. Ann Oncol. 2010, [280] Lu, DaYong, Lu, DingRen, Ding, Jian. Cell Biological Manifestations of Bisdioxopiperazines: Treatment of Human Tumor Cell Lines in Culture. ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY[J]. 2010, 10(9): 657-660, http://www.corc.org.cn/handle/1471x/2313782.
[281] Zhou, Bing, Miao, Zehong, Deng, Gang, Ding, Jian, Yang, Yaxi, Feng, Huijin, Li, Yuanchao. Synthesis and biological evaluation of novel triptolide analogues for anticancer activity. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS[J]. 2010, 20(21): 6217-6221, http://dx.doi.org/10.1016/j.bmcl.2010.08.106.
[282] Zhang, Zhixiang, Meng, Tao, He, Jingxue, Li, Ming, Tong, LinJiang, Xiong, Bing, Lin, Liping, Shen, Jingkang, Miao, ZeHong, Ding, Jian. MT7, a novel compound from a combinatorial library, arrests mitosis via inhibiting the polymerization of microtubules. INVESTIGATIONAL NEW DRUGS[J]. 2010, 28(6): 715-728, http://ir.simm.ac.cn/handle/153631/1923.
[283] Lu, JinJian, Meng, LingHua, Shankavaram, Uma T, Zhua, CaiHua, Tong, LinJiang, Chen, Guang, Lin, LiPing, Weinstein, John N, Ding, Jian. Dihydroartemisinin accelerates c-MYC oncoprotein degradation and induces apoptosis in c-MYC-overexpressing tumor cells. BIOCHEMICAL PHARMACOLOGY[J]. 2010, 80(1): 22-30, http://dx.doi.org/10.1016/j.bcp.2010.02.016.
[284] Liu, Xiaofeng, Xie, Hua, Luo, Cheng, Tong, Linjiang, Wang, Yi, Peng, Ting, Ding, Jian, Jiang, Hualiang, Li, Honglin. Discovery and SAR of Thiazolidine-2,4-dione Analogues as Insulin-like Growth Factor-1 Receptor (IGF-1R) Inhibitors via Hierarchical Virtual Screening. JOURNAL OF MEDICINAL CHEMISTRY[J]. 2010, 53(6): 2661-2665, https://www.webofscience.com/wos/woscc/full-record/WOS:000275711000033.
[285] Zhou, ZhaoLi, Luo, ZhiGuo, Yu, Bing, Jiang, Yi, Chen, Yi, Feng, JianMing, Dai, Mei, Tong, LinJiang, Li, Zheng, Li, YuanChao, Ding, Jian, Miao, ZeHong. Increased accumulation of hypoxia-inducible factor-1 alpha with reduced transcriptional activity mediates the antitumor effect of triptolide. MOLECULAR CANCER[J]. 2010, 9: http://ir.simm.ac.cn/handle/153631/1933.
[286] Chen, Guang, Yang, Na, Wang, Xiang, Zheng, SiYuan, Chen, Yi, Tong, LinJiang, Li, YiXue, Meng, LingHua, Ding, Jian. Identification of p27/KIP1 expression level as a candidate biomarker of response to rapalogs therapy in human cancer. JOURNAL OF MOLECULAR MEDICINE-JMM[J]. 2010, 88(9): 941-952, http://ir.simm.ac.cn/handle/153631/1976.
[287] Huang, He, Ma, Jingui, Shi, Jianmei, Meng, Linghua, Jiang, Hualiang, Ding, Jian, Liu, Hong. Discovery of novel purine derivatives with potent and selective inhibitory activity against c-Src tyrosine kinase. BIOORGANIC & MEDICINAL CHEMISTRY[J]. 2010, 18(13): 4615-4624, http://dx.doi.org/10.1016/j.bmc.2010.05.032.
[288] 丁健. 酪氨酸激酶抑制剂的研究与进展. 2010, 16-, https://kns.cnki.net/KCMS/detail/detail.aspx?dbcode=CPFD&dbname=CPFD0914&filename=ZGHY201010002003&v=MjczNzNyaWZaZVp2SGludFU3ckpLRjBXUHlyRGQ3RzRIOUhOcjQ5Rlp1c1BEeE5LdWhkaG5qOThUbmpxcXhkRWVNT1VL.
[289] Chen, HuaDong, Yang, ShengPing, He, XiuFeng, Liu, HongBing, Ding, Jian, Yue, JianMin. Trigochinins D-I: six new daphnane-type diterpenoids from Trigonostemon chinensis. TETRAHEDRON[J]. 2010, 66(27-28): 5065-5070, http://dx.doi.org/10.1016/j.tet.2010.04.118.
[290] Jing ZHANG Yi CHEN Xian-liang XIN Qiu-ning LI Ming LI Li-ping LIN Mei-yu GENG Jian DING. Oligomannurarate sulfate blocks tumor growth by inhibiting NF-κB activation. 中国药理学报：英文版[J]. 2010, 375-381, http://lib.cqvip.com/Qikan/Article/Detail?id=33580728.
[291] Chen, SiMeng, Meng, LingHua, Ding, Jian. New microtubule-inhibiting anticancer agents. EXPERT OPINION ON INVESTIGATIONAL DRUGSnull. 2010, 19(3): 329-343, https://www.webofscience.com/wos/woscc/full-record/WOS:000274886900002.
[292] Zhang, Jing, Chen, Yi, Xin, Xianliang, Li, Qiuning, Li, Ming, Lin, Liping, Geng, Meiyu, Ding, Jian. Oligomannurarate sulfate blocks tumor growth by inhibiting NF-kappa B activation. ACTA PHARMACOLOGICA SINICA[J]. 2010, 31(3): 375-381, https://www.webofscience.com/wos/woscc/full-record/WOS:000275824400014.
[293] 丁健. 转化医学框架下的新药研究. 2010, 14-, https://kns.cnki.net/KCMS/detail/detail.aspx?dbcode=CPFD&dbname=CPFD0914&filename=ZGYS201010002003&v=MDA5MDk0OUZadXNQRHhOS3VoZGhuajk4VG5qcXF4ZEVlTU9VS3JpZlplWnZIaW50VTdySkpsb1NQeXJTZmJHNEg5SE5y.
[294] 马金贵, 黄河, 蒙凌华, 柳红, 丁健. 新型Src激酶抑制剂PH006的抗肿瘤作用研究. 2009, 60-, https://kns.cnki.net/KCMS/detail/detail.aspx?dbcode=CPFD&dbname=CPFD0914&filename=ZGYS200904001029&v=MDgxOTRyU2ZiRzRIdGpNcTQ5Rlplc05CUk5LdWhkaG5qOThUbmpxcXhkRWVNT1VLcmlmWmVadkhpbnRVN3ZOSmw4UlB5.
[295] Huang, He, Jia, Qi, Ma, Jingui, Qin, Guangrong, Chen, Yingyi, Xi, Yonghua, Lin, Liping, Zhu, Weiliang, Ding, Jian, Jiang, Hualiang, Liu, Hong. Discovering novel quercetin-3-O-amino acid-esters as a new class of Src tyrosine kinase inhibitors. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY[J]. 2009, 44(5): 1982-1988, http://dx.doi.org/10.1016/j.ejmech.2008.09.051.
[296] Li, Zheng, Zhou, ZhaoLi, Miao, ZeHong, Lin, LiPing, Feng, HuiJin, Tong, LinJiang, Ding, Jian, Li, YuanChao. Design and Synthesis of Novel C14-Hydroxyl Substituted Triptolide Derivatives as Potential Selective Antitumor Agents. JOURNALOFMEDICINALCHEMISTRY[J]. 2009, 52(16): 5115-5123, http://ir.simm.ac.cn/handle/153631/1109.
[297] Zhang, Chao, Yang, Na, Yang, ChunHao, Ding, HuaSheng, Luo, Cheng, Zhang, Yu, Wu, MaoJiang, Zhang, XiongWen, Shen, Xu, Jiang, HuaLiang, Meng, LingHua, Ding, Jian. S9, a novel anticancer agent, exerts its anti -proliferative activity by interfering with both PI3K-Akt-mTOR signaling and microtubule cytoskeleton. CANCER RESEARCHnull. 2009, 69: http://apps.webofknowledge.com/CitedFullRecord.do?product=UA&colName=WOS&SID=5CCFccWmJJRAuMzNPjj&search_mode=CitedFullRecord&isickref=WOS:000209701802463.
[298] Xie, Hua, Qin, Yuxin, Zhou, Yunlong, Tong, Linjiang, Lin, Liping, Geng, Meiyu, Duan, Wenhu, Ding, Jian. GA3, a new gambogic acid derivative, exhibits potent antitumor activities in vitro via apoptosis-involved mechanisms. ACTA PHARMACOLOGICA SINICA[J]. 2009, 30(3): 346-354, http://lib.cqvip.com/Qikan/Article/Detail?id=29669679.
[299] 陆金健, 蒙凌华, 朱才华, 童林江, 林莉萍, 丁健. 二氢青蒿素促进癌蛋白c-MYC降解并诱发c-myc高表达的癌细胞凋亡. 2009, 170-, https://kns.cnki.net/KCMS/detail/detail.aspx?dbcode=CPFD&dbname=CPFD0914&filename=ZGYS200904001141&v=MTcyNDFoZGhuajk4VG5qcXF4ZEVlTU9VS3JpZlplWnZIaW50VTd2Tkkxd2NQeXJTZmJHNEh0ak1xNDlGWmVvTERSTkt1.
[300] Li, Qiuning, Liu, Haiying, Xin, Xianliang, Pan, Qiuming, Wang, Lu, Zhang, Jing, Chen, Qin, Geng, Meiyu, Ding, Jian. Marine-derived oligosaccharide sulfate (JG3) suppresses heparanase-driven cell adhesion events in heparanase over-expressing CHO-K1 cells. ACTA PHARMACOLOGICA SINICA[J]. 2009, 30(7): 1033-1038, http://lib.cqvip.com/Qikan/Article/Detail?id=30813330.
[301] Yin, Sheng, Chen, Xin, Su, ZuShang, Yang, ShengPing, Fan, ChengQi, Ding, Jian, Yue, JianMin. Harrisotones A-E, five novel prenylated polyketides with a rare spirocyclic skeleton from Harrisonia perforata. TETRAHEDRON[J]. 2009, 65(6): 1147-1152, http://dx.doi.org/10.1016/j.tet.2008.11.068.
[302] Wang, Ya, Xuan, Yaoji, Zhang, Ping, Jiang, Xi, Ni, Zhenhua, Tong, Linjiang, Zhou, Xiangshan, Lin, Liping, Ding, Jian, Zhang, Yuanxing. Targeting expression of the catalytic domain of the kinase insert domain receptor (KDR) in the peroxisomes of Pichia pastoris. FEMS YEAST RESEARCH[J]. 2009, 9(5): 732-741, http://ir.simm.ac.cn/handle/153631/1129.
[303] Li, Rui, Ding, ZhenYu, Wei, YuQuan, Ding, Jian. 5-(4-Acetylphenyl)aminomethylene-2,2-dimethyl-1,3-dioxane-4,6-dione. ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE[J]. 2009, 65(Pt 6): O1297-U2022, http://ir.simm.ac.cn/handle/153631/1165.
[304] Zhang, Chao, Yang, Na, Yang, Chunhao, Ding, Huasheng, Luo, Cheng, Zhang, Yu, Wu, Maojiang, Zhang, Xiongwen, Shen, Xu, Jiang, HuaLiang, Meng, Linghua, Ding, Jian. S9, a Novel Anticancer Agent, Exerts Its Anti-Proliferative Activity by Interfering with Both PI3K-Akt-mTOR Signaling and Microtubule Cytoskeleton. PLOS ONE[J]. 2009, 4(3): http://ir.simm.ac.cn/handle/153631/1233.
[305] Sun, QiMing, Miao, ZeHong, Lin, LiPing, Gui, Min, Zhu, CaiHua, Xie, Hua, Duan, WenHu, Ding, Jian. BB, a new EGFR inhibitor, exhibits prominent anti-angiogenesis and antitumor activities. CANCER BIOLOGY & THERAPY[J]. 2009, 8(17): 1647-1654, http://dx.doi.org/10.4161/cbt.8.17.9205.
[306] Hua XIE, Yu-xin QIN, Yun-long ZHOU, Lin-jiang TONG, Li-ping LIN, Mei-yu GENG, Wen-hu DUAN, Jian DING. GA3, a new gambogic acid derivative, exhibits potent antitumor activities in vitro via apoptosis-involved mechanisms. 中国药理学报：英文版[J]. 2009, 30(3): 346-354, http://lib.cqvip.com/Qikan/Article/Detail?id=29669679.
[307] Jiang, Min, Li, Ting, Meng, Linghua, Yang, Chunhao, Xie, Yuyuan, Ding, Jian. Direct Palladium-Catalyzed Arylations of Aryl Bromides with 2/9-Substituted Pyrimido5,4-bindolizines. JOURNAL OF COMBINATORIAL CHEMISTRY[J]. 2009, 11(5): 806-808, http://ir.simm.ac.cn/handle/153631/1104.
[308] Hu, XuJia, Di, YingTong, Wang, YueHu, Kong, LingYi, Gao, Suo, Li, ChunShun, Liu, HaiYang, He, HongPing, Ding, Jian, Xie, Hua, Hao, XiaoJiang. Carboline Alkaloids from Trigonostemon lii. PLANTA MEDICA[J]. 2009, 75(10): 1157-1161, http://www.irgrid.ac.cn/handle/1471x/461745.
[309] Wang, Wenjing, Dai, Mei, Zhu, Caihua, Zhang, Jiangang, Lin, Liping, Ding, Jian, Duan, Wenhu. Synthesis and biological activity of novel shikonin analogues. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS[J]. 2009, 19(3): 735-737, http://dx.doi.org/10.1016/j.bmcl.2008.12.032.
[310] Qiu-ning LI Hai-ying LIU Xian-liang XIN Qiu-ming PAN Lu WANG Jing ZHANG Qin CHEN Mei-yu GENG Jian DING. Marine-derived oligosaccharide sulfate (JG3) suppresses heparanase-driven cell adhesion events in heparanase over-expressing CHO-K1 cells. 中国药理学报：英文版[J]. 2009, 1033-1038, http://lib.cqvip.com/Qikan/Article/Detail?id=30813330.
[311] Li, Rui, Shi, JianYou, Ding, ZhenYu, Wei, YuQuan, Ding, Jian. 5-(3,4-Dimethoxybenzyl)aminomethylene-2,2-dimethyl-1,3-dioxane-4,6-dione. ACTA CRYSTALLOGRAPHICA SECTION E-CRYSTALLOGRAPHIC COMMUNICATIONS[J]. 2009, 65: O1298-U2033, https://www.webofscience.com/wos/woscc/full-record/WOS:000266514400182.
[312] Yu, Bing, Miao, ZeHong, Jiang, Yi, Li, MeiHong, Yang, Na, Li, Ting, Ding, Jian. c-Jun Protects Hypoxia-Inducible Factor-1 alpha from Degradation via Its Oxygen-Dependent Degradation Domain in a Nontranscriptional Manner. CANCER RESEARCH[J]. 2009, 69(19): 7704-7712, http://ir.simm.ac.cn/handle/153631/1067.
[313] Lu, JinJian, Meng, LingHua, Zhu, CaiHua, Tong, LinJiang, Lin, LiPing, Ding, Jian. Dihydroartemisinin accelerates c-Myc oncoprotein degradation and induces apoptosis in c-Myc overexpressed tumor cells. CANCER RESEARCHnull. 2009, 69: http://apps.webofknowledge.com/CitedFullRecord.do?product=UA&colName=WOS&SID=5CCFccWmJJRAuMzNPjj&search_mode=CitedFullRecord&isickref=WOS:000209701803374.
[314] 陈勤, 黄河, 蒙凌华, 朱才华, 陈志, 蒋华良, 林莉萍, 柳红, 丁健. 缩氨基硫脲类新化合物TSC的抗肿瘤作用及其分子机制研究. 2009, 99-, https://kns.cnki.net/KCMS/detail/detail.aspx?dbcode=CPFD&dbname=CPFD0914&filename=ZGYS200904001068&v=MTA3NDZ2Tkpsd1VQeXJTZmJHNEh0ak1xNDlGWmVzSkJCTkt1aGRobmo5OFRuanFxeGRFZU1PVUtyaWZaZVp2SGludFU3.
[315] 林莉萍, 姜勇, 谢华, 代梅, 童林江, 任晓维, 郭建辉, 丁健. 酪氨酸激酶EGFR和ErbB2双重抑制剂AST-6的抗肿瘤作用以及机理研究. 2009, 44-45, https://kns.cnki.net/KCMS/detail/detail.aspx?dbcode=CPFD&dbname=CPFD0914&filename=ZGYS200904001014&v=MTk2MDJzT0NCTkt1aGRobmo5OFRuanFxeGRFZU1PVUtyaWZaZVp2SGludFU3dk5KMTBRUHlyU2ZiRzRIdGpNcTQ5Rlpl.
[316] 孙启明, 缪泽鸿, 林莉萍, 桂敏, 谢华, 段文虎, 丁健. 喹啉类化合物BB抗肿瘤作用研究. 2009, 187-, https://kns.cnki.net/KCMS/detail/detail.aspx?dbcode=CPFD&dbname=CPFD0914&filename=ZGYS200904001161&v=MzExMjVSTkt1aGRobmo5OFRuanFxeGRFZU1PVUtyaWZaZVp2SGludFU3dk5LRm9RUHlyU2ZiRzRIdGpNcTQ5Rlplb0pE.
[317] Chen, Dongdong, Yang, Chunhao, Xie, Yuyuan, Ding, Jian. NOVEL PROCESS TO 4,4-DIALKYL-1,4-DIHYDRO-6-METHOXY-3-PHENYLCINNOLINES VIA GRIGNARD REACTION. HETEROCYCLES[J]. 2009, 77(1): 273-277, http://ir.simm.ac.cn/handle/153631/1293.
[318] Ren, Xuan, Dai, Mei, Lin, LiPing, Li, PuiKai, Ding, Jian. Anti-angiogenic and vascular disrupting effects of C9, a new microtubule-depolymerizing agent. BRITISH JOURNAL OF PHARMACOLOGY[J]. 2009, 156(8): 1228-1238, http://ir.simm.ac.cn/handle/153631/1216.
[319] Qian, Jin, Zhu, Caihua, Tang, Shuai, Shen, Aijun, Ai, Jing, Li, Jing, Geng, Meiyu, Ding, Jian. alpha 2,6-Hyposialylation of c-Met abolishes cell motility of ST6Gal-I-knockdown HCT116 cells. ACTA PHARMACOLOGICA SINICA[J]. 2009, 30(7): 1039-1045, http://ir.simm.ac.cn/handle/153631/1143.
[320] Li, Rui, Ding, ZhenYu, Wei, YuQuan, Ding, Jian. 2-{4-(2,2-Dimethyl-4,6-dioxo-1,3-dioxan-5-ylidene)methylaminophenyl}acetonitrile. ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE[J]. 2009, 65(Pt 6): O1296-U2014, http://ir.simm.ac.cn/handle/153631/1167.
[321] Jin QIAN, Cai-hua ZHU, Shuai TANG, Ai-jun SHEN, Jing AI, Jing LI, Mei-yu GENG, Jian DING. α2,6-Hyposialylation of c-Met abolishes cell motility of ST6Gal-l-knockdown HCT116 cells. 中国药理学报：英文版[J]. 2009, 1039-1045, http://lib.cqvip.com/Qikan/Article/Detail?id=30813331.
[322] Yang, Chunhao, Yu, Haofei, Yang, Na, Meng, Linghua, Xu, Jing, Zhang, Rongping, Xie, Yuyuan, Ding, Jian. Synthesis of 4-(5-Benzyl-2-phenylpyrimidin-4-yl)morpholines as Novel PI3K Inhibitors Via Acetates of Baylis-Hillman Adducts and Benzamidines. LETTERS IN ORGANIC CHEMISTRY[J]. 2009, 6(2): 134-140, http://ir.simm.ac.cn/handle/153631/1246.
[323] Zhu, Hong, Miao, ZeHong, Huang, Min, Feng, JianMing, Zhang, ZhiXiang, Lu, JinJian, Cai, YuJun, Tong, LinJiang, Xu, YuFang, Qian, XuHong, Ding, Jian. Naphthalimides Induce G(2) Arrest Through the ATM-Activated Chk2-Executed Pathway in HCT116 Cells. NEOPLASIA[J]. 2009, 11(11): 1226-1234, http://dx.doi.org/10.1593/neo.09986.
[324] 代梅, 缪泽鸿, 任萱, 童林江, 杨娜, 李婷, 林莉萍, 沈岳茅, 丁健. MFTZ-1,a novel topoisomerase Ⅱ poison,reduces constitutive and inducible HIF-1α accumulation and VEGF secretion independent of its Top2 inhibition. 2009, 106-, https://kns.cnki.net/KCMS/detail/detail.aspx?dbcode=CPFD&dbname=CPFD0914&filename=ZGYS200904001076&v=MTg0NjdxcXhkRWVNT1VLcmlmWmVadkhpbnRVN3ZOS1Y0UlB5clNmYkc0SHRqTXE0OUZaZXNJQ2hOS3VoZGhuajk4VG5q.
[325] Yu, Bing, Miao, ZeHong, Jiang, Yi, Li, MeiHong Li, Yang, Na Yang, Li, Ting, Ding, Jian. c-Jun protects HIF-1\#945; from degradation via binding to ODD domain in a non-transcriptional manner. CANCER RESEARCHnull. 2009, 69: [326] 张超, 杨娜, 杨春皓, 丁华胜, 罗成, 张余, 吴茂江, 章雄文, 沈旭, 蒋华良, 蒙凌华, 丁健. 同时靶向PI3K/mTOR和微管的双重抑制剂的S9抗肿瘤作用. 2009, 220-, https://kns.cnki.net/KCMS/detail/detail.aspx?dbcode=CPFD&dbname=CPFD0914&filename=ZGYS200904001199&v=MDA5NzQ5Rlplb0dCUk5LdWhkaG5qOThUbmpxcXhkRWVNT1VLcmlmWmVadkhpbnRVN3ZOSlY4UlB5clNmYkc0SHRqTXE0.
[327] Zhang, Wen, Krohn, Karsten, Ding, Jian, Miao, ZeHong, Zhou, XiuHong, Chen, SiHan, Pescitelli, Gennaro, Salvadori, Piero, Kurtan, Tibor, Guo, YueWei. Structural and stereochemical studies of alpha-methylene-gamma-lactone-bearing cembrane diterpenoids from a South China Sea Soft Coral Lobophytum crassum. JOURNAL OF NATURAL PRODUCTS[J]. 2008, 71(6): 961-966, https://www.webofscience.com/wos/woscc/full-record/WOS:000257227200007.
[328] Wang, XiaoNing, Fan, ChengQi, Yin, Sheng, Lin, LiPing, Ding, Jian, Yue, JianMin. Cytotoxic terpenoids from Turraea pubescens. HELVETICA CHIMICA ACTA[J]. 2008, 91(3): 510-519, https://www.webofscience.com/wos/woscc/full-record/WOS:000254909400013.
[329] Lu, JinJian, Meng, LingHua, Cai, YuJun, Chen, Qin, Tong, LinJiang, Lin, LiPing, Ding, Jian. Dihydroartemisinin induces apoptosis in HL-60 leukemia cells dependent of iron and p38 mitogen-activated protein kinase activation but independent of reactive oxygen species. CANCER BIOLOGY & THERAPY[J]. 2008, 7(7): 1017-1023, http://ir.simm.ac.cn/handle/153631/477.
[330] Zhou, Jin, Chen, Yi, Lang, JingYu, Lu, JinJian, Ding, Jian. Salvicine inactivates beta(1) integrin and inhibits adhesion of MDA-MB-435 cells to fibronectin via reactive oxygen species signaling. MOLECULAR CANCER RESEARCH[J]. 2008, 6(2): 194-204, https://www.webofscience.com/wos/woscc/full-record/WOS:000253602800003.
[331] Li, Haihong, Huang, He, Zhang, Xiuhua, Luo, Xiaomin, Lin, Liping, Jiang, Hualiang, Ding, Jian, Chen, Kaixian, Liu, Hong. Discovering novel 3-nitroquinolines as a new class of anticancer agents. ACTA PHARMACOLOGICA SINICA[J]. 2008, 29(12): 1529-1538, http://lib.cqvip.com/Qikan/Article/Detail?id=29097612.
[332] Juanjuan CHEN, Xiaoyu SU, Xiaodong XI, Liping LIN, Jian DING, He LU. Fibrinogen interaction of CHO cells expressing chimeric αⅡb/αvβ3 integrin. 中国药理学报英文版[J]. 2008, 29(2): 204-, http://lib.cqvip.com/Qikan/Article/Detail?id=26518046.
[333] Jin, HuiZi, Wang, XiaoLing, Wang, HongBing, Wang, YuBo, Lin, LiPing, Ding, Jian, Qin, GuoWei. Morphinane alkaloid dimers from Sinomenium acutum. JOURNAL OF NATURAL PRODUCTS[J]. 2008, 71(1): 127-129, http://ir.simm.ac.cn/handle/153631/576.
[334] Ma, ChunHui, Fan, MingSong, Lin, LiPing, Tang, WeiDong, Lou, LiGuang, Ding, Jian, Huang, ChengGang. Cytotoxic triterpenoid saponins from Vaccaria segetalis. JOURNAL OF ASIAN NATURAL PRODUCTS RESEARCH[J]. 2008, 10(2): 177-184, https://www.webofscience.com/wos/woscc/full-record/WOS:000256384400011.
[335] 李明, 缪泽鸿, 丁健. 蛋白酶体及其抑制剂的研究进展. 中国药理学通报[J]. 2008, 24(5): 565-, http://lib.cqvip.com/Qikan/Article/Detail?id=27363345.
[336] Chen, Qin, Meng, Linghua, Zhu, Caihua, Lin, Liping, Lu, He, Ding, Jian. ADAM15 suppresses cell motility by driving integrin alpha 5 beta 1 cell surface expression via Erk inactivation. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY[J]. 2008, 40(10): 2164-2173, https://www.webofscience.com/wos/woscc/full-record/WOS:000258479700022.
[337] Feng, JianMing, Zhu, Hong, Zhang, XiaoWei, Ding, Jian, Miao, ZeHong. Proteasome-dependent degradation of Chk1 kinase induced by the topoisomerase II inhibitor R16 contributes to its anticancer activity. CANCER BIOLOGY & THERAPY[J]. 2008, 7(11): 1726-1731, http://ir.simm.ac.cn/handle/153631/476.
[338] Chen, Juanjuan, Su, Xiaoyu, Xi, Xiaodong, Lin, Liping, Ding, Jian, Lu, He. Fibrinogen interaction of CHO cells expressing chimeric alpha IIb/alpha v beta 3 integrin. ACTA PHARMACOLOGICA SINICA[J]. 2008, 29(2): 204-210, http://ir.simm.ac.cn/handle/153631/432.
[339] Shen, Ying, Zhang, YongWei, Zhang, ZhiXiang, Miao, ZeHong, Ding, Jian. hTERT-targeted RNA interference inhibits tumorigenicity and motility of HCT116 cells. CANCER BIOLOGY & THERAPY[J]. 2008, 7(2): 228-236, http://ir.simm.ac.cn/handle/153631/478.
[340] Huang, Min, Miao, ZeHong, Zhu, Hong, Cai, YuJun, Lu, Wei, Ding, Jian. Chk1 and Chk2 are differentially involved in homologous recombination repair and cell cycle arrest in response to DNA double-strand breaks induced by camptothecins. MOLECULAR CANCER THERAPEUTICS[J]. 2008, 7(6): 1440-1449, http://ir.simm.ac.cn/handle/153631/616.
[341] Hai-hong LI, He HUANG, Xiu-hua ZHANG, Xiao-min LUO, Li-ping LIN, Hua-liang JIANG, Jian DING, Kai-xian CHEN, Hong LIU. Discovering novel 3-nitroquinolines as a new class of anticancer agents. 中国药理学报：英文版[J]. 2008, 29(12): 1529-1538, http://lib.cqvip.com/Qikan/Article/Detail?id=29097612.
[342] 岳建民. Structural Modification of an Angiogenesis Inhibitor Discovered from Traditional Chinese Medicine, and a Structure Activity Relationship Study. JOURNALOFMEDICINALCHEMISTRY[J]. 2008, 51(1): 77-85, http://ir.simm.ac.cn/handle/153631/550.
[343] 缪泽鸿, 代梅, 于冰, 李美红, 丁健. 抑制作用α抗肿瘤化合物的缺氧诱导因子HIF-1. 2008, 1152-, https://kns.cnki.net/KCMS/detail/detail.aspx?dbcode=IPFD&dbname=IPFD9914&filename=HJYB200809002B80&v=MTU0MjlMRzRIdG5NcG85Rlpwa0hEQk5LdWhkaG5qOThUbmpxcXhkRWVNT1VLcmlmWmVadkhpbnRVN2pOSkZvVUxTZlNi.
[344] 李明, 丁健, 缪泽鸿. 未折叠蛋白反应的信号转导. 生命科学[J]. 2008, 20(2): 246-, http://lib.cqvip.com/Qikan/Article/Detail?id=27242042.
[345] Su, ZuShang, Yin, Sheng, Zhou, ZhiWang, Wu, Yan, Ding, Jian, Yue, JianMin. Sesquiterpenoids from Hedyosmum orientale. JOURNAL OF NATURAL PRODUCTS[J]. 2008, 71(8): 1410-1413, http://ir.simm.ac.cn/handle/153631/557.
[346] Ji, NaiYun, Li, XiaoMing, Xie, Hua, Ding, Jian, Li, Ke, Ding, LanPing, Wang, BinGui. Highly Oxygenated Triterpenoids from the Marine Red Alga Laurencia mariannensis (Rhodomelaceae). HELVETICA CHIMICA ACTA[J]. 2008, 91(10): 1940-1946, http://ir.qdio.ac.cn/handle/337002/6283.
[347] He, Fei, Pu, JianXin, Huang, ShengXiong, Xiao, WeiLie, Yang, LiBin, Li, XiaoNian, Zhao, Yong, Ding, Jian, Xu, ChengHui, Sun, HanDong. Eight New Diterpenoids from the Roots of Euphorbia nematoopha. HELVETICA CHIMICA ACTA[J]. 2008, 91(11): 2139-2147, http://www.corc.org.cn/handle/1471x/2388898.
[348] Juan-juan CHEN, Xiao-yu SU, Xiao-dong XI, Li-ping LIN, Jian DING, He LU. fibrinogeninteractionofchocellsexpressingchimericbv3integrin. ACTAPHARMACOLOGICASINICA[J]. 2008, 29(2): 204-, http://lib.cqvip.com/Qikan/Article/Detail?id=26518046.
[349] Cai, YuJun, Lu, JinJian, Zhu, Hong, Xie, Hua, Huang, Min, Lin, LiPing, Zhang, XiongWen, Ding, Jian. Salvicine triggers DNA double-strand breaks and apoptosis by GSH-depletion-driven H2O2 generation and topoisomerase II inhibition. FREE RADICAL BIOLOGY AND MEDICINE[J]. 2008, 45(5): 627-635, http://dx.doi.org/10.1016/j.freeradbiomed.2008.05.017.
[350] Ma, Jingui, Xin, Xianliang, Meng, Linghua, Tong, Linjiang, Lin, Liping, Geng, Meiyu, Ding, Jian. The Marine-Derived Oligosaccharide Sulfate (MdOS), a Novel Multiple Tyrosine Kinase Inhibitor, Combats Tumor Angiogenesis both In Vitro and In Vivo. PLOS ONE[J]. 2008, 3(11): http://ir.simm.ac.cn/handle/153631/1338.
[351] Huo, Jun, Yang, ShengPing, Xie, BoJun, Liao, ShangGao, Lin, LiPing, Ding, Jian, Yue, JianMin. Cytotoxic sesquiterpenoids from Vernonia bockiana. JOURNAL OF ASIAN NATURAL PRODUCTS RESEARCH[J]. 2008, 10(6): 571-575, http://ir.simm.ac.cn/handle/153631/1408.
[352] Lin, LiGen, Xie, Hua, Li, HongLin, Tong, LinJiang, Tang, ChunPing, Ke, ChangQiang, Liu, QunFang, Lin, LiPing, Geng, MeiYu, Jiang, Hualiang, Zhao, WeiMin, Ding, Jian, Ye, Yang. Naturally occurring homoisoflavonoids function as potent protein tyrosine kinase inhibitors by c-Src-based high-throughput screening. JOURNAL OF MEDICINAL CHEMISTRY[J]. 2008, 51(15): 4419-4429, http://ir.simm.ac.cn/handle/153631/549.
[353] Tao, Hongwen, Hao, Xiaojiang, Liu, Jinggen, Ding, Jian, Fang, Yuchun, Gu, Qianqun, Zhu, Weiming. Resin Glycoside Constituents of Ipomoea pes-caprae (Beach Morning Glory). JOURNAL OF NATURAL PRODUCTS[J]. 2008, 71(12): 1998-2003, http://ir.simm.ac.cn/handle/153631/551.
[354] Zhu, Yingdong, Miao, Zehong, Ding, Jian, Zhao, Weimin. Cytotoxic dihydroagarofuranoid sesquiterpenes from the seeds of Celastrus orbiculatus. JOURNAL OF NATURAL PRODUCTS[J]. 2008, 71(6): 1005-1010, http://ir.simm.ac.cn/handle/153631/561.
[355] Zhang, ZhongHua, Chen, Yi, Zhao, HuaJun, Xie, ChengYing, Ding, Jian, Hou, YongTai. Silencing of heparanase by siRNA inhibits tumor metastasis and angiogenesis of human breast cancer in vitro and in vivo. CANCER BIOLOGY & THERAPY[J]. 2007, 6(4): 587-595, http://ir.simm.ac.cn/handle/153631/1809.
[356] 蒋超, 卿晨, 蒙凌华, 丁健, 姜永健. 双灵固本散对DNA拓扑异构酶的抑制作用及诱导K562细胞凋亡的研究. 浙江中医杂志. 2007, 8-9, https://kns.cnki.net/KCMS/detail/detail.aspx?dbcode=CJFQ&dbname=CJFD2007&filename=ZJZZ200701007&v=MDc2MTN5N25VYnZBUHlmUmRMRzRIdGJNcm85Rlk0UjhlWDFMdXhZUzdEaDFUM3FUcldNMUZyQ1VSN3FmYitabUY=.
[357] 张超, 章雄文, 丁健. Akt—mTOR的互动与癌症的发生. 生命科学[J]. 2007, 19(1): 21-, http://lib.cqvip.com/Qikan/Article/Detail?id=23974540.
[358] Wu, Maojiang, Sun, Qiming, Yang, Chunhao, Chen, Dongdong, Ding, Jian, Chen, Yi, Lin, Liping, Xie, Yuyuan. Synthesis and activity of Combretastatin A-4 analogues: 1,2,3-thiadiazoles as potent antitumor agents. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS[J]. 2007, 17(4): 869-873, http://dx.doi.org/10.1016/j.bmcl.2006.11.060.
[359] 秦玉新, 蒙凌华, 丁健. RNA干扰技术的研究进展. 中国药理学通报[J]. 2007, 23(4): 421-, http://lib.cqvip.com/Qikan/Article/Detail?id=24254209.
[360] Huang, Min, Gao, Heyong, Chen, Yi, Zhu, Hong, Cai, Yujun, Zhang, Xiongwen, Miao, Zehong, Jiang, Hualiang, Zhang, Jian, Shen, Hongwu, Lin, Liping, Lu, Wei, Ding, Jian. Chimmitecan, a novel 9-substituted camptothecin, with improved anticancer pharmacologic profiles in vitro and in vivo. CLINICAL CANCER RESEARCH[J]. 2007, 13(4): 1298-1307, http://ir.simm.ac.cn/handle/153631/1842.
[361] Xie, ChengYing, Zhu, Hong, Lin, LiFling, Miao, ZeHong, Geng, MeiYu, Cai, YuJun, Chen, Yi, Zhao, HuaJun, Luo, HaiBin, Zhang, XiongWen, Fan, LiMing, Shen, YueMao, Ding, Jian. MFTZ-1, an actinomycetes subspecies-derived antitumor macrolide, functions as a novel topoisomerase II poison. MOLECULAR CANCER THERAPEUTICS[J]. 2007, 6(11): 3059-3070, http://www.irgrid.ac.cn/handle/1471x/967387.
[362] 任萱, 林莉萍, 丁健. Combretastatin A4的抗肿瘤作用研究进展. 中国新药杂志[J]. 2007, 16(17): 1336-, http://lib.cqvip.com/Qikan/Article/Detail?id=25573881.
[363] 朱虹, 丁健. 萘酰亚胺类化合物作为抗肿瘤药物的研发现状. 中国新药杂志[J]. 2007, 16(10): 742-, http://lib.cqvip.com/Qikan/Article/Detail?id=24615510.
[364] Ling-hua MENG Jian DING. Salvicine, a novel topoisomerase Ⅱ inhibitor, exerts its potent anticancer activity by ROS generation. 中国药理学报：英文版[J]. 2007, 28(9): 1460-1465, http://lib.cqvip.com/Qikan/Article/Detail?id=25413321.
[365] Li, Weihong, Shao, Yong, Hu, Lihong, Zhang, Xiongwen, Chen, Yi, Tong, Linjiang, Li, Chuan, Shen, Xu, Ding, Jian. BM6, a new semi-synthetic Vinca alkaloid, exhibits its potent in vivo anti-tumor activities via its high binding affinity for tubulin and improved pharmacokinetic profiles. CANCER BIOLOGY & THERAPY[J]. 2007, 6(5): 787-794, http://ir.simm.ac.cn/handle/153631/1788.
[366] 黄敏, 缪泽鸿, 丁健. DNA双链断裂损伤修复系统研究进展. 生理科学进展[J]. 2007, 38(4): 295-, http://lib.cqvip.com/Qikan/Article/Detail?id=25723908.
[367] Wang, XiaoNing, Yin, Sheng, Fan, ChengQi, Lin, LiPing, Ding, Jian, Yue, JianMin. Eight new limonoids from Turraea pubescens. TETRAHEDRON[J]. 2007, 63(34): 8234-8241, http://dx.doi.org/10.1016/j.tet.2007.05.107.
[368] Yin, Sheng, Xue, JunJuan, Fan, ChengQi, Miao, ZeHong, Ding, Jian, Yue, JianMin. Eucalyptals A-C with a new skeleton isolated from Eucalyptus globulus. ORGANIC LETTERS[J]. 2007, 9(26): 5549-5552, https://www.webofscience.com/wos/woscc/full-record/WOS:000251614900055.
[369] Zhang, Hua, Wang, XiaoNing, Lin, LiPing, Ding, Jian, Yue, JianMin. Indole alkaloids from three species of the Ervatamia genus: E-officinalis, E-divaricata, and E-divaricata Gouyahua. JOURNAL OF NATURAL PRODUCTS[J]. 2007, 70(1): 54-59, https://www.webofscience.com/wos/woscc/full-record/WOS:000243734900012.
[370] Meng, Tao, Zhang, Zhixiang, Hu, Dingyu, Lin, Liping, Ding, Jian, Wang, Xin, Shen, Jingkang. Three-component combinatorial synthesis of a substituted 6H-Pyrido2 ',1 ': 2,3imidazo-4,5-cisoquinolin-5(6H)-one library with cytotoxic activity. JOURNAL OF COMBINATORIAL CHEMISTRY[J]. 2007, 9(5): 739-741, http://ir.simm.ac.cn/handle/153631/1702.
[371] Cai, Yujun, Lu, Jinjian, Miao, Zehong, Lin, Liping, Ding, Jian. Reactive oxygen species contribute to cell killing and P-glycoprotein downregulation by salvicine in multidrug resistant K562/A02 cells. CANCER BIOLOGY & THERAPY[J]. 2007, 6(11): 1794-1799, http://ir.simm.ac.cn/handle/153631/1666.
[372] Zheng, Mingfang, Xu, Chenghui, Ma, Jianwei, Sun, Yan, Du, Feifei, Liu, Hong, Lin, Liping, Li, Chuan, Ding, Jian, Chen, Kaixian, Jiang, Hualiang. Synthesis and antitumor evaluation of a novel series of triaminotriazine derivatives. BIOORGANIC & MEDICINAL CHEMISTRY[J]. 2007, 15(4): 1815-1827, http://dx.doi.org/10.1016/j.bmc.2006.11.028.
[373] Qin, Yuxin, Meng, Linghua, Hu, Chaoxin, Duan, Wenhu, Zuo, Zhili, Lin, Liping, Zhang, Xiongwen, Ding, Jian. Gambogic acid inhibits the catalytic activity of human topoisomerase II alpha by binding to its ATPase domain. MOLECULAR CANCER THERAPEUTICS[J]. 2007, 6(9): 2429-2440, http://ir.simm.ac.cn/handle/153631/1708.
[374] 金慧子, 王红兵, 王玉波, 林丽萍, 丁健, 秦国伟. 地不容块茎中的生物碱. 中国天然药物[J]. 2007, 5(2): 112-114, http://lib.cqvip.com/Qikan/Article/Detail?id=24047856.
[375] 丁健. 从天然产物中寻找发现抗肿瘤药物. 2007, 34-40, https://kns.cnki.net/KCMS/detail/detail.aspx?dbcode=CPFD&dbname=CPFD9908&filename=ZGKA200706001010&v=MDc0MTRudFU3bklJVjRXUHlyQWI3RzRIdGJNcVk5Rlplc09EQk5LdWhkaG5qOThUbmpxcXhkRWVNT1VLcmlmWmVadkhp.
[376] 任萱, 孙启明, 林莉萍, 丁健. 肿瘤血管靶向药物的研究进展. 生命科学[J]. 2007, 19(4): 427-, http://lib.cqvip.com/Qikan/Article/Detail?id=25307244.
[377] 黄敏, 丁健. 拓扑异构酶Ⅰ抑制剂研究进展. 中国新药杂志[J]. 2007, 16(13): 990-, http://lib.cqvip.com/Qikan/Article/Detail?id=24952983.
[378] Linghua MENG, Jian DING. Salvicine, a novel topoisomerase II inhibitor, exerts its potent anticancer activity by ROS generation1. ACTA PHARMACOLOGICA SINICA[J]. 2007, 28(9): 1460-,  http://dx.doi.org/10.1111/j.1745-7254.2007.00698.x.
[379] Yin, Sheng, Wang, XiaoNing, Fan, ChengQi, Lin, LiPing, Ding, Jian, Yue, JianMin. Limonoids from the seeds of the marine mangrove Xylocarpus granatum. JOURNALOFNATURALPRODUCTS[J]. 2007, 70(4): 682-685, https://www.webofscience.com/wos/woscc/full-record/WOS:000246007200039.
[380] Meng, LingHua, Ding, Jian. Salvicine, a novel topoisomerase II inhibitor, exerts its potent anticancer activity by ROS generation. ACTA PHARMACOLOGICA SINICA[J]. 2007, 28(9): 1460-1465, https://www.webofscience.com/wos/woscc/full-record/WOS:000249220900019.
[381] 周晋, 陈奕, 丁健. 整合素的活化调控. 生命科学[J]. 2006, 18(3): 233-, http://lib.cqvip.com/Qikan/Article/Detail?id=22084857.
[382] 张永炜, 缪泽鸿, 丁健. 端粒结合蛋白TRF2的研究进展. 生命科学[J]. 2006, 18(3): 239-, http://lib.cqvip.com/Qikan/Article/Detail?id=22084858.
[383] 章雄文, 丁健, 谢成英. TIEG与肿瘤的发生发展. 生命的化学[J]. 2006, 26(2): 102-, http://lib.cqvip.com/Qikan/Article/Detail?id=21629816.
[384] 张秀华, 林莉萍, 丁健. 靶向血小板源生长因子受体酪氨酸激酶抑制剂的临床研究进展. 中国新药与临床杂志[J]. 2006, 25(6): 454-, [385] 钱进, 章雄文, 丁健. 唾液酸转移酶对肿瘤中唾液酸化结构的影响. 生命科学[J]. 2006, 18(3): 227-, http://lib.cqvip.com/Qikan/Article/Detail?id=22084856.
[386] Wang, XiaoNing, Yin, Sheng, Fan, ChengQi, Wang, FangDao, Lin, LiPing, Ding, Jian, Yue, JianMin. Turrapubesins A and B, first examples of halogenated and maleimide-bearing limonoids in nature from Turraea pubescens. ORGANIC LETTERS[J]. 2006, 8(17): 3845-3848, https://www.webofscience.com/wos/woscc/full-record/WOS:000239655500057.
[387] Huang, Min, Zhu, Hong, Gao, Heyong, Chen, Yi, Cai, Yujun, Zhang, Xiongwen, Miao, Zehong, Shen, Hongwu, Lin, Liping, Lu, Wei, Ding, Jian. Chimmitecan, a novel 9-substituted camptothecin, is a promising anticancer drug candidate.. CANCER RESEARCHnull. 2006, 66(8): https://www.webofscience.com/wos/woscc/full-record/WOS:000454608805031.
[388] Gao, Yan, Lin, LiPing, Zhu, CaiHua, Chen, Yi, Hou, YongTai, Ding, Jian. Growth arrest induced by C75, a fatty acid synthase inhibitor, was partially modulated by p38 MAPK but not by p53 in human hepatocellular carcinoma. CANCER BIOLOGY & THERAPY[J]. 2006, 5(8): 978-985, http://ir.simm.ac.cn/handle/153631/1496.
[389] Xu, YouKai, Yang, ShengPing, Liao, ShangGao, Zhang, Hua, Lin, LiPing, Ding, Jian, Yue, JianMin. Alkaloids from Gelsemium elegans. JOURNAL OF NATURAL PRODUCTS[J]. 2006, 69(9): 1347-1350, http://dx.doi.org/10.1021/np060156y.
[390] Zhong, Li, Guo, XiaoNing, Zhang, XiuHua, Sun, QiMing, Tong, LinJiang, Wu, ZhiXing, Luo, XiaoMing, Jiang, HuaLiang, Nan, FaJun, Zhang, XiongWen, Lin, LiPing, Ding, Jian. TKI-31 inhibits angiogenesis by combined suppression signaling pathway of VEGFR2 and PDGFR beta. CANCER BIOLOGY & THERAPY[J]. 2006, 5(3): 323-330, http://ir.simm.ac.cn/handle/153631/1583.
[391] Ding, Jian, Miao, ZeHong, Meng, LingHua, Geng, MeiYu. Emerging cancer therapeutic opportunities target DNA-repair systems. TRENDS IN PHARMACOLOGICAL SCIENCESnull. 2006, 27(6): 338-344, http://dx.doi.org/10.1016/j.tips.2006.04.007.
[392] 张秀华, 林莉萍, 丁健. 血小板源生长因子受体与肿瘤. 生命科学[J]. 2006, 18(3): 220-, http://lib.cqvip.com/Qikan/Article/Detail?id=22084855.
[393] 黄敏, 丁健. 抗肿瘤药物新靶点. 中国处方药. 2006, 10-15, https://kns.cnki.net/KCMS/detail/detail.aspx?dbcode=CJFQ&dbname=CJFD2006&filename=ZGCF200612004&v=MDU2OTJGeTdnVnJ6T1B5cklhTEc0SHRmTnJZOUZZSVI4ZVgxTHV4WVM3RGgxVDNxVHJXTTFGckNVUjdxZmIrWm0=.
[394] Gan, LiShe, Fan, ChengQi, Yang, ShengPing, Wu, Yan, Lin, LiPing, Ding, Jian, Yue, JianMin. Flueggenines A and B, two novel C,C-linked dimeric indolizidine alkaloids from Flueggea virosa. ORGANIC LETTERS[J]. 2006, 8(11): 2285-2288, https://www.webofscience.com/wos/woscc/full-record/WOS:000237625700021.
[395] 周晋, 陈奕, 丁健. 基底膜和肿瘤转移. 生理科学进展[J]. 2006, 37(4): 307-, [396] 林莉萍, 丁健. 针对分子靶点的抗肿瘤药物研究进展. 中国新药杂志[J]. 2006, 15(3): 167-, https://kns.cnki.net/KCMS/detail/detail.aspx?dbcode=CJFQ&dbname=CJFD2006&filename=ZXYZ200603002&v=MjE3MjZHNEh0Zk1ySTlGWm9SOGVYMUx1eFlTN0RoMVQzcVRyV00xRnJDVVI3cWZiK1ptRnlIaFVyck5QelhTZEw=.
[397] Yang, Fan, Chen, Yi, Duan, Wenhu, Zhang, Chao, Zhu, Hong, Ding, Jian. SH-7, a new synthesized shikonin derivative, exerting its potent antitumor activities as a topoisomerase inhibitor. INTERNATIONAL JOURNAL OF CANCER[J]. 2006, 119(5): 1184-1193, http://ir.simm.ac.cn/handle/153631/1485.
[398] 钱进, 朱才华, 章雄文, 丁健. 糖链变化对肿瘤转移的影响及在肿瘤疫苗中的应用. 中国新药杂志[J]. 2006, 15(13): 1047-,  http://dx.doi.org/10.3321/j.issn:1003-3734.2006.13.005.
[399] Li, DaQiang, Hou, YiFeng, Wu, Jiong, Chen, Yi, Lu, JinSong, Di, GenHong, Ou, ZhouLuo, Shen, ZhenZhou, Ding, Jian, Shao, ZhiMin. Gene expression profile analysis of an isogenic tumour metastasis model reveals a functional role for oncogene AF1Q in breast cancer metastasis. EUROPEAN JOURNAL OF CANCER[J]. 2006, 42(18): 3274-3286, http://dx.doi.org/10.1016/j.ejca.2006.07.008.
[400] Ding, Jian. Anticancer agents discovery from nature products. ACTA PHARMACOLOGICA SINICA[J]. 2006, 27: 2-2, https://www.webofscience.com/wos/woscc/full-record/WOS:000239590000010.
[401] 金毅, 林莉萍, 丁健, 龙亚秋. 靶向EGFR信号传导途径的抗肿瘤剂：5，8-二取代喹唑啉的设计与合成. 2005, 225-, https://kns.cnki.net/KCMS/detail/detail.aspx?dbcode=CPFD&dbname=CPFD9908&filename=ZGHY200508001171&v=MTIyODRKRjBSUHlyRGQ3RzRIdFRNcDQ5Rlplb0lEUk5LdWhkaG5qOThUbmpxcXhkRWVNT1VLcmlmWmVadkhpam1VTDdL.
[402] 卢大用, 丁健. 21世纪的生物学--系统生物学. 生物学杂志[J]. 2005, 22(1): 60,44-, http://lib.cqvip.com/Qikan/Article/Detail?id=11830662.
[403] 侯意枫, 袁胜涛, 李鹤成, 吴炅, 陆劲松, 陆丽娟, 刘刚, 沈镇宙, 丁健, 邵志敏. 雌激素受体β亚型对人乳腺癌细胞株生物学特性的影响. 中华肿瘤杂志[J]. 2005, 27(7): 389-392, http://lib.cqvip.com/Qikan/Article/Detail?id=18081920.
[404] 王杰, 欧周罗, 侯意枫, 罗建民, 陈奕, 周晋, 沈镇宙, 丁健, 邵志敏. Duffy抗原趋化因子受体抑制人乳腺癌裸鼠移植瘤的生长和肺转移. 中华医学杂志[J]. 2005, 85(29): 2033-, http://lib.cqvip.com/Qikan/Article/Detail?id=20001905.
[405] 郭晓宁, 林莉萍, 章雄文, 丁健. 表皮生长因子受体酪氨酸激酶家族与肿瘤治疗. 中国新药杂志[J]. 2005, 14(10): 1136-, http://lib.cqvip.com/Qikan/Article/Detail?id=20281689.
[406] 高燕, 林莉萍, 丁健. 细胞周期调控的研究进展. 生命科学[J]. 2005, 17(4): 318-, http://lib.cqvip.com/Qikan/Article/Detail?id=20032022.
[407] 赵翠花, 陈奕, 丁健, 段文虎. 喹喔啉衍生物的设计合成及抗肿瘤活性研究. 药学学报[J]. 2005, 40(9): 814-, http://lib.cqvip.com/Qikan/Article/Detail?id=20267719.
[408] 赵华军, 章雄文, 丁健. 乙酰肝素酶——癌症转移治疗的靶点. 药学学报[J]. 2005, 40(10): 871-875, http://lib.cqvip.com/Qikan/Article/Detail?id=20330200.
[409] 钟利, 丁健. 血管内皮生长因子受体的信号转导通路. 生命的化学[J]. 2005, 25(2): 123-, http://lib.cqvip.com/Qikan/Article/Detail?id=15449317.
[410] 田芳, 缪泽鸿, 章雄文, 丁健. 整合蛋白信号转导研究进展. 生命科学[J]. 2005, 17(3): 240-, http://lib.cqvip.com/Qikan/Article/Detail?id=15800740.
[411] 陈奕, 丁健. 热休克蛋白90——癌症治疗的新靶点. 癌症：英文版[J]. 2004, 23(8): 968-974, http://lib.cqvip.com/Qikan/Article/Detail?id=10355207.
[412] 缪泽鸿, 丁健. 多药耐药基因的转录调控与治疗学机会. 生命科学[J]. 2004, 16(4): 200-, http://lib.cqvip.com/Qikan/Article/Detail?id=10218363.
[413] 陈奕, 缪泽鸿, 丁健. p38 MAPKs在细胞周期调控中的作用. 生理科学进展[J]. 2004, 35(4): 315-, http://lib.cqvip.com/Qikan/Article/Detail?id=10813161.
[414] 唐文皓, 王炳生, 袁祖荣, 袁胜涛, 陆丽娟, 丁健. 化疗药物对荷人胆管癌裸小鼠移植瘤的药效试验. 肝胆胰外科杂志[J]. 2004, 16(4): 258-259+262, http://lib.cqvip.com/Qikan/Article/Detail?id=11542896.
[415] 唐志红, 秦松, 吴少杰, 高江涛, 林莉萍, 丁健. 镭普克的制备及对小鼠H22肝癌的抑制作用. 高技术通讯[J]. 2004, 14(3): 83-, http://lib.cqvip.com/Qikan/Article/Detail?id=9430526.
[416] 李美红, 缪泽鸿, 丁健. 靶向肿瘤缺氧. 中国癌症杂志[J]. 2004, 14(5): 486-489, http://lib.cqvip.com/Qikan/Article/Detail?id=10853526.
[417] 郭晓宁, 丁健. 首个酪氨酸激酶抑制剂药物gleevec. 生理科学进展[J]. 2003, 34(2): 183-, http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=slkxjz200302025.
[418] 林芳, 钱之玉, 薛红卫, 丁健, 林莉萍. 青蒿素和青蒿琥酯对人乳腺癌MCF—7细胞的体外抑制作用比较研究. 中草药[J]. 2003, 34(4): 347-, http://lib.cqvip.com/Qikan/Article/Detail?id=7742543.
[419] 何小伟, 高解春, 袁胜涛, 陈连, 罗建明, 陆丽娟, 丁健. 维甲酸对肾母细胞瘤分化诱导和生长抑制的实验研究. 中华小儿外科杂志[J]. 2003, 24(5): 455-, http://lib.cqvip.com/Qikan/Article/Detail?id=8530375.
[420] 唐文皓, 袁胜涛, 王炳生, 陆丽娟, 丁健. 人胆管癌裸鼠移植瘤2号模型的建立. 中华肝胆外科杂志[J]. 2003, 9(12): 3-, http://lib.cqvip.com/Qikan/Article/Detail?id=8809731.
[421] 郭晓宁, 丁健. 首个酪氨酸激酶抑制剂药物G1eevec. 生理科学进展[J]. 2003, 34(2): 183-186, http://lib.cqvip.com/Qikan/Article/Detail?id=8000813.
[422] 易杨华, 孙鹏, 左建平, 林厚文, 李玲, 汤海峰, 丁健, 南发俊. 海洋生物活性物质总草苔虫内酯体外抗SARS相关冠状病毒的初步研究. 第二军医大学学报[J]. 2003, 24(8): 821-, http://lib.cqvip.com/Qikan/Article/Detail?id=8301258.
[423] 缪泽鸿, 丁健. 抗肿瘤多药耐的研究进展. 癌症[J]. 2003, 22(8): 886-, [424] 张永炜, 刘卫, 蒋建飞, 萧东, 丁健. 沙尔威辛诱导HL—60细胞凋亡过程中PRA活化并下调端粒酶活性. 中国药理通讯[J]. 2003, 20(2): 60-60, http://lib.cqvip.com/Qikan/Article/Detail?id=7833322.
[425] 刘卫军, 沈瑛, 丁健. Protein phosphatase 2A: Its structure, function and activity regulation. ACTA BIOCHIMICA ET BIOPHYSICA SINICA[J]. 2003, 35(2): 105-112, https://www.webofscience.com/wos/woscc/full-record/WOS:000181245500001.
[426] 何小伟, 袁胜涛, 高解春, 陆丽娟, 陈莲, 丁健, 罗建明. 人肾母细胞瘤裸小鼠肾原位移植模型的建立和生物学特性的研究. 中华小儿外科杂志[J]. 2003, 24(3): 258-, http://lib.cqvip.com/Qikan/Article/Detail?id=7969826.
[427] 缪泽鸿, 丁健. 转录因子c-jun激活下调mdr-1基因表达. 中国药理通讯[J]. 2003, 20(3): 31-31, http://lib.cqvip.com/Qikan/Article/Detail?id=8531631.
[428] 郭晓宁, 丁健. 慢性粒细胞白血病患者的福音. 抗癌[J]. 2003, 27-27, http://lib.cqvip.com/Qikan/Article/Detail?id=7758581.
[429] 童云广, 谭文福, 萧东, 丁健. 肿瘤新生血管生成及其抑制剂的研究进展. 中国科技成果[J]. 2003, 28-31, http://lib.cqvip.com/Qikan/Article/Detail?id=7963881.
[430] 缪泽鸿, 丁健. 抗肿瘤多药耐药的研究进展. 癌症：英文版[J]. 2003, 22(8): 886-892, http://lib.cqvip.com/Qikan/Article/Detail?id=8180616.
[431] 梁春, 吴宗贵, 丁健, 蒋建飞, 刘卫军, 蒋超, 葛均波. 腱糖蛋白-C对大鼠腹腔巨噬细胞活性及其分泌表达基质金属蛋白酶-2，9的影响. 中华心血管病杂志[J]. 2003, 31(5): 365-, http://lib.cqvip.com/Qikan/Article/Detail?id=8169212.
[432] 缪泽鸿, 丁健. 沙尔威辛经激活转录因子c—Jun下调K562／A02细胞的mdr—1基因表达. 中国药理通讯[J]. 2002, 19(4): 62-62, http://lib.cqvip.com/Qikan/Article/Detail?id=7453657.
[433] 缪泽鸿, 丁健. 慢性髓性白血病K—562细胞的凋亡耐受. 生理科学进展[J]. 2002, 33(2): 163-, http://lib.cqvip.com/Qikan/Article/Detail?id=6129493.
[434] 梁春, 丁健. 致动脉粥样硬化不同因素对大鼠腹腔巨噬细胞和主动脉平滑肌细胞分泌表达Tenascin—C的影响. 中华老年心脑血管病杂志[J]. 2002, 4(2): 115-118, http://lib.cqvip.com/Qikan/Article/Detail?id=6172969.
[435] 蒙凌华, 张永炜, 丁健. 以DNA拓扑异构酶Ⅱ为靶点的抗癌药物. 中国新药杂志[J]. 2002, 11(9): 675-683, http://lib.cqvip.com/Qikan/Article/Detail?id=6918091.
[436] 陈陵际, 韩家娴, 杨蔚怡, 陆丽娟, 张家骝, 杨秋龙, 袁胜涛, 丁健. 灵芝精粉和孢子粉混合物抑制肿瘤细胞生长的实验研究. 癌症[J]. 2002, 21(12): 1341-, http://lib.cqvip.com/Qikan/Article/Detail?id=7116536.
[437] 林芳, 钱之玉, 丁健, 林莉萍. 二氢青蒿素对人乳腺癌MCF—7细胞的体外抑制作用. 中国新药杂志[J]. 2002, 11(12): 934-, http://lib.cqvip.com/Qikan/Article/Detail?id=7254729.
[438] 丁健. 新DNA拓扑异构酶Ⅱ抑制剂沙尔威辛的药理药效学研究. 中国药理通讯[J]. 2002, 19(4): 30-31, http://lib.cqvip.com/Qikan/Article/Detail?id=7453527.
[439] 刘卫军, 丁健. 端粒酶活性调节的分子机制. 生理科学进展[J]. 2001, 32(3): 220-224, http://lib.cqvip.com/Qikan/Article/Detail?id=5308627.
[440] 谭文福, 肖东, 王家, 丁健. 血管内皮生长因子受体信号转导通路与肿瘤血管生成. 生物化学与生物物理进展[J]. 2001, 28(5): 623-626, http://lib.cqvip.com/Qikan/Article/Detail?id=5839248.
[441] 萧东, 丁健. 肿瘤新生血管生成抑制剂的研究进展. 中国新药杂志[J]. 2001, 10(4): 248-251, http://lib.cqvip.com/Qikan/Article/Detail?id=5141725.
[442] 袁胜涛, 丁健, 蔡永葆, 朱玉芳, 黄伟良, 张瑞芳, 萧东, 曾艳. 胃腺癌的血管内皮细胞生长因子和KDR受体的表达及其临床意义. 癌症[J]. 2001, 20(1): 61-, http://sciencechina.cn/gw.jsp?action=detail.jsp&internal_id=530348&detailType=1.
[443] 陈陵际, 丁健. 运用人癌裸小鼠移植瘤模型进行抗癌新药评价—NCI和EORTC临床前体内药效学研究方法和原则. 上海实验动物科学[J]. 2001, 21(4): 247-250, http://lib.cqvip.com/Qikan/Article/Detail?id=5840244.
[444] 丁健. 抗肿瘤药物的研究进展与发展策略. 江西医学院学报[J]. 2001, 41(2): 33-39, http://lib.cqvip.com/Qikan/Article/Detail?id=5933073.
[445] 陈陵际, 丁健, 汤涛, 蒙凌华. 鸦胆子油乳具有多药耐药逆转和拓扑异构酶Ⅱ抑制作用. 中国药理学通报[J]. 2001, 17(5): 534-, http://lib.cqvip.com/Qikan/Article/Detail?id=5622766.
[446] 卿晨, 丁健. Bcl—2基因家族在调节细胞凋亡中的作用. 国外医学：分子生物学分册[J]. 2000, 22(1): 17-21, http://lib.cqvip.com/Qikan/Article/Detail?id=4132583.
[447] 丁健, 刘卫军, 蒋建飞. 喜树碱诱导人白血病hl60细胞凋亡过程中端粒酶的调控. ACTAPHARMACOLOGICASINICA[J]. 2000, 21(8): 759-, [448] 丁健. 抗肿瘤药物的研究新进展. 中国新药杂志[J]. 2000, 9(3): 149-154, http://lib.cqvip.com/Qikan/Article/Detail?id=4208058.
[449] 蒋超, 刘兆乾, 丁健, 齐清, 蒙凌华. 螺旋藻提取物对DNA拓扑异构酶活性的抑制及对DNA的直接影响. 癌症：英文版[J]. 2000, 19(8): 768-, http://lib.cqvip.com/Qikan/Article/Detail?id=4594028.
[450] 卿晨, 刘兆乾, 齐清, 丁健, 蒙凌华, 蒋超. 螺旋藻提取物对表皮生长因子受体酪氨酸激酶的抑制作用及诱导hl60细胞凋亡. 癌症[J]. 2000, 19(12): 1101-,  http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=ez200012009.
[451] 卿晨, 张金生, 丁健. 新二萜醌类化合物salvicine体外抗肿瘤作用及其诱导凋亡机制的研究. 1999, 375-376, https://kns.cnki.net/KCMS/detail/detail.aspx?dbcode=CPFD&dbname=CPFD0914&filename=ZYTN199911001102&v=MTY3MDFWb2NQelRmWUxLeEY5ak5ybzlGWmVvUERoTkt1aGRobmo5OFRuanFxeGRFZU1PVUtyaWZaZVp2SGludFVMN0pK.
[452] 萧东, 丁健. 肿瘤新生血管生成抑制剂的研究开发思路. 1999, 301-303, https://kns.cnki.net/KCMS/detail/detail.aspx?dbcode=CPFD&dbname=CPFD0914&filename=ZYTN199911001088&v=MjcxNjRuajk4VG5qcXF4ZEVlTU9VS3JpZlplWnZIaW50VUw3SkoxMFRQelRmWUxLeEY5ak5ybzlGWmVzSEJCTkt1aGRo.
[453] 蒋建飞, 丁健. 端粒酶在salvicine诱导HL-60凋亡过程中的调控. 1999, 377-378, https://kns.cnki.net/KCMS/detail/detail.aspx?dbcode=CPFD&dbname=CPFD0914&filename=ZYTN199911001103&v=MTkyNTNpbnRVTDdKSkZ3VVB6VGZZTEt4RjlqTnJvOUZaZW9QRHhOS3VoZGhuajk4VG5qcXF4ZEVlTU9VS3JpZlplWnZI.
[454] 袁胜涛, 肖东, 智强, 陆丽娟, 许承辉, 韩家娴, 杨蔚怡, 张家骝, 丁健. 血管形成抑制剂重组人内抑素抗肿瘤作用研究. 1999, 379-380, https://kns.cnki.net/KCMS/detail/detail.aspx?dbcode=CPFD&dbname=CPFD0914&filename=ZYTN199911001104&v=MTE3NDZqcXF4ZEVlTU9VS3JpZlplWnZIaW50VUw3SkpGc1JQelRmWUxLeEY5ak5ybzlGWmVvUENCTkt1aGRobmo5OFRu.
[455] 张金生, 丁健, 卿晨. 新二萜醌化合物杀尔威辛的体外细胞毒作用. ACTAPHARMACOLOGICASINICA[J]. 1999, 20(4): 297-, [456] 萧东, 丁健. 肿瘤血管生成抑制剂的研究现状及我国的发展战略探讨. 世界科技研究与发展[J]. 1999, 3-5, http://lib.cqvip.com/Qikan/Article/Detail?id=3870176.
[457] 蒙凌华, 丁健. 拓扑异构酶Ⅱ抑制剂Salvicine导致HL-60白血病细胞DNA损伤及对c-myc表达的影响. 1999, 373-374, https://kns.cnki.net/KCMS/detail/detail.aspx?dbcode=CPFD&dbname=CPFD0914&filename=ZYTN199911001101&v=MDIyMzF0VUw3SkpGNFNQelRmWUxLeEY5ak5ybzlGWmVvUERSTkt1aGRobmo5OFRuanFxeGRFZU1PVUtyaWZaZVp2SGlu.
[458] 卿晨, 张金生, 丁健. 新二萜醌化合物杀尔威辛的体外细胞毒作用（英文）. ACTA PHARMACOLOGICA SINICA. 1999, 3-5, https://kns.cnki.net/KCMS/detail/detail.aspx?dbcode=CJFQ&dbname=CJFD9899&filename=ZGLL199904002&v=MDAxNDZZUzdEaDFUM3FUcldNMUZyQ1VSN3FmYitabUZDbm5VTHJCUHlySFlyS3hGOWpNcTQ5RlpvUjhlWDFMdXg=.
[459] 肖东, 丁健. 肿瘤血管生成抑制剂的作用机制研究进展. 生理科学进展[J]. 1999, 30(3): 3-5, http://lib.cqvip.com/Qikan/Article/Detail?id=3748793.
[460] 卿晨, 蒋超, 丁健, 蒙凌华. 灵芝提取物对DNA拓扑异构酶的抑制作用及诱导K562细胞凋亡. 癌症[J]. 1999, 18(6): 661-,  http://dx.doi.org/10.3321/j.issn:1000-467X.1999.06.011.
[461] 李青山, 袁胜涛, 刘锐玲, 赵正保, 丁健. 二乙基邻菲咯啉二氯合锡与DNA作用的研究. 药学学报[J]. 1998, 33(12): 927-, http://lib.cqvip.com/Qikan/Article/Detail?id=3236501.
[462] 杜祥, 丁健. 增殖生长因子及癌基因蛋白在人肉瘤及转移植瘤中的表达. 中国癌症杂志[J]. 1998, 8(4): 301-304, http://lib.cqvip.com/Qikan/Article/Detail?id=3328579.
[463] 蒋建飞, 丁健. 端粒酶——肿瘤治疗的新靶点. 国外医学(肿瘤学分册). 1997, 24(1): 29-31, http://lib.cqvip.com/Qikan/Article/Detail?id=2431486.
[464] 丁健, 陈陵际, 杜祥, 张素胤, 张家骝, 杨秋龙, 李晓玉. 两株人恶性纤维组织细胞瘤裸小鼠移植瘤的建立及实验治疗研究. 实验动物科学与管理. 1996, 1-, https://kns.cnki.net/KCMS/detail/detail.aspx?dbcode=CJFQ&dbname=CJFD9697&filename=SYDG603.017&v=MDczNDZBVTRqaDRPWDZUckgwM2ViQ1VSYktlWnVkcEZDL2tXdz09TmpUUGFiVzRIYy9Ncm9ncUY1NE9mZ2c1emg=.
[465] 张周, 张素胤, 杨秋龙, 丁健. 重度联合免疫缺陷（SCID）小鼠的繁育及其应用研究初报. 实验动物科学与管理. 1996, 1-, https://kns.cnki.net/KCMS/detail/detail.aspx?dbcode=CJFQ&dbname=CJFD9697&filename=SYDG603.040&v=MTM3MjZLZVp1ZHBGQzdrVWc9PU5qVFBhYlc0SGMvTXE0OHFGNTRPZmdnNXpoQVU0amg0T1g2VHJIMDNlYkNVUmI=.
[466] Ai Jing, Tang Qingjuan, Wu Yanlin, Xu Yang, Feng Teng, Zhou Ruiyu, Chen Yi, Gao Xin, Zhu Qingfeng, Yue Xihua, Pan Qiuming, Xu Siyun, Li Jing, Huang Min, Daugherty-Holtrop Jennifer, He Yuanzheng, Xu H. Eric, Fan Jia, Ding Jian, Geng Meiyu. The Role of Polymeric Immunoglobulin Receptor in Inflammation-Induced Tumor Metastasis of Human Hepatocellular Carcinoma. JNCI JOURNAL OF THE NATIONAL CANCER INSTITUTE. 103(22): 1696-1712, https://www.webofscience.com/wos/woscc/full-record/WOS:000297209000011.

（1） 高等药理学，Higher pharmacology，科学出版社，2013-05，第1作者

   

（1） 用于脑部肿瘤治疗的新型纳米药物研究，主持，国家级，2013-01--2016-12
（2） 免疫稳态失衡在炎癌转化的开关机制-免疫负性调控因子SIRPα 在免疫球蛋白受体pIgR 免疫背叛中的，主持，国家级，2013-01--2015-12
（3） 组蛋白甲基转移酶G9a在乳腺癌转移中的作用及机制研究？，主持，国家级，2013-01--2016-12
（4） 化学创新药物研发体系建设，参与，国家级，2012-01--2015-12
（5） 针对分子靶点的抗肿瘤药物发现及其机理研究，主持，国家级，2011-01--2013-12
（6） 基于蛋白质结构与功能的药物多靶标作用机制研究，参与，院级级，2011-01--2013-12
（7） 中国药物技术创新战略联盟，主持，部委级，2010-01--2012-12
（8） 1. 化学创新药物研发体系建设，主持，国家级，2009-06--2010-12
（9） 土槿皮乙酸对新生血管生成和微管抑制作用分子机制的深入研究，主持，国家级，2008-01--2011-12

已指导学生

田芳  博士研究生  100706-药理学  

赵华军   博士研究生  100706-药理学  

刘卫军  博士研究生  100706-药理学  

陈奕  博士研究生  100706-药理学  

张毅翔  博士研究生  100706-药理学  

张超  博士研究生  100706-药理学  

缪泽鸿  博士研究生  100706-药理学  

郭晓宁  博士研究生  100706-药理学  

秦玉新  博士研究生  100706-药理学  

张永炜  博士研究生  100706-药理学  

沈瑛  博士研究生  100706-药理学  

朱虹  博士研究生  100706-药理学  

黄敏  博士研究生  100706-药理学  

高燕  博士研究生  100706-药理学  

钟利  博士研究生  100706-药理学  

张媛媛  博士研究生  071010-生物化学与分子生物学  

李美红  博士研究生  100706-药理学  

蒙凌华  博士研究生  100706-药理学  

钱进  博士研究生  100706-药理学  

谢一利  博士研究生  100706-药理学  

刘伦华  博士研究生  100706-药理学  

袁胜涛  博士研究生  100706-药理学  

童云广  博士研究生  100706-药理学  

杨帆  博士研究生  100706-药理学  

周晋  博士研究生  100706-药理学  

郎靖瑜  博士研究生  100706-药理学  

任萱  博士研究生  100706-药理学  

卢大用  博士研究生  100706-药理学  

胡朝欣  博士研究生  100706-药理学  

张秀华  博士研究生  100706-药理学  

吕华瑞  博士研究生  100706-药理学  

杨帆  硕士研究生  100706-药理学  

朱才华  博士研究生  100706-药理学  

李卫红  博士研究生  100706-药理学  

孙启明  博士研究生  100706-药理学  

代梅  博士研究生  100706-药理学  

桂敏  博士研究生  100706-药理学  

李明  博士研究生  100706-药理学  

张靖  博士研究生  100706-药理学  

张志翔  博士研究生  100706-药理学  

马金贵  博士研究生  100706-药理学  

杨娜  博士研究生  100706-药理学  

陆金健  博士研究生  100706-药理学  

蒋轶  博士研究生  100706-药理学  

王帅  博士研究生  100706-药理学  

李婷  硕士研究生  100706-药理学  

张潇炜  博士研究生  100706-药理学  

于冰  博士研究生  100706-药理学  

高昕  硕士研究生  077906-药理学  

黄洵  博士研究生  100706-药理学  

冯建明  博士研究生  100706-药理学  

周远锋  博士研究生  100706-药理学  

李家鹏  硕士研究生  077906-药理学  

陈思萌  博士研究生  100706-药理学  

温微微  博士研究生  100706-药理学  

何长溪  硕士研究生  077906-药理学  

现指导学生

彭婷  博士研究生  100706-药理学  

刘加利  博士研究生  100706-药理学  

韩昆  硕士研究生  077906-药理学  

刘红艳  博士研究生  100706-药理学  

张大东  博士研究生  100706-药理学  

张洁  博士研究生  100706-药理学  

王薪懿  硕士研究生  078006-药理学  

瞿戎  硕士研究生  078006-药理学  

曾汉林  博士研究生  100706-药理学  

杨艳红  博士研究生  100706-药理学  

谢韶  博士研究生  100706-药理学  

周骥  博士研究生  100706-药理学